Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016407	p-fibr	g/l (g/l)	13564	38135	0.04%
3016407	p-fibr	— (—)	1097	1931	100.00%	Distribution not available
3016407	p-fibr.	g/l (g/l)	707	769	0.00%
3016407	p-fibr	g/l_______ (g/l)	241	325	0.00%
3016407	p-fibrspr	g/l (g/l)	132	138	0.72%
3016407	p-fibr.	— (—)	63	64	100.00%	Distribution not available
3016407	p-fibr	G/L (g/l)	40	74	0.00%
3016407	p-fibrspr	— (—)	38	41	100.00%	Distribution not available
3016407	p-fibr	g/L (g/l)	35	40	0.00%
3016407	p-fibr.	g/l_______ (g/l)	20	22	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Emergency coronary revascularization (for ACS)

2656

6933

2.38

320.30

3.6

2.6

3.48

3.65

g/l

6.31

2572

6649

Heart failure and coronary heart disease

1478

3389

3.20

318.53

3.5

2.3

3.70

3.69

g/l

0.11

1417

3245

Any event in cancer register

2956

7811

2.27

318.11

3.1

2.7

3.57

3.58

g/l

0.03

2859

7441

Secondary hypertension

401

462

9.44

318.00

3.8

2.9

3.64

3.48

g/l

0.84

391

436

All-cause Heart Failure

1934

5119

2.74

317.44

3.3

2.3

3.68

3.61

g/l

1.13

1869

4910

Ischemic heart diseases

2578

6568

2.41

316.94

3.7

2.6

3.50

3.63

g/l

4.20

2495

6301

Nutritional anaemias

1801

6565

2.72

316.11

3.1

2.5

3.54

3.60

g/l

0.94

1716

6259

Other diseases of blood and blood-forming organs, wide

1164

2769

4.61

307.65

3.8

2.7

3.40

3.61

g/l

4.45

1126

2633

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3284

7556

2.63

307.65

3.4

2.3

3.85

3.48

g/l

28.09

3176

7213

Implicit viral Sepsis

981

2312

4.57

307.65

5.2

2.2

3.62

3.51

g/l

1.16

944

2205

All pneumoniae

3791

10260

2.49

307.65

3.5

2.6

3.85

3.46

g/l

37.17

3665

9805

Tramadol

2670

6292

2.64

307.65

3.0

2.4

3.63

3.57

g/l

1.06

2559

6017

L04AA Selective immunosuppressants

1323

2935

5.00

307.65

6.0

2.7

3.37

3.58

g/l

4.78

1287

2807

Oxycodone

1471

3936

3.35

307.65

2.7

2.4

3.86

3.57

g/l

7.68

1429

3762

L04AD Calcineurin inhibitors

1244

1382

11.87

307.65

7.3

2.9

3.25

3.49

g/l

5.02

1214

1325

Coagulation defects, purpura and other haemorrhagic conditions

1691

2451

8.18

307.65

4.1

2.8

3.37

3.57

g/l

5.20

1616

2335

Cerebrovascular diseases (FINNGEN)

1282

1540

6.21

307.65

3.6

2.2

3.58

g/l

0.04

1241

1462

Viral pneumonia

795

1416

6.27

307.65

3.5

3.0

4.48

3.39

g/l

43.07

777

1349

Viral Sepsis

982

2312

4.57

307.65

5.2

2.2

3.62

3.51

g/l

1.15

945

2205

Non-rheumatic valve diseases

1697

3831

3.31

307.65

3.3

2.5

3.36

3.59

g/l

7.03

1645

3687

Implicit viral Sepsis, including avohilmo

1290

3551

3.85

307.65

4.6

2.2

3.64

3.52

g/l

1.59

1243

3395

Heart failure, not strict

3148

6152

3.64

307.65

3.8

2.5

3.64

3.56

g/l

1.70

3050

5899

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3833

9537

2.64

307.65

4.1

2.3

3.48

3.62

g/l

6.72

3695

9113

Bleeding

3148

8166

2.82

307.65

3.4

2.6

3.47

3.62

g/l

5.71

3019

7840

ILD medications

3742

9593

2.16

307.65

4.3

2.2

3.55

3.59

g/l

0.55

3584

9192

Hernia of abdominal wall, postoperative

673

1304

5.42

307.65

2.7

2.0

3.53

3.56

g/l

0.13

649

1252

Caries of dentine

1252

2882

4.55

307.65

4.7

2.5

3.50

3.61

g/l

1.54

1205

2756

Dental caries

1443

3259

4.54

307.65

5.1

2.5

3.46

3.62

g/l

2.82

1391

3122

Valvular operations

835

1289

7.25

307.65

3.3

2.7

3.18

3.55

g/l

7.94

813

1241

Pneumonia, organism unspecified

3196

9453

2.39

307.65

3.4

2.6

3.78

3.45

g/l

22.72

3080

9040

Other septicaemia

1870

4167

4.55

307.65

4.3

2.4

3.76

3.44

g/l

11.24

1789

3996

ILD medications: prednisolone, methylprednisolone, prednisone

3622

9383

2.20

307.65

4.0

2.2

3.58

3.59

g/l

0.25

3470

8994

Other and unspecified anaemias

1791

5022

3.54

307.65

3.3

2.5

3.59

3.60

g/l

0.02

1715

4798

Heart failure and antihypertensive medication

1157

1393

5.82

307.65

4.4

2.5

3.66

3.55

g/l

1.22

1120

1332

Complications of medical and surgical care

2906

9760

2.79

307.65

3.1

2.4

3.56

3.61

g/l

1.01

2786

9338

DVT of lower extremities and pulmonary embolism

1998

5020

4.26

307.65

3.3

2.3

3.70

3.60

g/l

1.84

1916

4793

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1656

2488

4.40

307.65

3.9

2.1

3.47

3.58

g/l

1.73

1594

2355

Liquid cancers, including Hilmo

1866

3351

5.34

307.65

3.8

2.6

3.57

3.59

g/l

0.17

1809

3190

Cardiovascular diseases

2332

3849

3.35

307.65

4.0

2.4

3.48

3.55

g/l

1.22

2231

3653

Malignant neoplasm

2849

6639

2.60

307.65

3.2

2.8

3.59

3.57

g/l

0.37

2763

6324

Persons encountering health services for specific procedures and health care

3861

9742

2.41

307.65

3.4

2.6

3.63

3.55

g/l

2.03

3733

9296

Iron deficiency anaemia

1644

5738

2.94

307.65

3.2

2.5

3.54

3.60

g/l

0.87

1569

5473

ILD medications: immunosuppressive drugs

2671

8595

2.95

307.65

5.3

2.2

3.43

3.57

g/l

4.77

2573

8251

Care involving dialysis

671

848

9.61

307.65

4.9

2.8

3.68

3.45

g/l

2.49

654

814

Implicit bacterial Sepsis

1860

4107

4.13

307.65

4.2

2.1

3.76

3.53

g/l

5.97

1774

3938

Diseases of arteries, arterioles and capillaries

2495

6339

3.02

307.65

3.0

2.4

3.59

3.62

g/l

0.38

2401

6072

Other heart diseases, wide

3040

8276

2.29

307.65

3.7

2.6

3.52

3.57

g/l

0.93

2926

7933

Other coagulation defects

819

837

12.67

307.65

4.9

2.7

3.38

3.62

g/l

3.63

778

794

Fever of other and unknown origin

2487

6556

3.46

307.65

3.9

2.3

3.59

3.58

g/l

0.06

2389

6272

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3467

10488

2.27

307.65

3.5

2.6

3.78

3.49

g/l

19.73

3343

10041

Chronic Coagulation defects

320

277

16.89

307.65

4.7

3.2

3.20

3.56

g/l

3.57

298

263

First line medication for Crohn's disease

3736

9061

2.28

307.65

4.0

2.3

3.56

3.57

g/l

0.20

3577

8680

Liquid cancers

1684

2863

6.14

307.65

3.9

2.6

3.55

3.58

g/l

0.30

1632

2720

Other and unspecified coagulation defects

565

558

13.38

307.65

5.6

2.7

3.43

3.62

g/l

1.69

544

531

Pulmonary heart disease, diseases of pulmonary circulation

1666

3737

4.85

307.65

3.5

2.4

3.72

3.59

g/l

2.53

1605

3558

Other septicaemia, including avohilmo

1906

4261

4.51

307.65

4.2

2.4

3.77

3.45

g/l

11.82

1824

4086

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2102

8212

2.66

307.65

3.0

2.5

3.57

3.60

g/l

0.29

2018

7850

Implicit Sepsis

2952

7554

3.01

307.65

4.0

2.3

3.63

3.54

g/l

2.01

2831

7250

Hypertensive diseases (excluding secondary)

1687

2738

3.73

307.65

4.0

2.2

3.63

3.54

g/l

1.31

1630

2597

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5022

8839

4.08

307.65

3.6

2.3

3.49

3.62

g/l

6.84

4828

8465

Implicit Sepsis, including avohilmo

3065

8211

2.77

307.65

4.0

2.3

3.61

3.54

g/l

1.46

2937

7889

Implicit bacterial Sepsis, including avohilmo

2001

4477

3.94

307.65

4.1

2.1

3.73

3.54

g/l

5.05

1914

4291

GASTRO-related operations

2628

4158

3.28

307.65

3.7

2.0

3.50

3.56

g/l

1.06

2508

3981

Acute myeloid leukaemia and myelodysplastic syndromes

265

165

21.74

307.65

3.5

2.4

3.67

3.57

g/l

0.30

260

154

Coronary revascularization (ANGIO or CABG)

2506

6323

2.49

307.65

3.7

2.6

3.47

3.64

g/l

6.15

2428

6068

Cardiovascular diseases (excluding rheumatic etc)

2534

4316

3.51

307.65

4.2

2.4

3.47

3.53

g/l

1.22

2440

4097

Pneumonias (Asthma/COPD co-morbidities)

3765

10199

2.50

307.65

3.5

2.6

3.85

3.46

g/l

36.96

3641

9745

Complications of surgical and medical care, not elsewhere classified

3916

9932

2.74

307.65

3.1

2.5

3.56

3.62

g/l

1.44

3766

9501

Bacterial infection, other or unspecified

2479

5565

4.00

307.65

3.7

2.3

3.86

3.47

g/l

22.19

2388

5329

Pulmonary heart disease

1521

3424

4.83

307.65

3.4

2.3

3.74

3.60

g/l

2.48

1463

3264

Malignant neoplasm, wide definition

2924

6831

2.58

307.65

3.3

2.8

3.57

g/l

0.01

2832

6504

Explicit Sepsis

2178

5007

4.24

307.65

4.2

2.2

3.77

3.50

g/l

9.34

2085

4788

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3148

8791

2.50

307.65

4.0

2.3

3.56

3.55

g/l

0.14

3018

8429

Malignant neoplasm, including Hilmo

2930

6794

2.60

307.65

3.2

2.8

3.56

3.57

g/l

0.09

2837

6468

Bacterial infection, other or unspecified, including avohilmo

2633

6114

3.74

307.65

3.7

2.4

3.86

3.46

g/l

24.48

2535

5848

Anaemias

1380

1098

8.83

307.65

4.4

2.0

3.39

3.59

g/l

3.13

1325

1046

Malignant neoplasm

2844

6624

2.60

307.65

3.2

2.8

3.59

3.57

g/l

0.25

2758

6308

Atrial fibrillation and flutter

1087

1309

5.64

307.65

3.5

2.1

3.62

3.61

g/l

0.05

1043

1251

Influenza and pneumonia

3895

10147

2.45

307.65

3.5

2.5

3.82

3.46

g/l

31.77

3764

9693

Other bacterial diseases

3952

8698

3.15

307.65

3.7

2.5

3.77

3.48

g/l

20.46

3815

8345

Percutaneous Coronary Intervention

2499

6320

2.48

307.65

3.7

2.6

3.47

3.64

g/l

5.65

2421

6065

Atrial fibrillation and flutter with reimbursement

820

976

5.56

307.65

3.2

2.2

3.66

3.60

g/l

0.44

792

939

Hard cardiovascular diseases

2861

6216

2.82

307.65

3.7

2.6

3.49

3.62

g/l

4.19

2766

5954

Other heart diseases

1892

2956

4.38

307.65

4.3

2.5

3.47

3.51

g/l

0.44

1832

2806

3284

7556

2.63

307.65

3.4

2.3

3.85

3.48

g/l

28.09

3176

7213

Any death

2385

5726

3.06

307.65

3.1

2.5

3.75

3.56

g/l

5.70

2292

5512

Renal tubulo-interstitial diseases

3491

9612

2.77

307.65

3.7

2.4

3.70

3.54

g/l

6.27

3359

9195

Heart failure, strict

2024

5208

2.82

307.65

3.4

2.3

3.68

3.61

g/l

1.09

1949

4997

Other bacterial diseases, including avohilmo

4029

9091

2.88

307.65

3.7

2.5

3.74

3.48

g/l

17.73

3882

8706

Any gastric operation

2628

4158

3.28

307.65

3.7

2.0

3.50

3.56

g/l

1.06

2508

3981

Acute renal failure

1254

2475

5.59

307.65

4.7

2.3

3.66

3.58

g/l

0.89

1207

2361

Other anaemias

1806

5054

3.54

307.65

3.3

2.5

3.60

g/l

0.01

1730

4828

All kidney diseases

3737

10079

2.58

307.65

3.6

2.5

3.71

3.53

g/l

8.12

3595

9638

Aplastic and other anaemias

2028

5364

3.67

307.65

3.3

2.5

3.59

g/l

0.00

1942

5128

Dialysis, with operation codes

1385

1428

12.59

307.65

5.7

2.7

3.45

3.53

g/l

0.81

1350

1366

Valvular heart disease excluding rheumatic fever

1765

3888

3.40

307.65

3.4

2.6

3.35

3.58

g/l

7.15

1712

3743

Pulmonary embolism

1521

3391

4.88

307.65

3.4

2.3

3.74

3.60

g/l

2.55

1463

3230

Covid-19 confirmed case

2010

4959

4.39

307.65

3.6

2.5

4.13

3.51

g/l

44.61

1960

4710

Venous thromboembolism

2447

6615

3.79

307.65

3.2

2.3

3.66

3.61

g/l

0.96

2353

6315

Complications of procedures, not elsewhere classified

3194

9523

2.82

307.65

2.8

2.5

3.54

3.62

g/l

2.09

3062

9111

Transplanted organ and tissue status

1291

1084

16.63

307.65

7.4

2.5

3.24

3.55

g/l

6.72

1261

1037

Condition for Implicit Sepsis (Organ dysfunction codes)

3084

8331

2.66

307.65

4.0

2.3

3.58

3.55

g/l

0.52

2958

7996

Bacterial Sepsis

2119

4698

3.96

307.65

4.1

2.2

3.78

3.53

g/l

7.97

2020

4506

Codes for special purposes

2442

7896

3.24

307.65

3.4

2.5

4.05

3.49

g/l

46.86

2370

7523

Primary_lymphoid and hematopoietic malignant neoplasms

1232

2896

4.65

307.65

4.3

2.5

3.65

3.58

g/l

0.62

1198

2770

Provisional assignment of new diseases of uncertain etiology

2439

7891

3.24

307.65

3.4

2.5

4.05

3.49

g/l

46.93

2369

7516

Nephropathy related operations

1327

1488

11.60

307.65

5.8

2.9

3.43

3.53

g/l

1.01

1294

1425

Chronic kidney disease

1503

3503

4.44

307.65

4.3

2.4

3.70

3.57

g/l

2.19

1450

3346

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2389

8496

2.88

307.65

3.1

2.4

3.56

3.61

g/l

0.97

2294

8120

Extracorporeal dialysis

497

723

8.39

307.65

5.4

2.9

3.67

3.57

g/l

0.55

483

692

Other medical care

1824

5222

3.07

307.65

2.9

2.4

3.75

3.55

g/l

5.26

1772

4980

Kidney transplant status

538

688

10.15

307.65

5.0

3.7

3.44

3.49

g/l

0.24

524

662

Septicaemia

2084

4607

4.42

307.65

4.2

2.4

3.78

3.44

g/l

14.42

1995

4419

Viral pneumonia (unknown virus, not influenza)

571

808

8.49

307.65

3.2

2.9

4.78

3.48

g/l

41.72

566

771

Renal failure

2323

5064

4.19

307.65

4.3

2.4

3.72

3.57

g/l

3.69

2237

4842

Heart failure,strict

1924

4222

3.34

307.65

3.5

2.3

3.67

3.57

g/l

1.80

1853

4046

STROKE

1893

3980

3.34

307.65

3.2

2.4

3.54

3.66

g/l

2.47

1820

3810

Purpura and other haemorrhagic conditions

916

1626

6.44

307.65

3.5

3.0

3.35

3.54

g/l

2.94

880

1548

General symptoms and signs

3414

7695

2.28

307.65

3.2

2.3

3.56

3.61

g/l

0.78

3273

7367

Explicit Sepsis, including avohilmo

2226

5099

4.24

307.65

4.1

2.2

3.78

3.50

g/l

10.32

2131

4873

Thrombocytopenia, unspecified

548

795

8.17

307.65

3.5

2.6

3.33

3.61

g/l

3.37

527

756

All chronic kidney diseases

2343

5753

3.42

307.65

3.7

2.5

3.76

3.48

g/l

11.75

2263

5508

Diseases of arteries, arterioles and capillaries (FINNGEN)

1220

1023

8.97

307.65

3.3

2.1

3.53

3.60

g/l

0.54

1176

979

Diseases of liver

1362

4603

3.12

306.54

3.7

2.5

3.20

3.65

g/l

19.48

1312

4406

Major coronary heart disease event

2583

6727

2.37

306.02

3.7

2.6

3.49

3.64

g/l

4.74

2498

6456

Other diseases of the digestive system

1250

4037

3.26

303.96

3.6

2.7

3.28

3.62

g/l

11.67

1189

3860

GI-bleeding

1246

4036

3.25

301.31

3.6

2.7

3.30

3.62

g/l

10.29

1185

3855

Ulcer of lower limb, not elsewhere classified

725

1637

4.84

300.22

3.4

2.3

4.03

3.60

g/l

7.77

692

1566

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

746

1804

4.54

283.48

4.0

2.7

2.92

3.67

g/l

30.37

723

1737

Cerebrovascular diseases

2307

7042

2.34

277.42

3.0

2.5

3.60

3.61

g/l

0.11

2228

6746

Solid cancers, including Hilmo

2532

6623

2.29

277.08

2.6

2.7

3.61

3.58

g/l

0.45

2450

6302

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2997

9193

2.11

276.37

3.3

2.4

3.54

3.63

g/l

2.24

2881

8804

Haemorrhage from respiratory passages

1264

3789

3.08

273.91

3.5

2.4

3.51

3.63

g/l

1.74

1208

3651

Glomerular diseases

845

2292

3.99

272.95

3.5

2.8

3.90

3.56

g/l

6.74

818

2192

Malignant neoplasm of digestive organs, including Hilmo

1345

3381

3.04

272.26

2.5

3.53

3.60

g/l

0.81

1301

3221

Ascites

470

797

6.70

271.30

3.3

2.4

3.29

3.69

g/l

4.61

459

765

Solid cancers

2439

6389

2.30

270.25

2.6

2.7

3.64

3.58

g/l

0.99

2362

6081

Myeloid leukaemia

282

275

13.65

265.78

4.1

2.9

3.70

3.63

g/l

0.24

274

264

Infections, IBD-co-morbidities

722

1142

4.74

263.89

4.3

2.4

3.46

3.53

g/l

0.43

692

1095

Glomerular disorders in diseases classified elsewhere

629

1417

4.92

262.58

3.5

2.6

3.88

3.56

g/l

4.66

610

1353

Diseases of the digestive system

1608

6363

2.61

261.36

3.4

2.6

3.35

3.60

g/l

8.67

1533

6090

Presence of cardiac and vascular implants and grafts

1468

3982

2.82

259.72

3.6

2.2

3.46

3.70

g/l

6.48

1414

3812

Metabolic disorders

2893

8510

2.09

256.18

3.2

2.7

3.64

3.56

g/l

1.93

2785

8149

Congenital malformations of the circulatory system

777

2045

4.04

250.65

4.8

3.8

3.09

3.44

g/l

10.30

759

1962

Oesophageal varices

327

413

9.63

250.39

4.9

2.8

2.61

3.65

g/l

22.17

321

393

Cardiac arrhythmias

1774

4613

2.54

248.95

3.7

2.5

3.52

3.55

g/l

0.35

1697

4397

Other embolism and thrombosis

601

1356

4.82

248.77

4.2

2.6

3.57

3.64

g/l

0.46

585

1288

Opioids

2880

7315

2.08

242.67

2.9

2.4

3.64

3.58

g/l

1.28

2753

6986

malignant neoplasm of female genital organs, including Hilmo

617

1357

4.61

242.62

1.8

2.4

3.86

3.62

g/l

2.89

600

1277

Erysipelas, including avohilmo

2073

6931

2.27

237.87

2.7

2.3

3.80

3.51

g/l

12.46

1979

6646

Certain infectious and parasitic diseases

2814

6903

2.09

237.69

3.5

2.3

3.64

3.51

g/l

3.72

2692

6616

Oedema, not elsewhere classified

1107

3738

3.01

236.54

2.8

2.2

3.65

3.61

g/l

0.29

1067

3561

Phlebitis and thrombophlebitis (not including DVT)

867

2617

3.51

236.20

3.1

2.4

3.53

3.64

g/l

1.39

833

2499

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3340

9362

1.94

233.57

3.1

2.6

3.58

3.57

g/l

0.14

3216

8949

Preparatory care for dialysis

337

480

8.53

232.97

4.1

2.8

3.85

3.66

g/l

1.00

329

461

Other and unspecified iron deficiency

1230

4556

2.82

231.92

2.9

2.6

3.55

3.61

g/l

0.84

1173

4350

Myeloproliferative diseases

459

882

5.85

231.72

2.8

2.3

3.32

3.60

g/l

3.99

438

841

Examination and observation for other reasons

1948

4747

2.38

231.19

3.5

2.3

3.48

3.69

g/l

7.25

1876

4551

Malaise and fatigue

1639

5363

2.48

230.57

2.9

2.2

3.55

3.60

g/l

0.70

1573

5130

Malignant neoplasm of digestive organs

1177

3174

2.94

228.06

2.5

3.53

3.62

g/l

0.98

1143

3023

Stroke, including SAH

1899

6068

2.32

224.32

2.9

2.4

3.62

g/l

0.03

1834

5816

Neoplasms

2360

5838

2.17

222.80

3.6

2.8

3.48

3.58

g/l

2.02

2260

5556

Erysipelas

1603

5834

2.44

222.22

2.6

2.3

3.86

3.49

g/l

15.55

1530

5592

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

834

2488

3.51

221.22

4.9

3.6

3.22

3.46

g/l

4.82

810

2389

Iron deficiency anaemia secondary to blood loss (chronic)

669

1787

4.00

219.93

4.0

2.5

3.45

3.62

g/l

1.90

637

1709

Peripheral artery disease

1309

3952

2.71

219.92

2.8

2.2

3.86

3.62

g/l

5.09

1249

3786

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

803

2347

3.58

219.66

5.0

3.6

3.20

3.45

g/l

5.10

780

2256

Stroke, excluding SAH

1803

5740

2.34

218.08

2.9

2.4

3.63

3.61

g/l

0.17

1745

5507

Hypertensive diseases

2261

6022

2.17

217.12

3.7

2.6

3.67

3.50

g/l

5.20

2180

5749

L01XX Other antineoplastic agents

365

606

6.96

216.25

3.2

2.3

3.38

3.62

g/l

2.32

350

576

649

1720

4.05

216.12

4.5

2.4

3.58

3.57

g/l

0.09

624

1631

Any reimbursement code in KELA

1716

3547

2.49

216.11

3.5

2.1

3.52

3.54

g/l

0.13

1636

3375

Dialysis

310

437

8.58

216.10

4.7

3.7

3.73

3.40

g/l

2.33

305

419

Aortic aneurysm

814

2451

3.43

214.10

2.6

2.3

3.31

3.60

g/l

5.40

783

2355

Hypertension

2247

6011

2.16

213.31

3.7

2.6

3.67

3.50

g/l

5.23

2166

5739

DVT of lower extremities

713

2056

3.68

208.74

3.2

2.3

3.59

3.66

g/l

0.58

681

1955

Persons encountering health services in other circumstances, wide

3339

9374

1.87

208.25

3.3

2.6

3.59

3.57

g/l

0.24

3204

8961

Dyspnoea

2750

10467

1.94

207.16

3.0

2.6

3.67

3.57

g/l

2.85

2621

10035

Myeloproliferative diseases (CML excluded)

410

791

5.82

206.09

2.8

2.3

3.28

3.61

g/l

5.02

391

754

Postpartum haemorrhage

983

2790

3.06

204.84

1.7

2.6

3.59

3.58

g/l

0.04

926

2664

Cardiomyopathy

626

1678

3.95

203.73

5.0

2.5

3.60

3.58

g/l

0.12

598

1613

malignant neoplasm of female genital organs

523

1202

4.52

202.64

1.7

2.4

3.87

3.62

g/l

2.78

508

1129

Fibrosis and cirrhosis of liver

430

883

5.46

201.36

4.1

2.5

2.86

3.65

g/l

20.50

424

847

Atherosclerosis, excluding cerebral and coronary sclerosis

1208

3646

2.70

200.60

2.8

2.2

3.84

3.63

g/l

3.83

1152

3494

Inflammatory bowel disease treatment related agents

3395

10549

1.82

199.12

3.7

2.4

3.61

3.57

g/l

0.56

3239

10122

Intestinal stricture

1056

3924

2.81

198.93

3.0

2.5

3.56

3.61

g/l

0.40

1031

3742

Non-ischemic cardiomyopathy

999

2773

2.98

198.87

3.4

2.3

3.61

g/l

0.05

964

2649

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

202

182

13.56

198.13

1.7

2.1

3.80

3.48

g/l

1.70

202

173

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

477

677

5.29

196.46

3.5

2.3

3.84

3.49

g/l

3.80

468

651

Continuous positive airway pressure

593

1270

4.07

193.28

3.6

3.1

3.89

3.45

g/l

6.60

565

1218

ILD medications: azathioprine

624

1740

3.83

192.77

6.0

2.3

3.39

3.51

g/l

1.13

598

1663

Oral corticosteroids

3108

10105

1.84

190.89

3.1

2.4

3.67

3.59

g/l

2.23

2958

9699

Endocarditis

240

287

9.75

190.56

4.4

2.7

3.84

3.66

g/l

0.64

230

275

Explicit bacterial Sepsis, including avohilmo

474

1098

4.65

189.30

4.1

2.3

3.88

3.48

g/l

4.42

454

1048

Postpartum hemorraghe, all women as controls

983

3519

2.86

189.27

1.7

2.7

3.59

3.64

g/l

0.60

926

3343

Other disorders of fluid, electrolyte and acid-base balance

1003

3480

2.82

188.96

3.1

2.5

3.60

3.56

g/l

0.32

958

3328

Other diseases of pleura

1402

5227

2.41

188.84

3.6

2.5

3.72

3.58

g/l

2.36

1353

5008

Hypertension, essential

2089

5714

2.11

188.51

2.9

2.4

3.74

3.52

g/l

7.43

2014

5456

Adjustment and management of implanted device

636

1824

3.68

187.44

3.9

2.4

3.67

3.55

g/l

1.09

617

1744

Malignant neoplasm of ovary, including Hilmo

301

471

7.10

187.13

1.7

2.3

3.75

3.54

g/l

1.34

293

441

Peripheral arterial reconstruction

629

1821

3.67

183.26

2.9

2.2

3.81

3.63

g/l

1.65

604

1733

Paroxysmal tachycardia

640

1505

3.67

181.37

4.5

2.4

3.51

3.52

g/l

0.00

617

1425

Acute tubulo-interstitial nephritis

1862

7661

2.11

181.16

3.1

2.4

3.75

3.54

g/l

6.79

1777

7312

COPD/asthma related infections

2794

7556

1.89

179.34

3.1

2.3

3.73

3.48

g/l

13.37

2679

7213

COPD/asthma/ILD related infections

2794

7556

1.89

179.34

3.1

2.3

3.73

3.48

g/l

13.37

2679

7213

Abnormalities of breathing

2613

7989

1.91

179.06

3.1

2.6

3.64

3.59

g/l

1.01

2490

7683

Non-Hodgkin lymphoma, all, including Hilmo

482

1185

4.34

177.65

3.3

2.3

3.64

3.57

g/l

0.37

468

1121

Asthma, excluding more controls

1964

4829

2.13

176.93

2.8

2.2

3.67

3.45

g/l

7.34

1869

4615

Explicit bacterial Sepsis

453

1068

4.56

176.80

4.2

2.3

3.85

3.49

g/l

3.59

433

1018

ILD, hospital admission 2, with pulmonary infections

409

891

4.95

176.49

3.5

2.4

3.91

3.42

g/l

7.04

398

847

Bacterial pneumoniae

1224

4504

2.46

173.69

3.6

2.4

3.90

3.44

g/l

15.69

1172

4297

Streptococcal septicaemia, including avohilmo

416

934

4.83

173.38

4.2

2.5

3.89

3.41

g/l

5.26

400

898

Sequelae of external causes of morbidity and mortality

911

3375

2.83

173.08

3.1

2.6

3.60

g/l

0.01

883

3223

Congenital malformations of heart and great arteries

625

1823

3.60

172.11

5.0

4.0

3.13

3.41

g/l

5.27

609

1749

Arterial embolism and thrombosis

289

472

6.77

172.08

4.0

2.1

3.48

3.57

g/l

0.38

278

450

Postpartum hemorraghe, parous women as controls

983

3127

2.76

170.74

1.7

2.5

3.59

3.69

g/l

1.76

926

2977

Nausea and vomiting

954

3542

2.73

170.09

4.4

2.7

3.50

3.55

g/l

0.47

922

3379

Peripheral artery operations in Hilmo

475

1193

4.23

169.77

2.7

2.2

3.94

3.60

g/l

3.69

457

1137

Unspecified kidney failure

433

1021

4.56

169.09

3.2

2.2

3.86

3.57

g/l

2.63

414

972

Haemorrhage, not elsewhere classified

244

344

8.12

168.19

5.3

2.1

3.69

3.66

g/l

0.09

231

333

Bacterial pneumonia, not elsewhere classified

1156

4207

2.49

168.17

3.4

2.4

3.89

3.44

g/l

14.85

1106

4008

Heart failure and bmi 25plus

1059

2727

2.69

167.44

3.1

2.3

3.78

3.71

g/l

0.68

1014

2624

Azathioprine

624

1919

3.46

165.78

6.0

2.7

3.39

3.50

g/l

0.99

598

1844

Need for other prophylactic measures

349

713

5.55

165.15

4.1

3.5

3.94

3.46

g/l

5.47

340

685

Asthma, unspecified (mode), excluding more controls

1413

4515

2.29

164.94

2.7

2.2

3.73

3.45

g/l

9.22

1351

4313

Invasive ventilation

389

874

4.94

163.33

3.7

3.4

3.44

3.49

g/l

0.20

377

839

Agranulocytosis

488

1303

4.05

161.55

4.1

2.8

3.45

3.57

g/l

0.87

471

1242

Antihypertensive medication - note that there are other indications

1862

4746

2.10

161.45

4.1

2.4

3.56

3.51

g/l

0.68

1783

4525

Artificial opening status

309

577

6.04

161.30

4.0

2.7

3.79

3.55

g/l

1.31

300

549

Intestinal infectious diseases

2796

11931

1.78

161.08

3.6

2.6

3.56

3.59

g/l

0.48

2675

11428

Streptococcal septicaemia

398

915

4.71

160.97

4.3

2.5

3.85

3.40

g/l

4.59

382

879

Left ventricular outflow tract obstruction (LVOTO), broad definition

497

1365

3.98

158.75

4.6

3.4

3.27

3.50

g/l

2.67

481

1310

Essential (haemorrhagic) thrombocythaemia

226

313

8.32

158.50

2.6

2.1

3.29

3.52

g/l

1.49

216

292

Cardiomyopathies, Primary/intrinsic

440

1101

4.25

158.28

5.7

2.5

3.68

3.63

g/l

0.23

423

1061

Paralytic ileus and intestinal obstruction

824

3029

2.83

157.89

2.8

2.5

3.62

g/l

0.01

804

2900

Care involving use of rehabilitation procedures

1764

8020

2.02

156.80

3.5

2.6

3.54

3.53

g/l

0.08

1681

7669

Gout, FINNGEN

932

3639

2.65

156.58

2.6

2.3

3.89

3.60

g/l

6.02

892

3494

Pain, not elsewhere classified

904

3499

2.68

156.51

3.3

2.2

3.67

3.59

g/l

0.77

868

3335

Ischaemic Stroke, excluding all haemorrhages

1558

5479

2.15

155.64

2.8

2.4

3.67

3.61

g/l

0.74

1498

5262

Other disorders of skin and subcutaneous tissue

2098

9496

1.91

155.05

3.2

2.5

3.68

3.58

g/l

2.18

1994

9107

Cardiomyopathy (excluding other)

448

1153

4.13

154.98

5.6

2.6

3.68

3.61

g/l

0.34

430

1115

Codeine

2442

7197

1.87

154.90

2.7

2.4

3.68

3.58

g/l

2.34

2328

6873

Asthma

2027

5332

2.00

154.81

2.7

2.3

3.66

3.46

g/l

6.75

1930

5101

Coronary atherosclerosis

1636

4967

2.13

154.27

3.0

2.3

3.63

3.70

g/l

0.94

1593

4758

Disorders of lipoprotein metabolism and other lipidaemias

2155

6945

1.92

153.68

2.6

2.5

3.74

3.59

g/l

4.33

2076

6661

Diarrhoea and gastroenteritis of presumed infectious origin

2136

10354

1.88

153.26

3.8

2.6

3.54

3.58

g/l

0.65

2046

9896

Exposure to unspecified factor

2973

11919

1.73

153.09

2.7

2.8

3.60

3.58

g/l

0.26

2842

11419

Congenital malformations, deformations and chromosomal abnormalities

1830

9026

1.97

151.65

3.3

2.7

3.38

3.60

g/l

8.41

1763

8617

Hepatic failure, not elsewhere classified

246

396

7.23

150.64

6.0

2.5

2.66

3.67

g/l

16.38

238

377

Gout

932

3158

2.64

150.37

2.6

2.4

3.89

3.58

g/l

6.24

892

3034

Sequelae with surgical and medical care as external cause

730

2596

2.96

150.32

3.0

2.5

3.61

g/l

0.03

709

2472

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1977

9616

1.92

150.32

3.3

2.7

3.42

3.60

g/l

6.70

1899

9196

Other diseases of blood and blood-forming organs

350

775

5.00

149.48

3.0

2.4

3.28

3.63

g/l

4.73

339

736

Other respiratory diseases principally affecting the interstitium

631

2083

3.19

148.41

3.6

2.3

3.86

3.60

g/l

3.34

617

1983

Bacterial pneumonia (organism specified)

1321

5569

2.21

147.28

3.6

2.5

3.88

3.55

g/l

9.85

1266

5312

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1099

2890

2.49

146.13

2.6

2.4

3.81

3.51

g/l

9.26

1037

2739

All influenza

829

3184

2.70

145.94

3.9

2.7

3.54

3.42

g/l

1.40

794

3041

Asthma (only as main-diagnosis), excluding more controls

1753

4829

2.05

145.40

2.7

2.2

3.65

3.45

g/l

5.83

1664

4615

ILD, hospital admissions 3, with pneumonia sepsis

349

784

4.80

145.17

3.6

2.4

3.94

3.44

g/l

6.13

339

746

Asthma, unspecified (mode)

1450

4989

2.14

144.44

2.6

2.3

3.73

3.46

g/l

9.06

1387

4770

Fungal Sepsis

238

388

6.93

142.93

5.3

2.1

3.60

3.55

g/l

0.16

231

367

Other pulmonary diagnosis

2044

5375

1.94

142.78

3.1

2.3

3.64

3.46

g/l

5.69

1964

5142

Calcific aortic valvular stenosis, operated

867

3306

2.62

142.14

2.7

2.4

3.43

3.68

g/l

5.30

832

3156

Calcific aortic valvular stenosis

867

3306

2.62

142.14

2.7

2.4

3.43

3.68

g/l

5.30

832

3156

Thoracic aortic aneurysm

521

1577

3.51

141.91

2.8

2.4

3.36

3.60

g/l

2.83

504

1514

Other obstetric conditions, not elsewhere classified

1104

2957

2.44

141.66

2.5

2.4

3.80

3.51

g/l

8.96

1043

2804

Cytomegalovirus infection, IBD co-morbidity

197

271

9.06

141.29

5.0

3.5

3.13

3.65

g/l

3.34

191

263

Colorectal cancer, including Hilmo

722

2429

2.87

140.95

2.0

2.4

3.73

3.63

g/l

0.82

701

2306

Pure hypercholesterolaemia

1938

6512

1.93

140.40

2.4

2.5

3.72

3.60

g/l

2.75

1869

6252

Cytomegaloviral disease

198

276

8.86

140.13

5.0

3.3

3.13

3.65

g/l

3.43

192

269

Asthma (mode)

1955

5377

1.95

139.27

2.7

2.3

3.66

3.46

g/l

6.48

1853

5145

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

686

2367

2.92

139.02

1.9

2.4

3.81

3.63

g/l

2.09

670

2249

Calcific aortic valvular stenosis, including rheumatic fever

860

3298

2.60

138.94

2.2

2.3

3.44

3.68

g/l

5.01

825

3148

Cytomegaloviral disease, including avohilmo

198

279

8.73

138.70

5.0

3.3

3.13

3.65

g/l

3.41

192

271

Pain in limb

2496

9128

1.77

138.33

3.2

2.7

3.59

3.58

g/l

0.17

2393

8756

Calcific aortic valvular stenosis, diagnosis (helper)

856

3290

2.60

138.00

2.2

2.3

3.43

3.68

g/l

5.19

821

3140

Operations 2 for CAVS

856

3290

2.60

138.00

2.2

2.3

3.43

3.68

g/l

5.19

821

3140

Excluding asthma or asthma-COPD overlap

2026

5375

1.92

137.90

3.1

2.3

3.64

3.46

g/l

5.63

1948

5142

Bronchitis

3042

11059

1.68

137.40

3.1

2.4

3.62

3.60

g/l

0.45

2907

10583

Hypothyroidism (congenital or acquired)

637

1109

3.30

137.32

3.5

1.9

3.61

3.63

g/l

0.12

601

1053

COPD differential diagnosis

2024

5377

1.92

137.26

3.1

2.3

3.64

3.46

g/l

5.22

1944

5145

Myocardial infarction

1252

4015

2.24

136.74

2.9

2.2

3.61

3.70

g/l

1.26

1210

3847

ILD differential diagnosis

2022

5377

1.92

136.69

3.1

2.3

3.64

3.46

g/l

5.25

1942

5145

Asthma-related pneumonia

1117

5041

2.28

136.21

3.0

2.9

3.84

3.54

g/l

7.34

1072

4808

Asthma-related pneumonia or sepsis

1119

5054

2.28

136.18

3.0

2.9

3.83

3.54

g/l

7.23

1074

4821

Asthma, hospital admissions 3, pneumonia

1119

5054

2.28

136.18

3.0

2.9

3.83

3.54

g/l

7.23

1074

4821

Amputation

398

1041

4.09

135.07

2.7

2.3

4.08

3.54

g/l

6.79

381

998

Parasetamol

1984

5322

1.92

134.56

2.9

2.7

3.60

3.52

g/l

1.63

1885

5103

Idiopathic thrombocytopenic purpura

208

318

7.70

134.13

2.9

3.1

3.27

3.64

g/l

2.41

200

309

Misadventures to patients during surgical and medical care

531

1685

3.33

133.80

3.1

2.4

3.53

3.59

g/l

0.33

505

1601

Implicit fungal Sepsis, including avohilmo

312

691

4.90

132.43

4.7

2.2

3.58

3.51

g/l

0.27

300

651

Headache

1753

7177

1.92

131.74

3.1

2.3

3.49

3.61

g/l

2.94

1667

6867

Infections of the skin and subcutaneous tissue

1800

9635

1.88

130.90

3.3

2.8

3.66

3.54

g/l

2.66

1724

9241

Symptoms and signs involving the circulatory and respiratory systems

2711

8003

1.73

130.52

3.2

2.6

3.57

3.59

g/l

0.20

2580

7697

Procreative management

1060

3879

2.33

130.43

3.8

3.4

3.49

3.46

g/l

0.22

1026

3728

Cardiac arrest

214

267

7.20

130.33

4.2

2.4

3.46

3.52

g/l

0.14

205

253

Aortic valve malfunction, age under 60 years

428

1227

3.79

128.12

3.9

3.2

3.29

3.55

g/l

2.76

413

1180

Hypothyroidism, levothyroxine purchases

617

1105

3.21

127.59

3.4

1.9

3.59

3.63

g/l

0.28

582

1050

Hypothyroidism and >3 levothyroxin purchases

617

1105

3.21

127.59

3.4

1.9

3.59

3.63

g/l

0.28

582

1050

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

426

1223

3.76

126.87

4.1

2.6

3.45

3.59

g/l

0.91

409

1162

Depression medications

685

1151

3.06

126.66

2.6

1.9

3.59

3.63

g/l

0.21

654

1093

Implicit fungal Sepsis

214

357

6.75

125.59

5.3

2.1

3.59

g/l

0.00

207

339

Coronary artery bypass grafting

725

2011

2.77

125.40

2.3

2.1

3.45

3.73

g/l

4.19

707

1916

Other soft tissue disorders, not elsewhere classified

2714

9289

1.69

124.87

3.2

2.7

3.59

3.58

g/l

0.23

2605

8907

Major coronary heart disease event excluding revascularizations

1460

4831

2.04

124.84

3.0

2.3

3.64

3.71

g/l

0.81

1408

4628

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1805

8622

1.86

124.61

2.8

2.6

3.71

3.59

g/l

2.83

1737

8252

Multiple myeloma, including Hilmo

205

329

6.89

124.41

3.4

2.2

3.70

3.54

g/l

0.69

200

311

Ischaemic heart disease, wide definition

1931

6526

1.86

124.25

3.0

2.5

3.61

3.65

g/l

0.53

1877

6263

Asthma (only as main-diagnosis)

1793

5332

1.91

123.89

2.6

2.3

3.65

3.46

g/l

5.69

1702

5101

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

257

511

5.43

123.67

4.4

2.2

3.04

3.52

g/l

4.04

250

485

Malignant neoplasm of ovary

209

344

6.69

123.59

1.8

2.2

3.79

3.55

g/l

1.21

201

323

Disorders of gallbladder, biliary tract and pancreas

2646

9930

1.69

122.96

3.1

2.5

3.63

3.59

g/l

0.69

2547

9495

Cardiomyopathy, other and unspecified

300

682

4.73

122.91

4.9

2.4

3.45

3.57

g/l

0.64

286

656

Sequelae of cerebrovascular disease

981

3704

2.33

122.85

2.8

2.3

3.71

3.62

g/l

1.14

942

3535

Other CVD (FINNGEN)

310

509

4.85

122.51

2.7

1.9

3.68

3.60

g/l

0.35

297

480

Other or unspecified ileus, impaction or obstruction

589

2080

2.95

122.20

2.9

2.5

3.67

3.62

g/l

0.30

575

1983

Autoimmune diseases excluding thyroid diseases

2918

9754

1.65

120.58

3.0

2.7

3.61

3.57

g/l

0.68

2785

9375

Other diseases of pericardium

217

382

6.28

120.02

3.7

2.5

3.63

3.60

g/l

0.10

211

369

Malignant neoplasm of other and unspecified female genital organs

117

14.46

119.48

1.5

1.7

3.91

3.53

g/l

1.30

117

Medical observation and evaluation for suspected diseases and conditions

1752

4763

1.92

118.55

3.3

2.3

3.49

3.69

g/l

6.07

1694

4566

Malignant neoplasm of colon, including Hilmo

506

1662

3.15

118.29

2.0

2.3

3.72

3.63

g/l

0.59

490

1575

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

212

369

6.27

118.24

4.8

2.3

2.90

3.49

g/l

4.89

206

350

Polycythaemia vera

175

252

7.84

118.13

3.0

2.2

3.17

3.47

g/l

1.81

167

234

Gout, idiopatic and unspecified

763

3124

2.54

118.08

2.6

2.3

3.95

3.59

g/l

6.88

726

2998

Autoimmune diseases excluding thyroid diseases, strict definition

2834

9494

1.65

117.87

3.0

2.7

3.63

3.57

g/l

1.02

2706

9125

Alcoholic liver disease

401

1160

3.71

117.80

3.1

2.6

2.86

3.71

g/l

21.91

380

1115

Colorectal cancer

624

2210

2.80

117.51

2.0

2.3

3.69

3.64

g/l

0.34

609

2102

Other interstitial pulmonary diseases

521

1764

3.11

117.43

3.4

2.3

3.83

3.63

g/l

2.10

508

1675

Interstitial lung disease endpoints

521

1766

3.11

117.20

3.4

2.3

3.83

3.63

g/l

2.11

508

1677

Interstitial lung disease

521

1766

3.11

117.20

3.4

2.3

3.83

3.63

g/l

2.11

508

1677

Gout, unspecified

648

2466

2.75

116.93

2.6

2.3

3.97

3.60

g/l

6.36

614

2363

Cardiodefibrillation

991

4547

2.25

116.53

3.5

2.3

3.59

3.63

g/l

0.31

955

4362

Certain infectious and parasitic diseases, including avohilmo

1801

4865

1.89

116.15

3.1

2.3

3.63

3.49

g/l

3.13

1715

4676

ILD, hospital admissions

514

1740

3.11

115.93

3.4

2.3

3.81

3.63

g/l

1.89

502

1651

Pain in throat and chest

2226

7687

1.74

115.50

3.0

2.6

3.53

3.60

g/l

1.15

2131

7389

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

520

1769

3.06

115.47

2.1

2.4

3.67

3.64

g/l

0.19

507

1683

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

904

1863

2.48

114.80

3.3

2.1

3.49

3.64

g/l

2.02

863

1782

Pacemaker

988

4231

2.24

113.96

3.9

2.3

3.56

3.63

g/l

0.67

942

4046

Haemolytic anaemias

213

391

6.25

113.91

6.2

2.9

3.19

3.58

g/l

3.05

208

372

Intestinal infectious diseases, including avohilmo, including avohilmo

3101

10984

1.60

113.54

3.3

2.5

3.59

g/l

0.02

2968

10527

Symptoms and signs involving the digestive system and abdomen

2619

7968

1.67

112.85

3.4

2.6

3.49

3.61

g/l

3.46

2506

7645

Disorders resulting from impaired renal tubular function

220

420

6.01

112.83

3.5

3.0

3.71

3.56

g/l

0.51

212

403

ILD, hospital admissions 1, main diag only

472

1552

3.22

112.18

3.5

2.3

3.81

3.60

g/l

2.14

464

1475

Gastroduodenal ulcer

740

3051

2.50

111.46

2.9

2.3

3.47

3.64

g/l

2.00

717

2915

Postpartum haemorrhage due to retained placenta

521

1825

3.03

111.05

1.7

2.3

3.52

3.74

g/l

4.25

492

1731

Nontraumatic intracranial haemmorrhage

585

2165

2.81

111.02

2.9

2.4

3.62

3.61

g/l

0.10

566

2060

Intracerebral haemorrhage

418

1284

3.42

110.78

3.0

2.3

3.59

g/l

0.01

410

1227

Acute peritonitis

294

719

4.47

110.39

3.1

2.6

3.64

g/l

0.00

287

682

Endocrine, nutritional and metabolic diseases

2131

6218

1.76

110.06

3.4

2.7

3.58

3.48

g/l

2.27

2031

5947

Colectomy operation

558

2033

2.88

109.91

2.8

2.5

3.64

3.59

g/l

0.28

541

1940

Persons encountering health services for specific procedures, not carried out

354

986

3.83

109.89

3.2

2.8

3.75

3.46

g/l

2.70

343

947

Asthma-related infections

1705

9382

1.81

109.53

3.0

2.9

3.73

3.53

g/l

5.68

1629

8972

Asthma, hospital admission 2, infections

1705

9382

1.81

109.53

3.0

2.9

3.73

3.53

g/l

5.68

1629

8972

Left ventricular outflow tract obstruction, narrow definition

290

713

4.58

109.30

5.7

4.2

3.10

3.41

g/l

3.01

284

685

2959

9491

1.60

108.36

2.9

2.4

3.62

3.58

g/l

0.81

2829

9076

Convulsions, not elsewhere classified

706

2864

2.51

107.69

3.5

2.4

3.41

3.56

g/l

1.90

686

2736

Non-Hodgkin lymphoma, all

188

319

6.44

107.68

3.1

2.3

3.69

3.49

g/l

0.75

182

303

Diseases of oesophagus, stomach and duodenum

2822

10533

1.61

107.40

2.9

2.7

3.54

3.61

g/l

1.49

2695

10105

Other diseases of intestines

2861

10096

1.60

106.64

3.1

2.8

3.54

3.58

g/l

0.60

2752

9656

Acute upper respiratory infections of multiple and unspecified sites

2145

9353

1.70

106.55

3.4

2.5

3.58

3.59

g/l

0.05

2055

8942

Gastrointestinal diseases

1548

4100

1.93

106.21

3.5

2.1

3.50

3.61

g/l

1.82

1472

3920

Other bacterial intestinal infections

570

2138

2.78

105.69

4.0

2.5

3.59

3.56

g/l

0.15

537

2035

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2738

11114

1.60

105.46

3.3

2.6

3.56

3.59

g/l

0.35

2623

10648

Myocardial infarction, strict

1099

3768

2.11

105.07

2.9

2.2

3.61

3.70

g/l

1.20

1067

3605

Insulin, combination of fast acting with intermediate-acting or long-acting

1659

8525

1.80

103.97

3.1

2.6

3.86

3.55

g/l

11.31

1588

8167

Other diseases of arteries and capillaries

333

924

3.84

103.86

4.0

2.4

3.57

3.54

g/l

0.12

317

877

Diabetic nephropathy, excluding more controls

524

1513

2.98

103.82

2.9

2.8

4.02

3.70

g/l

4.22

505

1458

Other aneurysm

229

481

5.17

103.76

4.0

2.5

3.25

3.59

g/l

2.57

221

457

Other respiratory disorders and diseases

615

2422

2.64

103.31

4.3

2.7

3.75

3.58

g/l

1.75

591

2299

Other diseases of the respiratory system

615

2422

2.64

103.31

4.3

2.7

3.75

3.58

g/l

1.75

591

2299

Vascular disorders of the intestines

265

627

4.53

103.11

4.4

2.0

3.56

3.63

g/l

0.26

254

598

Insulin medication

1659

7788

1.80

102.94

3.1

2.7

3.86

3.52

g/l

13.32

1588

7462

COPD (mode)

744

2431

2.45

102.93

2.4

2.2

3.78

3.42

g/l

7.26

708

2323

Systemic connective tissue disorders

968

4668

2.13

100.81

3.5

2.4

3.56

3.61

g/l

0.52

928

4434

Unspecified haematuria

1150

4739

2.03

100.72

2.7

2.5

3.69

3.60

g/l

1.23

1105

4539

Malignant neoplasm of colon

412

1326

3.23

100.68

1.9

2.3

3.67

3.63

g/l

0.19

402

1256

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

201

387

5.61

100.41

4.7

2.3

2.97

3.50

g/l

3.81

195

368

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

440

1477

3.11

100.25

2.6

2.5

3.90

3.59

g/l

2.86

429

1402

Diseases of peritoneum

380

1179

3.43

99.84

3.0

2.6

3.58

g/l

0.00

370

1120

Other bacterial intestinal infections, including avohilmo

700

2980

2.43

99.19

3.7

2.4

3.57

3.60

g/l

0.18

660

2832

Abnormal findings on diagnostic imaging of lung

1255

6288

1.93

99.13

2.8

2.3

3.76

3.60

g/l

3.06

1212

6012

Other diseases of intestine

496

1793

2.89

98.91

3.2

2.5

3.73

3.62

g/l

0.74

479

1714

Congenital malformations of cardiac septa

342

970

3.74

98.88

4.7

4.9

3.06

3.27

g/l

2.27

333

937

Secondary and unspecified malignant neoplasm of lymph nodes

287

744

4.10

98.59

3.1

2.5

3.86

3.53

g/l

2.17

279

708

Rare circulating lymphoid malignancy, including Hilmo

171

292

6.68

98.43

10.5

3.5

3.39

3.41

g/l

0.05

165

279

Other acute lower respiratory infections

1506

8049

1.82

98.35

3.2

2.9

3.59

3.56

g/l

0.45

1445

7689

Enterocolitis due to Clostridium difficile

374

1167

3.38

96.98

4.1

2.6

3.62

g/l

0.01

353

1110

Abdominal aortic aneurysm (AAA)

300

804

3.88

96.40

2.1

2.0

3.13

3.63

g/l

5.51

288

758

Gout, strict definition

561

2194

2.67

95.95

2.6

2.3

3.97

3.61

g/l

5.51

530

2100

Secondary uncertain malignant neoplasm

381

1207

3.29

95.83

2.8

2.3

3.86

3.56

g/l

2.60

369

1142

Pre-eclampsia or eclampsia

658

2773

2.47

95.75

2.5

2.4

4.03

3.57

g/l

12.64

618

2640

Second line medication for Crohn's disease

1595

9198

1.77

95.36

4.7

2.6

3.52

3.56

g/l

0.57

1532

8819

Other viral diseases

937

4552

2.12

95.04

4.7

3.2

3.38

3.52

g/l

2.06

896

4354

Lymphoid leukaemia

261

656

4.37

94.79

7.7

3.0

3.45

3.55

g/l

0.36

250

623

Polyarthropathies

1875

7123

1.72

94.68

2.8

2.7

3.78

3.55

g/l

7.70

1798

6856

Early onset COPD, excluding more controls

521

1968

2.73

94.62

2.7

2.2

3.73

3.42

g/l

4.37

492

1879

Codeine or tramadol medication

2901

10288

1.55

94.29

2.6

2.5

3.67

3.61

g/l

1.47

2773

9858

Type 2 diabetes, wide definition

1927

7240

1.71

94.12

2.9

2.5

3.81

3.56

g/l

9.18

1841

6938

Bacterial intestinal infections, IBD co-morbidities

567

2252

2.62

93.72

4.0

2.6

3.58

g/l

0.00

534

2148

L04AX Other immunosuppressants

1544

8877

1.78

93.51

4.8

2.6

3.52

3.56

g/l

0.51

1481

8506

Pre-eclampsia

621

2579

2.51

93.41

2.5

2.4

4.04

3.58

g/l

12.22

584

2456

Certain disorders involving the immune mechanism

597

2438

2.55

93.27

5.4

2.9

3.62

3.56

g/l

0.41

571

2328

Enlarged lymph nodes

480

1760

2.84

92.94

3.6

2.3

3.66

3.62

g/l

0.17

462

1683

Factors influencing health status and contact with health services

650

1264

2.63

92.75

2.9

2.0

3.55

3.72

g/l

1.59

621

1209

Chronic pancreatitis

423

1463

3.05

92.01

2.6

3.57

3.61

g/l

0.20

411

1405

Arterial embolism and thrombosis of lower extremity artery

164

285

6.35

91.92

4.1

2.2

3.51

3.57

g/l

0.19

158

268

Symptoms and signs involving the skin and subcutaneous tissue

1944

11257

1.66

91.49

2.9

2.6

3.51

3.60

g/l

1.92

1861

10788

Other diseases of liver

559

2238

2.60

90.96

3.5

2.7

3.36

3.62

g/l

3.08

538

2139

Other disorders of veins

1030

5180

2.00

90.73

2.4

2.3

3.64

g/l

0.02

987

4938

Unspecified privation

393

1324

3.14

89.78

3.5

2.7

3.61

3.54

g/l

0.39

382

1259

Insulin, intermediate and long-acting

1444

7946

1.79

89.54

2.9

2.6

3.89

3.55

g/l

12.00

1380

7613

Gastric ulcer

512

1987

2.67

88.62

2.9

2.3

3.48

3.65

g/l

1.66

498

1896

Abnormal findings on examination of blood, without diagnosis

1276

6356

1.86

88.43

3.5

2.6

3.65

3.59

g/l

0.74

1219

6101

Other disorders of kidney and ureter

442

1606

2.90

87.83

3.3

2.6

3.70

3.59

g/l

0.70

422

1540

Pre-eclampsia or poor fetal growth

887

4345

2.10

87.70

2.5

2.4

3.94

3.56

g/l

12.63

834

4135

Abdominal and pelvic pain

2485

7964

1.59

87.66

3.2

2.6

3.52

3.61

g/l

2.01

2377

7641

Acute bronchitis

1118

5853

1.92

86.45

3.2

2.9

3.63

3.57

g/l

0.74

1068

5580

Non-invasive ventilation

579

2044

2.50

86.31

3.5

2.4

3.53

g/l

0.04

529

1954

Amiodarone users

354

1150

3.27

86.30

5.1

2.4

3.63

3.59

g/l

0.17

346

1095

Osteopathies and chondropathies

1479

7826

1.76

86.22

3.8

2.5

3.62

3.58

g/l

0.57

1417

7487

Pleural effusion

465

1747

2.78

86.17

2.9

2.3

3.79

3.60

g/l

1.50

451

1663

Other reaction to severe stress, and adjustment disorders

1081

5731

1.93

85.68

4.0

2.6

3.43

3.59

g/l

3.72

1035

5468

Non-follicular lymphoma

341

1090

3.33

85.43

3.4

2.4

3.74

3.57

g/l

1.05

332

1041

Hypertensive heart and/or renal disease

648

2020

2.41

84.97

2.5

2.3

3.71

3.51

g/l

2.42

626

1927

Acute posthaemorrhagic anaemia

166

316

5.79

84.55

3.7

2.2

3.41

3.63

g/l

1.02

157

304

Other arterial embolism and thrombosis

137

217

7.02

84.46

4.2

2.5

3.49

3.53

g/l

0.09

132

205

Cutaneous abscess, furuncle and carbuncle

798

3832

2.15

84.40

3.3

2.8

3.60

3.54

g/l

0.52

773

3657

Genitourinary diseases

1481

4184

1.81

83.57

3.6

3.1

3.52

3.50

g/l

0.14

1417

4030

Pregnancy hypertension

1110

5325

1.91

83.28

2.5

2.4

3.96

3.56

g/l

17.75

1038

5082

Other viral diseases, including avohilmo

1149

6226

1.87

82.60

4.4

3.0

3.41

3.53

g/l

2.12

1098

5956

Insulin, fast-acting

999

5260

1.95

81.02

3.4

2.8

3.85

3.51

g/l

8.75

960

5038

Multiple myeloma and malignant plasma cell neoplasms

207

493

4.59

80.65

3.4

2.3

3.70

3.61

g/l

0.32

202

469

Autoimmune diseases related-to ILD

2182

11777

1.57

80.58

3.2

2.5

3.63

3.59

g/l

0.62

2079

11280

Other neurological diseases

1781

8493

1.65

80.33

2.8

2.5

3.49

3.62

g/l

3.58

1689

8143

Diabetic nephropathy

529

2181

2.51

79.08

2.9

2.7

4.03

3.73

g/l

4.09

510

2087

Symptoms and signs involving the urinary system

1901

8985

1.62

78.97

2.9

2.7

3.63

3.60

g/l

0.37

1820

8611

Myocardial infarction, without ST-elevation

980

4638

1.95

78.91

2.3

3.57

3.64

g/l

0.74

942

4442

Amputation of toe

262

750

3.73

78.33

2.2

2.4

4.17

3.62

g/l

4.85

248

716

Diverticular disease of intestine

1648

6159

1.69

78.12

2.6

2.4

3.62

3.64

g/l

0.15

1591

5908

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1189

5757

1.83

78.11

2.5

2.4

3.93

3.56

g/l

16.33

1113

5499

Other complications of surgical and medical care, not elsewhere classified

324

1058

3.22

77.94

3.2

2.6

3.62

3.56

g/l

0.28

313

1003

Postpartum haemorrhage due to anatomy

455

1793

2.69

77.57

1.6

2.2

3.64

3.73

g/l

0.89

426

1695

Dilated cardiomyopathy

391

1428

2.89

77.10

5.8

2.6

3.75

3.57

g/l

1.36

376

1367

1258

7158

1.78

77.04

3.1

3.0

3.68

3.51

g/l

3.77

1196

6853

Nonischemic cardiomyopathy

323

1061

3.20

76.79

5.3

2.7

3.62

3.61

g/l

0.03

313

1012

Acute pancreatitis

549

2354

2.41

76.74

3.0

2.5

3.73

3.62

g/l

0.80

524

2244

Other arrhythmias

1466

6466

1.72

76.44

3.1

2.4

3.52

3.60

g/l

1.23

1394

6203

Polyneuropathies and other disorders of the peripheral nervous system

611

2758

2.29

75.77

4.8

2.5

3.65

3.61

g/l

0.26

584

2639

Glomerulonephritis

355

1245

3.02

75.68

3.7

3.1

3.89

3.50

g/l

3.76

343

1188

Idiopathic pulmonary fibrosis

269

801

3.57

75.59

3.2

2.3

3.89

3.62

g/l

2.03

261

758

Respiratory insufficiency

239

654

3.82

75.34

5.7

2.3

3.78

3.40

g/l

3.02

231

616

Cellulitis

658

3068

2.22

75.23

3.5

3.0

3.72

3.52

g/l

2.54

633

2941

Hypo-osmolality and hyponatraemia

466

1858

2.57

74.86

2.7

2.4

3.56

g/l

0.01

442

1765

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

214

551

4.12

74.34

2.4

3.76

3.51

g/l

1.13

206

523

Autoimmune diseases

2833

9810

1.48

73.72

3.1

2.7

3.60

3.57

g/l

0.44

2691

9428

Hyperkalaemia

209

536

4.15

73.09

4.6

2.4

3.54

3.57

g/l

0.09

202

510

Syncope and collapse

1047

4778

1.86

72.82

2.8

2.2

3.53

3.61

g/l

0.95

1000

4566

Insulin, fast-acting or short human

1001

5460

1.88

72.75

3.4

2.8

3.85

3.53

g/l

7.89

962

5224

Injuries to the abdomen, lower back, lumbar spine and pelvis

1077

5915

1.83

72.74

2.8

2.6

3.40

3.61

g/l

4.83

1025

5641

Hydronephrosis

345

1217

2.96

72.20

2.6

2.4

3.77

3.54

g/l

1.78

337

1161

Diseases of the skin and subcutaneous tissue

2441

8135

1.52

72.17

3.0

2.6

3.57

g/l

0.07

2313

7825

Diseases of the respiratory system

1522

4530

1.71

71.46

2.8

2.3

3.59

3.46

g/l

2.38

1451

4336

Vocal cord dysfunction

357

1113

2.91

71.41

2.4

2.3

3.70

3.55

g/l

0.96

345

1058

Used for control exclusion in common control thyroid runs

2679

9191

1.49

70.61

3.2

2.7

3.58

3.57

g/l

0.09

2545

8832

Complications of cardiac and vascular prosthetic devices, implants and grafts

116

188

7.02

70.41

5.6

2.6

3.61

3.66

g/l

0.12

111

177

Fall on same level

2940

10901

1.45

70.01

2.8

3.58

g/l

0.08

2814

10448

Other gastritis (incl. Duodenitis)

583

2668

2.25

69.71

2.8

2.5

3.54

3.63

g/l

0.75

566

2554

AV-block

425

1421

2.63

69.60

3.8

2.3

3.55

3.60

g/l

0.22

409

1363

Colorectal adenocarcinoma

460

1874

2.49

69.52

2.0

2.3

3.69

3.63

g/l

0.33

451

1781

Other nutritional deficiencies

1778

10446

1.58

68.35

2.5

2.7

3.91

3.54

g/l

20.83

1698

10019

Visual disturbances and blindness

1354

8184

1.68

68.18

3.3

2.7

3.48

3.58

g/l

1.98

1295

7832

Conduction disorders

662

2528

2.14

67.98

3.7

2.4

3.57

3.58

g/l

0.03

632

2428

Transient ischemic attack

1172

5382

1.77

67.79

2.5

2.3

3.53

3.62

g/l

1.29

1108

5163

General examination and investigation of persons without complaint and reported diagnosis

1519

4762

1.68

67.71

3.7

2.3

3.47

3.69

g/l

6.48

1453

4565

Acute pancreatitis (for exclusion)

549

2487

2.28

67.50

3.0

2.6

3.73

3.62

g/l

0.73

524

2371

Cystitis

2127

8348

1.54

67.42

2.7

2.6

3.58

g/l

0.01

2043

7983

Osteoporosis

657

2918

2.12

67.10

4.5

2.3

3.49

3.59

g/l

0.92

625

2781

Hypertensive Heart Disease

564

1916

2.29

66.91

2.4

2.2

3.72

3.50

g/l

2.40

545

1824

Other diseases of urinary system

2484

9496

1.49

66.77

2.8

2.7

3.64

3.57

g/l

1.32

2374

9105

Mycoses

773

3994

1.99

66.70

3.5

2.6

3.58

3.59

g/l

0.08

735

3802

Acute upper respiratory infections

2580

10643

1.47

66.44

3.0

2.5

3.60

g/l

0.02

2467

10177

Hyperlipidaemia, other/unspecified

895

4337

1.89

66.17

2.8

2.4

3.79

3.60

g/l

3.14

859

4157

Benign neoplasm of colon, rectum, anus and anal canal

1489

7806

1.64

66.05

2.5

2.4

3.67

3.62

g/l

0.65

1434

7478

Undetermined asthma, excluding more controls

336

1222

2.84

65.92

2.7

2.1

3.83

3.47

g/l

3.65

315

1149

Viral infections characterized by skin and mucous membrane lesions

1134

6611

1.75

65.60

3.9

2.9

3.47

3.56

g/l

1.36

1092

6321

Diaphragmatic hernia

852

4567

1.91

65.49

2.7

2.4

3.63

3.64

g/l

0.00

827

4366

1458

8074

1.64

65.29

2.8

2.6

3.56

3.62

g/l

0.83

1386

7755

Non-allergic asthma (mode), excluding more controls

450

1876

2.44

65.21

2.5

2.2

3.53

3.44

g/l

0.59

417

1776

Disorders of other endocrine glands

1178

6845

1.73

65.04

3.7

2.9

3.60

3.53

g/l

0.91

1132

6542

Viral hepatitis, IBD co-morbidity

191

500

4.03

64.74

3.2

2.2

3.52

3.50

g/l

0.05

185

475

Alcohol use disorder, Swedish definition

1369

7627

1.66

64.46

2.7

2.6

3.54

3.63

g/l

1.30

1298

7327

Anxiety disorders, excluding more controls

2069

8802

1.52

63.77

3.4

2.6

3.49

3.61

g/l

3.08

1979

8462

Other disorders of urethra and urinary system

1745

7819

1.57

63.70

2.6

2.5

3.70

3.60

g/l

1.98

1654

7472

Visual disturbances

1255

7583

1.69

63.66

3.3

2.6

3.48

3.58

g/l

1.97

1200

7254

Other diseases of anus and rectum

743

3828

1.98

63.58

3.0

2.5

3.46

3.62

g/l

2.01

695

3652

Anaemia in chronic diseases classified elsewhere

129

255

5.69

63.54

3.9

3.1

3.82

3.58

g/l

0.76

122

246

Asthma (diagnoses ohter than nonallergic)

2226

12262

1.48

63.45

2.7

2.8

3.67

3.56

g/l

3.01

2116

11753

Hypokalaemia

344

1300

2.75

63.10

2.9

2.4

3.56

3.53

g/l

0.14

331

1235

1517

8327

1.61

62.90

2.7

2.6

3.55

3.62

g/l

0.87

1442

7999

Decubitus ulcer and pressure area

207

591

3.71

62.00

4.0

2.4

3.92

3.64

g/l

1.32

194

564

Pain (limb, back, neck, head abdominally)

1744

5578

1.59

61.73

3.2

2.7

3.54

3.60

g/l

0.84

1664

5364

Diabetes, varying definitions

2498

10042

1.46

61.61

3.0

2.6

3.75

3.53

g/l

10.16

2387

9608

Pain in joint

1430

5407

1.65

61.57

2.7

2.6

3.64

3.62

g/l

0.18

1360

5202

Neurotic, stress-related and somatoform disorders

2245

10578

1.48

61.45

3.4

2.6

3.50

3.60

g/l

2.91

2146

10150

Immunodeficiencies

203

580

3.79

61.40

5.9

3.6

3.71

3.49

g/l

0.99

191

554

Septal defects

288

995

3.06

61.20

4.7

5.6

3.04

3.23

g/l

1.78

279

963

Diabetes mellitus

2506

10060

1.45

60.93

3.0

2.6

3.76

3.53

g/l

11.02

2394

9625

Volume depletion

285

994

2.99

60.93

3.7

2.8

3.48

3.53

g/l

0.19

275

944

Hernia of abdominal wall

1135

6762

1.71

60.82

2.4

2.6

3.58

3.61

g/l

0.21

1089

6486

Hernia

2213

10040

1.48

60.67

2.8

2.7

3.55

3.61

g/l

0.86

2129

9611

Statin medication

1589

5648

1.61

60.53

4.1

2.4

3.61

3.51

g/l

1.62

1522

5386

Neurological diseases, wide definition

810

2094

1.98

60.48

4.4

2.7

3.41

3.50

g/l

0.96

772

2002

Ventral hernia

609

2996

2.09

60.39

2.6

3.63

3.65

g/l

0.10

585

2865

Intestinal adhesions without obstruction

264

889

3.11

60.28

2.7

2.4

3.50

3.61

g/l

0.53

257

849

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

264

892

3.13

60.24

3.7

2.3

3.51

3.60

g/l

0.43

251

846

Personal history of other diseases and conditions

384

1568

2.54

59.65

3.9

2.6

3.61

3.45

g/l

1.46

369

1486

Maternal care for known or suspected abnormality of pelvic organs

665

2227

2.07

59.63

2.7

3.78

3.56

g/l

3.51

634

2133

Anxiety disorders

2255

10652

1.47

59.61

3.4

2.6

3.50

3.60

g/l

2.88

2156

10218

Hereditary factor VIII deficiency

31.71

58.63

10.4

8.0

3.16

3.32

g/l

0.23

Other special examinations and investigations of persons without complaint or reported diagnosis

1506

4763

1.62

58.59

3.2

2.3

3.51

3.69

g/l

4.52

1430

4566

Follow-up examination after treatment for conditions other than malignant neoplasms

1066

4120

1.75

58.25

2.5

2.2

3.54

3.68

g/l

2.46

1020

3946

Other and unspecified polyneuropathies, also in other diseases

508

2377

2.21

57.75

4.4

2.4

3.73

3.63

g/l

0.78

485

2271

Chronic ulcer of skin, not elsewhere classified

226

714

3.34

57.73

3.4

2.4

3.69

3.62

g/l

0.22

214

683

Undetermined asthma

336

1311

2.64

57.47

2.7

2.3

3.83

3.47

g/l

3.74

315

1234

Other pleural conditions

297

1096

2.83

57.27

3.1

2.4

3.65

3.61

g/l

0.16

287

1042

Benign neoplasm: Colon

1251

7261

1.64

57.17

2.6

2.4

3.70

3.61

g/l

1.20

1206

6951

Other diseases of pancreas

270

951

2.99

57.08

2.6

2.4

3.65

3.58

g/l

0.26

260

907

Postpartum care and examination

362

874

2.68

56.98

2.8

2.5

3.84

3.47

g/l

4.73

340

822

Other necrotizing vasculopathies

236

772

3.23

56.97

4.6

2.4

3.47

3.63

g/l

0.76

229

731

Candidiasis

430

1900

2.35

56.45

3.6

2.5

3.55

3.58

g/l

0.13

412

1805

Other disorders of white blood cells

202

606

3.57

56.44

3.4

2.7

3.54

3.65

g/l

0.45

193

573

Persons with potential health hazards related to communicable diseases

1070

6351

1.71

56.28

3.9

3.0

3.66

3.53

g/l

2.18

1020

6070

COPD-related respiratory insufficiency

327

1278

2.66

56.21

3.0

2.2

3.80

3.59

g/l

1.43

308

1220

Chronic gastritis

628

3202

2.01

56.21

2.4

3.49

3.65

g/l

1.88

599

3058

Drug-induced neutropenia

243

816

3.16

56.18

2.8

2.4

3.77

3.60

g/l

0.83

235

778

Other and unspecified disorders of white blood cells

163

427

4.14

55.91

2.9

2.7

3.58

3.63

g/l

0.13

158

406

Other noninfective gastroenteritis and colitis

673

3527

1.96

55.63

3.7

3.2

3.60

3.49

g/l

1.05

648

3371

Chronic lower respiratory diseases

2980

11399

1.39

55.45

2.8

3.66

3.56

g/l

3.24

2834

10948

Non-allergic asthma (mode)

450

2015

2.27

55.31

2.5

2.3

3.53

3.45

g/l

0.50

417

1911

Angina pectoris

1132

4494

1.70

55.27

2.7

2.3

3.59

3.70

g/l

1.64

1087

4305

Depression

2362

11117

1.44

55.21

2.8

2.6

3.58

3.60

g/l

0.22

2260

10655

Immunodeficiency with predominantly antibody defects

132

300

4.90

55.08

7.5

3.6

3.73

3.54

g/l

0.56

127

288

Type 2 diabetes

2307

9320

1.45

55.00

2.9

2.5

3.79

3.55

g/l

10.22

2206

8916

Benign neoplasms

2429

9294

1.44

54.95

2.8

2.7

3.52

3.60

g/l

1.77

2322

8907

Mood disorders, excluding more controls

2265

9274

1.45

54.70

2.8

2.5

3.59

3.61

g/l

0.32

2176

8913

Hypothyroidism, drug reimbursement

257

592

3.09

54.53

2.8

1.8

3.63

3.61

g/l

0.05

246

555

Acute sinusitis

1337

7740

1.59

53.81

2.9

2.5

3.60

3.59

g/l

0.08

1277

7393

Other viral diseases, not elsewhere classified

545

2682

2.09

53.80

5.2

3.4

3.38

3.45

g/l

0.51

527

2567

Type 1 diabetes

667

3529

1.93

53.40

2.8

3.1

3.87

3.44

g/l

10.04

636

3379

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2270

12495

1.43

53.12

3.1

2.7

3.54

3.59

g/l

0.90

2181

11962

Fentanyl

260

931

2.88

52.58

3.2

2.4

3.93

3.55

g/l

2.87

254

881

Intracranial trauma

1423

6170

1.58

52.51

2.7

2.6

3.47

3.60

g/l

2.54

1353

5912

Benign neoplasm of other and ill-defined parts of digestive system

461

2158

2.20

52.42

3.7

2.4

3.68

3.59

g/l

0.58

446

2058

Persons encountering health services in other circumstances

997

5907

1.70

52.22

2.9

2.5

3.63

3.55

g/l

0.94

952

5632

Special screening examination for infectious and parasitic diseases

667

2545

1.95

52.16

2.7

2.3

3.63

3.68

g/l

0.32

632

2438

Injuries to the thorax

1106

6806

1.65

52.04

3.0

2.6

3.58

3.61

g/l

0.28

1063

6513

Mood disorders

2483

11396

1.41

51.53

2.8

2.6

3.59

3.60

g/l

0.09

2378

10924

Mood [affective] disorders

2478

11391

1.41

51.50

2.8

2.6

3.59

3.60

g/l

0.11

2374

10920

Noninfective enteritis and colitis

1172

7339

1.62

51.28

3.4

2.9

3.57

3.54

g/l

0.28

1125

7017

Pregnancy examination and test

383

996

2.45

50.38

2.2

2.5

3.78

3.50

g/l

2.93

365

942

Cough

959

5354

1.70

49.94

3.4

2.7

3.51

3.57

g/l

0.59

902

5154

COPD

1012

4965

1.68

49.74

2.3

2.4

3.77

3.59

g/l

2.94

955

4773

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

270

1022

2.76

49.68

4.1

2.7

3.59

3.58

g/l

0.02

254

968

All influenza (not pneumonia)

384

1709

2.31

49.35

4.2

2.9

3.50

3.41

g/l

0.57

369

1636

Supervision of high-risk pregnancy

473

1320

2.21

48.91

2.1

2.6

3.75

3.56

g/l

2.07

451

1257

Other disorders involving the immune mechanism, not elsewhere classified

148

400

4.06

48.90

7.8

3.7

3.53

3.56

g/l

0.09

143

384

Persons encountering health services for examination and investigation

1466

4763

1.56

48.81

3.0

2.3

3.50

3.69

g/l

4.93

1395

4566

Obesity and other hyperalimentation

1598

10178

1.50

48.49

2.4

2.7

3.98

3.54

g/l

25.60

1529

9755

Fracture of lumbar spine and pelvis

535

2712

2.02

48.47

2.9

2.4

3.45

3.63

g/l

2.06

508

2581

Epilepsy

785

4490

1.78

48.35

2.9

3.1

3.40

3.54

g/l

1.82

753

4301

Constipation

2110

10111

1.43

48.24

2.7

2.8

3.59

3.57

g/l

0.22

2007

9711

Obesity

1591

10151

1.50

48.23

2.4

2.7

3.98

3.54

g/l

25.59

1522

9728

External causes of morbidity and mortality

1515

4976

1.54

47.92

2.9

2.7

3.52

3.63

g/l

2.02

1454

4760

Other viral diseases, not elsewhere classified, including avohilmo

744

4203

1.80

47.48

4.5

3.2

3.40

3.50

g/l

1.13

714

4018

Urinary track infection

1423

4621

1.56

47.43

3.0

2.6

3.61

3.57

g/l

0.44

1366

4404

Maternal care for other known or suspected fetal problems

619

2027

1.96

47.39

2.3

2.7

3.87

3.53

g/l

7.29

580

1941

Obesity related asthma

844

4974

1.73

47.29

2.8

2.6

3.84

3.57

g/l

5.98

801

4752

Disorders of lens

1519

6267

1.52

47.05

2.9

2.6

3.64

3.61

g/l

0.27

1458

6035

Abnormalities of heart beat

820

4645

1.74

46.97

2.7

2.3

3.55

3.60

g/l

0.38

777

4451

Injuries to the head

2724

11932

1.37

46.94

2.6

2.8

3.55

3.60

g/l

0.94

2602

11438

Right hemicolectomy

187

599

3.30

46.88

3.0

2.3

3.53

3.60

g/l

0.23

179

568

Atrial septal defect

178

555

3.48

46.75

4.8

5.6

3.06

3.28

g/l

1.31

172

537

Other problems related to primary support group, including family circumstances

388

1730

2.27

46.68

8.9

3.0

3.11

3.43

g/l

5.40

369

1653

Heart failure and hypertrophic cardiomyopathy

185

5.73

46.66

5.2

2.8

3.61

3.62

g/l

0.01

176

Malignant neoplasm of pancreas, including Hilmo

206

700

3.05

46.18

2.0

2.2

3.19

3.56

g/l

3.18

199

663

Injuries to unspecified part of trunk, limb or body region

314

1324

2.47

46.13

3.2

3.0

3.53

3.52

g/l

0.04

304

1259

Molar incisor enamel hypoplasia

210

698

3.15

46.08

9.6

5.9

3.00

3.02

g/l

0.09

205

681

Obesity, other/unspecified

862

5152

1.71

45.86

2.4

2.7

4.03

3.54

g/l

16.90

819

4904

Migraine

1299

6598

1.55

45.85

3.2

2.7

3.44

3.57

g/l

3.21

1239

6308

Other CVD

480

2396

2.05

45.84

2.8

2.4

3.54

3.63

g/l

0.70

459

2275

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

474

1910

2.08

45.76

2.1

2.3

3.97

3.63

g/l

4.01

455

1813

Osteomyelitis

215

757

3.00

45.69

3.0

2.5

4.08

3.56

g/l

3.63

206

727

Disorders of mineral metabolism

246

928

2.76

45.58

2.8

2.7

3.55

3.50

g/l

0.15

235

887

Anxiety (asthma-related co-morbidities)

1503

7692

1.50

45.56

3.0

2.8

3.54

3.57

g/l

0.32

1425

7373

Diabetes mellitus in pregnancy

829

3054

1.76

45.49

2.1

2.6

3.96

3.53

g/l

14.05

782

2909

Appendectomy

1551

10077

1.48

45.38

2.5

2.7

3.62

3.59

g/l

0.39

1489

9653

Malignant neoplasm of skin, including Hilmo

970

3937

1.67

45.27

2.5

3.60

g/l

0.03

935

3749

Traumatic subdural haemorrhage

327

1314

2.39

45.02

2.7

2.3

3.58

3.67

g/l

0.46

308

1256

Symptoms and signs involving cognition, perception, emotional state and behaviour

2295

11137

1.39

44.84

2.7

3.54

3.61

g/l

1.40

2180

10692

Candidiasis, including avohilmo

779

4568

1.74

44.58

3.0

2.5

3.56

3.60

g/l

0.33

740

4356

Malignant neoplasm of urinary organs, including Hilmo

256

994

2.66

44.50

2.1

2.4

3.87

3.65

g/l

1.13

247

945

Maternal care for known or suspected fetal abnormality and damage

427

1731

2.15

44.46

2.2

2.7

3.69

3.56

g/l

1.16

403

1658

Other systemic involvement of connective tissue

637

3526

1.85

44.46

3.1

2.3

3.57

3.62

g/l

0.48

610

3354

COPD related to multimorbidity

871

4416

1.70

44.39

2.3

3.78

3.61

g/l

2.45

819

4239

Other chronic obstructive pulmonary disease

952

4779

1.66

44.22

2.3

3.77

3.59

g/l

2.91

897

4596

Substance abuse, excluding more controls

1337

7421

1.53

43.97

2.6

2.5

3.66

3.62

g/l

0.47

1271

7133

Vitreous haemorrhage

290

1212

2.49

43.46

2.4

2.5

3.79

3.53

g/l

1.91

283

1155

Congenital malformations of the urinary system, including avohilmo

224

830

2.86

43.43

3.8

4.8

3.51

3.41

g/l

0.38

217

796

All anxiety disorders

1543

8190

1.48

43.39

3.0

2.7

3.56

3.59

g/l

0.35

1462

7849

Dysphagia

569

3066

1.89

43.24

2.5

2.3

3.64

g/l

0.01

545

2931

Covid-19 suspected case

550

2937

1.92

43.16

2.8

2.7

3.88

3.51

g/l

5.34

526

2795

Malignant neoplasm of breast, including Hilmo

728

2649

1.78

42.60

1.9

2.5

3.54

3.61

g/l

0.62

706

2500

Subjective visual disturbances

634

3553

1.82

42.58

3.0

2.6

3.50

3.61

g/l

1.25

600

3386

Malignant neoplasm of breast, HER2-negative, including Hilmo

728

2650

1.78

42.56

1.9

2.5

3.54

3.61

g/l

0.62

706

2501

Dermatitis

1495

10055

1.47

42.31

3.2

2.6

3.56

3.58

g/l

0.17

1422

9655

Other functional intestinal disorders

1053

6103

1.59

42.16

3.1

2.8

3.57

3.56

g/l

0.12

1006

5827

Malignant neoplasm of corpus uteri, including Hilmo

186

628

3.06

42.14

1.5

2.2

4.24

3.54

g/l

5.84

180

595

Cerebral palsy and other paralytic syndromes

320

1415

2.34

42.11

4.7

3.0

3.42

3.51

g/l

0.44

302

1350

Malignant neoplasm of breast

711

2597

1.79

42.08

1.9

2.5

3.54

3.61

g/l

0.64

689

2452

Episodal and paroxysmal disorders

2587

9734

1.36

42.04

2.9

2.8

3.53

3.58

g/l

0.98

2468

9335

Fracture of rib(s), sternum and thoracic spine

716

4170

1.75

41.95

2.8

2.5

3.55

3.62

g/l

0.58

694

3982

Disturbances of skin sensation

694

4015

1.76

41.73

2.7

2.6

3.52

3.63

g/l

1.14

660

3828

Diabetic retinopathy, excluding more controls

631

1921

1.88

41.70

2.7

2.8

3.82

3.70

g/l

1.09

612

1853

Congenital malformations of the urinary system

213

786

2.87

41.69

3.9

4.9

3.50

3.40

g/l

0.40

206

753

Focal epilepsy

549

2965

1.90

41.63

3.1

3.3

3.41

3.53

g/l

1.09

527

2838

Malignant neoplasm of rectum, including Hilmo

262

1064

2.54

41.47

2.0

2.3

3.73

3.64

g/l

0.38

255

1008

Dermatitis and eczema

2678

11901

1.34

41.45

2.9

2.7

3.58

3.59

g/l

0.03

2548

11413

Malignant neoplasm of breast, HER2-negative

707

2593

1.78

41.31

1.9

2.5

3.54

3.61

g/l

0.65

685

2448

Later onset COPD, excluding more controls

413

1515

2.12

41.26

1.9

2.0

3.81

3.44

g/l

4.55

390

1443

Basal cell carcinoma, including Hilmo

825

3331

1.70

41.10

2.5

2.4

3.56

3.63

g/l

0.62

792

3168

Other metabolic disorders

338

1545

2.25

40.87

3.8

2.6

3.46

3.57

g/l

0.77

328

1469

Total colectomy

157

494

3.40

40.84

3.4

2.7

3.51

3.62

g/l

0.35

151

472

Total colectomy operation

157

494

3.40

40.84

3.4

2.7

3.51

3.62

g/l

0.35

151

472

Lung cancer and mesothelioma

388

1566

2.15

40.80

2.0

2.1

3.98

3.41

g/l

8.73

372

1493

Unspecified fall

1221

7980

1.52

40.73

2.9

3.55

g/l

0.02

1168

7629

Injuries to the hip and thigh

1092

6348

1.56

40.66

2.7

2.5

3.63

3.59

g/l

0.34

1031

6063

Elevated blood glucose level

251

1013

2.58

40.65

5.2

2.9

3.56

3.55

g/l

0.01

243

968

Other and unspecified dermatitis

1259

8450

1.51

40.56

3.0

2.7

3.56

3.58

g/l

0.15

1198

8116

Diagnoses used for exclusion with ILD

579

3205

1.84

40.46

3.1

2.5

3.68

3.62

g/l

0.45

559

3061

Other inflammatory liver diseases

201

730

2.89

40.30

3.4

2.5

3.27

3.67

g/l

3.03

193

695

Cystic kidney disease

134

386

3.77

40.26

4.0

3.4

3.46

3.52

g/l

0.14

129

368

Other systemic involvement of connective tissue (FG)

596

3270

1.82

40.16

2.7

2.4

3.60

3.59

g/l

0.06

569

3110

Zoster [herpes zoster]

452

2319

2.00

40.09

3.6

2.5

3.44

3.63

g/l

1.96

440

2207

Other surgical follow-up care

129

362

3.81

40.02

2.7

2.9

3.54

3.53

g/l

0.02

123

353

Unspecified misadventure during surgical and medical care

186

653

3.01

39.84

2.8

2.5

3.48

3.66

g/l

0.77

176

621

Cystic kidney disease, including avohilmo

141

423

3.60

39.75

3.9

3.3

3.46

3.53

g/l

0.17

136

403

Noninfectious colitis NAS

370

1775

2.15

39.66

3.4

3.0

3.63

3.49

g/l

1.07

355

1693

Chronic nephritic syndrome

142

428

3.55

39.60

3.5

2.6

3.99

3.65

g/l

1.29

137

409

Sequelae of other external causes

184

644

3.00

39.55

3.8

2.4

3.61

3.64

g/l

0.09

177

607

Cholelithiasis, broad definition with cholecystitis

1905

9119

1.40

39.52

2.7

2.4

3.68

3.59

g/l

1.66

1828

8708

Reimbursement for rheumatic diseases

1291

8698

1.49

39.50

3.3

2.6

3.62

3.58

g/l

0.43

1238

8323

Early onset COPD

521

2817

1.89

39.43

2.7

2.6

3.73

3.59

g/l

1.32

492

2700

Other skin changes

485

2564

1.94

39.35

3.1

2.4

3.37

3.61

g/l

3.48

466

2438

Use of hypnotics and sedatives

2456

10484

1.35

39.12

2.8

2.7

3.60

g/l

0.01

2337

10072

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2090

9053

1.38

38.77

2.9

2.7

3.81

3.53

g/l

12.13

1991

8671

Type 1 diabetes, wide definition, subgroup 1

527

2871

1.88

38.76

2.7

3.1

3.91

3.44

g/l

10.67

507

2747

Malignant neoplasm of skin

892

3731

1.64

38.72

2.4

3.59

3.61

g/l

0.14

858

3550

Injury of unspecified body region

237

954

2.60

38.68

3.4

2.8

3.57

3.56

g/l

0.01

228

909

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

760

4546

1.69

38.68

5.8

2.7

3.32

3.54

g/l

4.47

720

4333

Falls/tendency to fall

2537

9521

1.35

38.59

2.8

3.55

3.58

g/l

0.50

2422

9125

Other necrotizing vasculopathies (FG)

177

615

3.02

38.50

3.5

2.5

3.60

3.58

g/l

0.05

172

584

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

840

3456

1.66

38.44

2.5

2.4

3.59

3.63

g/l

0.26

808

3289

Hypertrophic cardiomyopathy

145

451

3.43

38.41

4.2

2.8

3.47

3.61

g/l

0.52

132

431

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1194

6242

1.52

38.33

3.0

2.4

3.84

3.56

g/l

6.60

1136

5975

Abnormalities of gait and mobility

330

1537

2.22

38.31

3.1

3.0

3.61

3.54

g/l

0.32

313

1464

COPD, hospital admission 2, with asthma infections

697

3537

1.73

38.15

2.3

3.81

3.61

g/l

2.66

653

3382

Other anxiety disorders

1165

6608

1.52

37.93

2.9

2.7

3.60

3.58

g/l

0.17

1110

6315

Retention of urine

758

3693

1.69

37.79

2.5

2.4

3.68

3.62

g/l

0.47

726

3533

Amputation of foot

105

267

4.27

37.73

2.3

2.5

4.24

3.64

g/l

2.07

250

Focal epilepsy, strict definition

502

2723

1.89

37.64

3.2

3.3

3.40

3.52

g/l

1.04

481

2606

Mental and behavioural disorders due to psychoactive substance use

1389

8811

1.46

37.61

2.6

2.7

3.67

3.61

g/l

0.67

1324

8460

Chronic periodontitis, complicated

1256

8342

1.49

37.38

2.8

2.5

3.68

3.61

g/l

0.82

1204

8019

Asthma, hospital admissions , main diagnosis only

1932

12333

1.38

36.99

2.7

2.8

3.62

3.57

g/l

0.88

1837

11813

Other disorders of skin and subcutaneous tissue, not elsewhere classified

349

1683

2.13

36.86

3.1

2.4

3.63

3.58

g/l

0.26

327

1607

Other or ill-defined heart diseases

148

475

3.25

36.80

4.9

2.5

3.73

3.52

g/l

0.72

140

458

COPD, hospital admissions 3, with asthma pneumonia sepsis

586

2848

1.80

36.80

2.3

3.87

3.63

g/l

2.91

550

2727

Disorder of lipoprotein metabolism, unspecified

299

1359

2.26

36.69

3.1

2.4

3.76

3.59

g/l

1.09

289

1299

Focal epilepsy, mode (most common among epilepsy diagnosis)

475

2556

1.90

36.55

2.7

3.2

3.40

3.53

g/l

1.08

453

2450

Sub-endpoint used in defining T1D endpoints

690

4064

1.70

36.46

2.8

3.1

3.86

3.50

g/l

7.87

659

3873

Malignant neoplasm of urinary organs

212

829

2.64

36.44

2.1

2.3

3.91

3.62

g/l

1.43

206

785

Gingival hyperplasia

152

504

3.25

36.43

7.6

4.0

3.30

3.47

g/l

0.74

144

481

Other abnormal findings of blood chemistry

158

534

3.13

36.28

2.5

2.2

3.42

3.69

g/l

1.39

152

509

COPD, early/later onset

956

5174

1.57

36.26

2.3

3.77

3.60

g/l

2.69

901

4973

Malignant neoplasm of respiratory system and intrathoracic organs

405

1695

2.02

36.23

2.1

2.3

4.00

3.64

g/l

3.89

390

1610

Cardiomyopathy, Hypertrophic obstructive

139

5.64

36.21

5.0

2.3

3.42

3.64

g/l

0.47

133

Disorders of choroid and retina

1761

8903

1.40

36.06

2.7

2.6

3.70

3.60

g/l

1.91

1702

8524

severe traumatic brain injury, does not include concussion

498

2729

1.86

36.03

2.6

2.5

3.55

3.61

g/l

0.45

470

2606

Disorders of parathyroid gland

445

2325

1.93

35.97

4.3

2.3

3.64

3.58

g/l

0.36

427

2212

Failed induction of labour

187

697

2.80

35.68

1.7

2.7

4.05

3.61

g/l

4.45

172

659

Other and unspecified drugs and medicaments

244

1033

2.46

35.67

4.0

2.9

3.57

3.58

g/l

0.05

229

979

Symptoms and signs involving speech and voice

745

4579

1.66

35.67

3.0

2.5

3.62

3.61

g/l

0.09

718

4363

Gestational [pregnancy-induced] hypertension

615

3590

1.75

35.65

2.6

2.4

3.96

3.53

g/l

11.64

567

3415

Type 2 diabetes, definitions combined

2063

8861

1.37

35.64

2.9

2.4

3.76

3.56

g/l

6.86

1976

8469

Other external causes of accidental injury

1842

6658

1.40

35.62

2.9

2.8

3.57

3.61

g/l

0.48

1753

6380

Attention to artificial openings

129

391

3.48

35.47

2.8

3.0

4.06

3.46

g/l

2.98

129

378

Other antidepressants

2347

8992

1.34

35.46

2.7

3.59

g/l

0.01

2235

8644

Neurological diseases

2036

7506

1.37

35.44

3.5

2.7

3.48

3.59

g/l

2.66

1943

7204

Injury, poisoning and certain other consequences of external causes

1208

4048

1.51

35.06

3.0

2.6

3.50

3.63

g/l

2.34

1158

3872

Other viral hepatitis, including avohilmo

205

808

2.65

35.04

3.7

3.0

3.47

3.56

g/l

0.33

198

770

Substance abuse

1337

8663

1.45

34.98

2.6

2.7

3.66

3.61

g/l

0.63

1271

8319

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

216

872

2.55

34.73

2.0

2.4

3.63

3.62

g/l

0.03

211

826

Obesity due to excess calories

1160

7923

1.49

34.44

2.4

2.7

3.98

3.53

g/l

20.34

1116

7582

Other malignant neoplasms of skin (=non-melanoma skin cancer)

791

3318

1.64

34.43

2.4

3.59

3.63

g/l

0.27

760

3157

Type 2 diabetes, strict (exclude DM1)

2071

8950

1.36

34.42

2.9

2.4

3.76

3.56

g/l

6.99

1984

8553

Type 1 diabetes, wide definition

538

3059

1.79

34.36

2.7

3.1

3.88

3.42

g/l

10.33

518

2921

Accidents

1832

6658

1.39

34.32

2.9

2.8

3.57

3.61

g/l

0.46

1745

6380

Other viral hepatitis

195

759

2.69

34.23

3.7

2.9

3.48

3.57

g/l

0.33

190

725

Soft tissue disorders

2412

9362

1.33

34.14

3.3

2.7

3.58

3.57

g/l

0.03

2306

8976

Cholelithiasis

1794

8954

1.38

33.90

2.6

2.4

3.67

3.59

g/l

1.27

1718

8549

Chronic periodontitis, including avohilmo

2217

10672

1.34

33.74

2.9

2.5

3.61

3.62

g/l

0.13

2142

10207

COPD, hospital admissions

936

5145

1.55

33.73

2.3

3.77

3.61

g/l

2.44

881

4944

Other congenital malformations

286

1330

2.24

33.58

3.5

4.5

3.26

3.36

g/l

0.52

275

1278

Suppurative and necrotic conditions of lower respiratory tract

172

635

2.85

33.57

4.1

2.6

4.10

3.63

g/l

2.39

167

606

Open wound of lower leg

387

2005

1.98

33.51

3.2

2.9

3.58

3.55

g/l

0.13

370

1913

Hyperparathyroidism

387

1979

1.98

33.49

4.1

2.3

3.64

3.61

g/l

0.16

372

1882

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

211

859

2.53

33.37

2.2

2.3

3.83

3.64

g/l

0.84

204

814

Asthma, including avohilmo

2771

11844

1.30

33.34

2.6

2.8

3.65

3.57

g/l

2.16

2627

11370

Disorders of thyroid, IBD co-morbidities

419

1489

1.96

33.29

4.0

2.1

3.55

3.60

g/l

0.27

399

1422

Other infectious diseases

209

851

2.55

33.29

3.4

2.6

3.63

3.58

g/l

0.16

203

809

Complications of internal orthopaedic prosthetic devices, implants and grafts

445

2414

1.88

33.26

2.3

3.79

3.67

g/l

0.87

425

2297

Unspecified jaundice

151

522

3.03

33.22

4.6

2.5

3.16

3.66

g/l

3.87

146

500

Mental and behavioural disorders due to alcohol

1160

7584

1.47

33.21

2.6

2.7

3.67

3.62

g/l

0.49

1104

7276

Malignant neoplasm of corpus uteri

160

569

2.90

33.11

1.5

2.2

4.17

3.54

g/l

4.51

154

538

Gestational diabetes (for exclusion)

895

3970

1.58

33.02

2.2

2.5

3.89

3.56

g/l

9.36

849

3765

Chronic apical periodontitis

2556

11032

1.31

32.92

2.7

2.6

3.64

3.59

g/l

0.91

2444

10551

Aneurysms, operations, SAH

357

1811

2.02

32.79

2.6

2.4

3.61

3.60

g/l

0.07

343

1724

Viral and other specified intestinal infections, including avohilmo

714

4262

1.64

32.78

4.5

2.8

3.43

3.52

g/l

0.98

683

4063

Periodontitis

2213

10685

1.33

32.72

2.9

2.5

3.61

3.62

g/l

0.14

2138

10219

In situ neoplasms

868

5644

1.56

32.69

2.6

2.3

3.63

g/l

0.05

821

5359

Diseases of the eye and adnexa

1908

7040

1.37

32.66

3.6

2.8

3.53

3.58

g/l

0.68

1820

6752

Other and unspecified local infections of skin and subcutaneous tissue

274

1265

2.24

32.63

4.1

3.1

3.85

3.49

g/l

3.20

263

1205

Speech and linguistic disorders, excluding more controls

271

1165

2.26

32.53

6.1

3.7

3.28

3.38

g/l

0.51

260

1122

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

676

4098

1.66

32.49

2.7

2.5

3.71

3.61

g/l

0.97

634

3920

Other cataract

959

4696

1.54

32.40

2.9

2.4

3.65

3.60

g/l

0.52

925

4510

Adenocarcinoma and papilloma adenocarcinoma of rectum

204

831

2.53

32.22

2.0

2.3

3.65

3.58

g/l

0.23

199

786

Any mental disorder

2477

9509

1.31

32.21

3.0

2.6

3.55

3.60

g/l

0.86

2363

9140

Viral hepatitis, including avohilmo

221

939

2.45

32.12

3.6

2.9

3.45

3.57

g/l

0.53

214

893

Hypersplenism

12.48

32.11

3.9

1.9

2.64

4.05

g/l

3.24

Basal cell carcinoma

757

3216

1.62

31.97

2.5

2.4

3.59

3.63

g/l

0.35

727

3057

Exposure to other specified factors

1917

12343

1.35

31.89

2.9

2.8

3.55

3.58

g/l

0.36

1834

11826

Disorders of calcium metabolism

175

669

2.72

31.77

2.9

2.8

3.63

3.53

g/l

0.32

168

637

Intracranial injury

1354

8977

1.42

31.74

2.7

2.8

3.46

3.58

g/l

2.35

1281

8600

Dizziness and giddiness

1672

9540

1.38

31.69

2.5

3.51

3.61

g/l

2.11

1583

9152

Diabetic maculopathy, excluding more controls

278

1305

2.20

31.67

2.7

2.4

4.07

3.56

g/l

5.80

271

1245

Type 2 diabetes, definitions combined, including avohilmo

2061

8957

1.34

31.64

2.9

2.4

3.76

3.55

g/l

7.00

1970

8564

Budesonide

344

1746

2.02

31.61

2.9

2.3

3.38

3.57

g/l

1.63

329

1667

Cholecystectomy

1514

9307

1.40

31.60

2.6

2.4

3.68

3.60

g/l

1.24

1456

8881

Diabetes medication

2369

10620

1.31

31.43

2.9

2.6

3.81

3.53

g/l

14.45

2268

10162

Diabetes, insulin treatment (Kela reimbursement)

2217

10040

1.32

31.39

2.9

2.7

3.81

3.54

g/l

12.31

2113

9626

Transport accidents

1082

6147

1.48

31.27

2.4

2.7

3.54

3.61

g/l

0.85

1022

5890

Viral hepatitis

211

890

2.47

31.21

3.5

2.9

3.46

3.58

g/l

0.49

205

846

Postprocedural endocrine and metabolic disorders, not elsewhere classified

290

1393

2.14

31.02

3.6

2.5

3.50

3.57

g/l

0.33

282

1326

Livedoid vasculitis

13.03

30.96

2.4

2.2

3.64

4.06

g/l

0.51

Zoster [herpes zoster], including avohilmo

1118

7467

1.46

30.76

2.8

2.4

3.57

3.61

g/l

0.43

1084

7120

Maternal care for other conditions predominantly related to pregnancy

507

2854

1.77

30.76

2.4

2.6

3.83

3.53

g/l

4.46

474

2717

Female infertility, cervical, vaginal, other or unspecified origin

647

2503

1.68

30.67

2.3

2.5

3.68

3.65

g/l

0.26

624

2384

Allergic asthma (mode), excluding more controls

490

2731

1.78

30.67

2.8

2.2

3.62

3.46

g/l

1.62

460

2597

Duodenal ulcer

253

1160

2.24

30.51

2.8

2.4

3.44

3.63

g/l

0.96

244

1106

Other disorders of glucose regulation and pancreatic internal secretion

236

1055

2.32

30.47

3.4

3.55

3.51

g/l

0.15

220

1008

Exclusions for E4_PCOS_CONSORTIUM

1634

7470

1.38

30.28

2.7

2.8

3.52

3.56

g/l

0.45

1550

7129

Nonalcoholic fatty liver disease

268

1264

2.19

30.26

2.6

2.7

3.57

g/l

0.01

258

1208

Embolic stroke

122

393

3.23

30.23

2.5

2.2

3.66

3.65

g/l

0.02

117

371

Urticaria and erythema

871

5770

1.53

30.17

3.5

2.9

3.54

3.56

g/l

0.15

821

5526

Other local infections of skin and subcutaneous tissue

281

1352

2.15

30.12

4.0

3.0

3.84

3.50

g/l

3.02

270

1287

Other infectious diseases, including avohilmo

235

1055

2.30

29.99

3.3

2.7

3.62

3.55

g/l

0.30

229

998

Mental and behavioural disorders due to alcohol, excluding acute intoxication

990

6677

1.49

29.95

2.6

2.7

3.66

3.62

g/l

0.35

939

6418

Malignant neoplasm of kidney, except renal pelvis

188

764

2.53

29.92

2.1

2.3

3.91

3.60

g/l

1.47

183

723

Concussion

1132

6084

1.46

29.84

2.7

2.6

3.46

3.59

g/l

2.43

1076

5833

Finngen Rheumatological endpoints

2202

9564

1.32

29.76

3.0

2.7

3.64

3.57

g/l

1.37

2095

9171

Other retinal disorders

1352

7354

1.41

29.70

2.7

2.5

3.74

3.59

g/l

2.98

1306

7026

Other noninfective disorders of lymphatic vessels and lymph nodes

110

338

3.43

29.66

2.6

2.5

3.82

3.62

g/l

0.64

103

317

Single delivery by caesarean section

471

1491

1.85

29.65

2.4

3.0

3.98

3.57

g/l

7.88

448

1426

Viral and other specified intestinal infections

543

3156

1.71

29.43

5.1

2.9

3.35

3.49

g/l

1.57

523

3009

Injuries to the knee and lower leg

2748

11701

1.28

29.42

2.6

2.7

3.57

3.59

g/l

0.25

2630

11204

Unspecified acute lower respiratory infection

377

2025

1.91

29.32

4.0

3.2

3.71

3.53

g/l

1.33

365

1926

Other chronic obstructive pulmonary disease, including avohilmo

1100

6264

1.46

29.29

2.3

2.4

3.75

3.61

g/l

2.35

1037

6024

Malignant neoplasm of rectum

201

850

2.43

29.29

2.0

2.4

3.74

3.60

g/l

0.56

196

805

Benzodiazepine use

2291

11969

1.30

29.27

2.4

2.6

3.63

3.61

g/l

0.29

2173

11483

Other arthritis (FG)

701

4461

1.60

29.15

2.9

2.6

3.77

3.54

g/l

3.28

672

4271

Chronic viral hepatitis

162

624

2.72

29.15

3.4

2.9

3.43

3.61

g/l

0.77

157

597

Idiopathic gout

237

1081

2.27

29.13

2.3

2.4

3.92

3.59

g/l

2.20

229

1035

Speech therapy

559

3368

1.69

29.12

2.9

2.7

3.61

3.60

g/l

0.07

534

3219

Fracture of femur

542

2904

1.71

29.07

2.5

2.4

3.61

g/l

0.03

516

2761

Medical treatment for female infertility

523

3073

1.72

28.96

2.1

2.5

3.71

3.59

g/l

1.29

498

2909

Mycoses, including avohilmo

2129

12476

1.31

28.94

2.8

2.7

3.62

3.59

g/l

0.45

2016

11970

Other congenital malformations, including avohilmo

366

1959

1.92

28.92

3.2

3.9

3.41

3.44

g/l

0.14

352

1874

Caries of enamel

2221

11215

1.31

28.92

3.3

2.6

3.54

3.60

g/l

0.99

2136

10742

Complications of the puerperium, not elsewhere classified

143

520

2.90

28.88

2.9

2.3

3.66

3.67

g/l

0.01

135

491

Other headache syndromes

945

6402

1.49

28.76

2.8

2.5

3.54

3.59

g/l

0.55

902

6131

Perineal laceration during delivery

416

1850

1.86

28.76

1.5

2.7

3.64

3.54

g/l

0.89

399

1757

Myalgia

566

3434

1.68

28.69

2.9

2.4

3.51

3.60

g/l

0.92

541

3273

Senile cataract

1289

5565

1.42

28.65

2.8

2.4

3.67

3.62

g/l

0.55

1234

5358

Low back pain

1816

9222

1.34

28.61

2.7

2.6

3.60

g/l

0.03

1724

8839

Malignant melanoma, including Hilmo

316

1613

2.00

28.48

2.5

2.3

3.52

3.61

g/l

0.48

306

1523

Malignant melanoma

288

1424

2.06

28.42

2.7

2.3

3.54

3.61

g/l

0.36

281

1343

Alcohol use disorder, ICD-based

919

6238

1.49

28.28

2.6

2.7

3.66

3.61

g/l

0.43

871

5993

Female infertility

683

2557

1.63

28.20

2.2

2.5

3.69

3.64

g/l

0.40

660

2436

Malignant neoplasm of breast, HER-negative

318

1563

1.99

28.17

1.9

2.3

3.62

3.61

g/l

0.01

309

1468

Non-small cell lung cancer, including Hilmo

272

1235

2.11

28.08

2.0

2.2

4.09

3.62

g/l

4.33

264

1165

Malignant neoplasm of breast, ER-negative, including Hilmo

343

1685

1.93

28.02

1.9

2.3

3.62

3.61

g/l

0.02

334

1588

Other maternal disorders predominantly related to pregnancy

1188

5236

1.44

27.82

2.2

2.5

3.83

3.54

g/l

9.06

1119

5005

Migraine with aura

622

3893

1.62

27.78

2.9

2.6

3.43

3.59

g/l

2.50

595

3712

Hypotension

373

2032

1.87

27.67

2.6

2.3

3.67

3.64

g/l

0.12

356

1927

Pneumothorax

181

754

2.49

27.51

3.0

2.4

3.71

3.59

g/l

0.45

176

721

Outcome of delivery

328

1024

2.00

27.13

1.9

2.6

3.60

3.54

g/l

0.25

313

971

Autoimmune hepatitis, wide definition

135

492

2.87

27.05

3.9

2.6

2.94

3.58

g/l

6.18

127

471

Insulin, fast-acting (human)

338

1805

1.92

26.81

2.9

2.7

3.98

3.50

g/l

6.78

324

1723

Malignant neoplasm of breast, ER-positive, including Hilmo

502

2202

1.72

26.78

2.0

2.4

3.52

3.60

g/l

0.66

484

2080

Allergic asthma (mode)

490

2845

1.71

26.57

2.8

2.3

3.62

3.46

g/l

1.57

460

2708

Other/unspecified dorsalgia

842

5614

1.50

26.55

2.5

2.6

3.58

3.60

g/l

0.10

808

5370

Localized swelling, mass and lump of skin and subcutaneous tissue

706

4603

1.56

26.44

3.1

2.7

3.58

3.60

g/l

0.12

673

4403

Family history of malignant neoplasm

250

1209

2.12

26.35

2.0

2.1

3.49

3.64

g/l

1.02

243

1142

Umbilical hernia

612

3870

1.61

26.29

2.3

2.7

3.58

3.65

g/l

0.58

592

3714

Malignant neoplasm of breast, HER-positive

497

2191

1.71

26.17

2.0

2.4

3.52

3.61

g/l

0.72

479

2069

Emphysema

183

784

2.41

26.11

2.7

2.4

3.83

3.53

g/l

1.59

175

753

Fracture of lower leg, including ankle

1204

8541

1.40

26.08

2.6

2.8

3.60

3.59

g/l

0.07

1148

8198

Superficial injury of lower leg

610

3861

1.61

26.07

2.7

3.48

3.56

g/l

0.69

578

3682

Problems related to lifestyle

264

1309

2.07

26.07

3.0

2.5

3.70

3.60

g/l

0.42

251

1247

Symptoms and signs concerning food and fluid intake

241

1153

2.14

25.98

3.4

2.4

3.43

3.55

g/l

0.61

229

1108

Other postsurgical states

171

713

2.49

25.97

6.8

2.6

3.47

3.54

g/l

0.20

163

675

Unstable angina pectoris

645

3223

1.59

25.83

2.3

2.1

3.54

3.70

g/l

1.90

617

3078

Speech and linguistic disorders

292

1444

2.01

25.80

6.2

4.7

3.22

3.27

g/l

0.25

281

1401

Non-seminoma of testis, including Hilmo

8.50

25.79

1.4

3.7

3.40

3.85

g/l

0.52

Cystic fibrosis, other manifestations/unspecified

48.32

25.75

6.3

2.5

3.33

3.15

g/l

0.19

Voice disturbances

572

3580

1.62

25.66

2.7

2.5

3.61

g/l

0.00

553

3407

Hypoglycaemia, other or unspecified

195

868

2.33

25.58

3.6

3.4

3.53

3.50

g/l

0.09

184

828

Malignant neoplasm of head and neck

166

686

2.49

25.53

2.1

2.4

3.72

3.58

g/l

0.56

159

654

Benign neoplasm: Colon, unspecified

526

3234

1.66

25.40

2.2

2.4

3.72

3.62

g/l

0.74

504

3092

Fracture of skull and facial bones

488

2949

1.68

25.22

2.8

3.50

3.59

g/l

0.69

465

2828

Malignant neoplasm of bronchus and lung, including Hilmo

363

1667

1.84

25.15

2.0

2.3

4.00

3.63

g/l

3.73

348

1579

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

181

785

2.38

25.11

3.3

2.3

4.15

3.62

g/l

3.49

169

745

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

139

540

2.75

24.89

4.0

6.5

3.20

3.19

g/l

0.01

134

524

Malignant neoplasm of head and neck, including Hilmo

192

855

2.30

24.89

2.2

2.4

3.71

3.62

g/l

0.33

181

814

Presence of other functional implants

1077

5226

1.42

24.73

2.4

2.1

3.61

3.68

g/l

0.72

1024

5001

Recurrent or chronic depression

900

4287

1.47

24.70

2.9

2.8

3.60

g/l

0.03

858

4125

Abnormal findings on diagnostic imaging of other body structures

321

1739

1.89

24.41

2.7

2.6

3.52

3.57

g/l

0.21

310

1656

Malignant neoplasm of brain, including Hilmo

123

451

2.83

24.32

2.6

2.9

3.13

3.54

g/l

2.68

123

427

Twin gestation

216

1021

2.18

24.31

2.0

2.7

3.61

3.57

g/l

0.17

201

975

Irregular menses

1091

5863

1.41

24.24

3.0

2.4

3.50

3.63

g/l

2.62

1040

5581

Other disorders of lacrimal gland

780

5292

1.49

24.16

3.3

2.5

3.60

3.61

g/l

0.09

749

5059

Superficial injury of head

536

3351

1.62

24.04

2.2

3.1

3.60

3.56

g/l

0.22

510

3202

Progressive vascular leukoencephalopathy

320

3.20

23.90

1.6

2.0

3.63

g/l

0.01

302

Multiple gestation

220

1058

2.14

23.68

2.0

2.7

3.61

3.57

g/l

0.20

205

1011

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

213

999

2.15

23.54

2.1

2.0

3.61

3.60

g/l

0.03

202

941

Cholecystitis

290

1543

1.92

23.27

2.9

2.3

3.76

3.60

g/l

0.88

280

1466

Adrenocortical insufficiency

112

402

2.93

23.25

5.1

3.2

3.37

3.54

g/l

0.49

101

386

Gingivitis and periodontal diseases

2140

8701

1.28

22.99

3.1

2.5

3.55

3.59

g/l

0.65

2041

8342

Gastro-oesophageal reflux disease

1414

8985

1.34

22.95

2.7

3.58

3.61

g/l

0.27

1336

8626

Collagenous colitis

226

1114

2.09

22.83

4.0

2.7

3.66

3.55

g/l

0.48

219

1058

Congenital malformations of the musculoskeletal system, not elsewhere classified

170

4.16

22.67

6.7

4.4

3.07

3.43

g/l

1.63

165

Other specified/unspecified arthritis

605

3950

1.55

22.62

2.9

2.7

3.76

3.54

g/l

2.75

579

3784

Malignant neoplasm of bladder, including Hilmo

210

993

2.13

22.62

2.3

2.2

3.71

3.64

g/l

0.25

204

937

Other puerperal infections

224

1108

2.09

22.50

2.0

2.2

3.97

3.65

g/l

2.60

206

1046

Squamous cell neoplasms and carcinomas of the skin

173

769

2.30

22.49

1.8

2.0

3.62

g/l

0.01

166

721

Asthma/COPD (KELA code 203)

2145

11380

1.27

22.48

2.5

2.8

3.66

3.56

g/l

2.34

2023

10930

Other specific joint derangements/joint disorders

1722

8285

1.31

22.39

2.7

2.8

3.63

3.56

g/l

1.17

1638

7970

Alcohol dependence

564

3637

1.57

22.32

2.6

2.7

3.65

3.60

g/l

0.28

534

3493

Pneumonitis due to solids and liquids

193

905

2.19

22.20

2.8

2.4

3.89

3.60

g/l

1.25

184

865

Disorders of lacrimal system

919

6421

1.42

22.19

3.2

2.5

3.60

3.61

g/l

0.07

882

6137

Missing teeth due to accident, extraction or parodontitis

1276

8516

1.35

22.15

2.6

2.5

3.58

3.63

g/l

0.52

1208

8179

Other abnormal products of conception

731

3230

1.51

22.08

2.1

2.5

3.64

3.59

g/l

0.56

681

3085

Retinal detachments and breaks

713

4841

1.49

22.06

2.5

2.4

3.66

3.61

g/l

0.34

691

4633

Cerebral cysts

159

692

2.38

22.06

3.6

3.0

3.21

3.60

g/l

2.67

149

660

Traumatic subarachnoid haemorrhage

102

358

2.97

21.97

2.5

2.1

3.55

3.58

g/l

0.07

336

Superficial injury of hip and thigh

328

1847

1.81

21.94

2.7

2.5

3.59

3.57

g/l

0.09

306

1760

Disorders of psychological development

351

1868

1.79

21.93

6.1

4.0

3.30

3.35

g/l

0.23

336

1798

Fracture of shoulder and upper arm

767

5284

1.47

21.83

3.2

2.7

3.50

3.56

g/l

0.47

739

5055

Benign neoplasm: Stomach

219

1085

2.08

21.83

4.3

2.4

3.59

3.61

g/l

0.07

213

1031

Persons encountering health services in circumstances related to reproduction

1200

5930

1.37

21.83

3.7

3.3

3.44

3.53

g/l

1.12

1162

5710

Status post-ami

452

2085

1.67

21.77

2.6

2.1

3.72

g/l

0.03

437

1989

Disorders of conjunctiva

1891

11540

1.28

21.71

2.8

3.57

g/l

0.02

1801

11053

Diseases of the musculoskeletal system and connective tissue

1302

4841

1.36

21.63

3.7

2.8

3.53

g/l

0.05

1239

4652

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

676

4564

1.50

21.60

2.7

3.71

3.57

g/l

1.45

634

4359

Overexertion and strenuous or repetitive movements

243

1255

1.99

21.55

2.7

3.73

3.56

g/l

0.98

234

1197

Symptoms and signs involving the nervous and musculoskeletal systems

1252

9396

1.34

21.44

3.0

2.7

3.54

3.57

g/l

0.28

1200

8995

Non-small cell lung cancer

184

847

2.19

21.35

1.9

2.1

4.14

3.62

g/l

3.35

177

796

Other and unspecified effects of external causes

641

4301

1.51

21.13

2.8

3.2

3.59

3.54

g/l

0.38

604

4107

Childhood asthma (age<16), excluding more controls

332

1465

1.80

21.11

3.0

2.5

3.55

3.46

g/l

0.52

320

1391

Injuries to the ankle and foot

1663

11077

1.29

21.01

2.9

2.8

3.54

3.58

g/l

0.51

1591

10609

Asthma and allergy, excluding more controls

285

1539

1.86

20.95

3.1

2.4

3.54

3.45

g/l

0.42

269

1459

Labour and delivery complicated by fetal stress [distress]

520

2141

1.60

20.81

2.2

2.6

3.72

3.54

g/l

2.34

482

2039

Chronic sinusitis

920

6606

1.41

20.80

3.0

2.6

3.66

3.60

g/l

0.65

871

6323

Dorsalgia

2222

9434

1.26

20.72

2.7

2.6

3.59

g/l

0.05

2121

9040

Acute generalized exanthematous pustulosis

128

521

2.56

20.70

3.0

3.1

3.65

3.60

g/l

0.14

121

499

Excessive, frequent and irregular menstruation

828

3066

1.46

20.67

3.0

2.5

3.50

3.62

g/l

1.66

780

2915

Herpesviral [herpes simplex] infections

272

1477

1.89

20.66

3.4

2.6

3.60

g/l

0.01

262

1405

Conjunctivitis (acute, non atopic), including avohilmo

2252

10945

1.25

20.65

2.7

2.8

3.62

3.58

g/l

0.65

2146

10504

Visual field defects

200

979

2.10

20.65

3.7

2.4

3.40

3.58

g/l

1.07

192

923

Adverse effects, not elsewhere classified

463

2909

1.62

20.64

3.0

3.2

3.54

g/l

0.03

437

2763

Alcohol-induced chronic pancreatitis

168

771

2.26

20.60

2.2

2.6

3.68

3.57

g/l

0.35

160

743

Other disorders of eye and adnexa

337

1952

1.76

20.60

3.0

3.45

3.54

g/l

0.58

319

1859

Sequelae of injuries, of poisoning and of other consequences of external causes

506

3246

1.58

20.57

2.8

3.62

3.58

g/l

0.22

483

3102

Other disorders of adrenal gland

132

547

2.52

20.55

4.8

3.7

3.50

3.48

g/l

0.04

121

523

Maternal care for known or suspected malpresentation of fetus

412

1769

1.69

20.54

2.1

2.7

3.58

3.53

g/l

0.29

394

1691

Prophylactic surgery

5.97

20.53

2.0

1.9

3.09

3.48

g/l

0.91

Delirium, not induced by alcohol and other psychoactive substances

268

1450

1.88

20.38

2.4

2.2

3.69

3.60

g/l

0.43

258

1377

Depression or dysthymia

1427

5925

1.33

20.34

2.7

3.61

3.59

g/l

0.19

1363

5713

Stomatitis and related lesions

454

2849

1.62

20.33

4.0

2.9

3.57

3.55

g/l

0.09

439

2724

Migraine without aura

499

3200

1.59

20.33

3.7

2.9

3.45

3.56

g/l

1.14

474

3050

Lung diseases due to external agents

287

1592

1.84

20.27

2.7

2.4

3.86

3.58

g/l

1.92

276

1520

Complications predominantly related to the puerperium

578

3836

1.53

20.16

2.1

2.4

3.74

3.62

g/l

1.43

542

3650

Childhood asthma (age<16)

333

1492

1.78

20.15

3.0

2.6

3.55

3.47

g/l

0.49

320

1419

Exclusions for E4_PCOS_BROAD

415

2556

1.65

20.05

3.6

3.7

3.45

g/l

0.01

394

2448

Subarachnoid haemorrhage

208

1044

2.04

19.95

2.6

2.4

3.73

3.59

g/l

0.65

197

999

conjunctival haemorrhage

181

865

2.16

19.95

3.4

2.5

3.58

3.61

g/l

0.07

169

821

Viral warts, including avohilmo

512

3322

1.57

19.84

3.5

3.1

3.45

3.54

g/l

0.64

492

3168

Retained placenta and membranes, without haemorrhage

248

1325

1.91

19.82

1.9

2.5

3.51

3.62

g/l

0.59

235

1259

Personality disorders, excluding more controls

569

3768

1.53

19.76

2.5

2.6

3.71

3.61

g/l

0.83

539

3604

Osteoporosis with pathological fracture (FG)

152

682

2.29

19.56

4.2

2.4

3.33

3.57

g/l

1.24

144

651

Open wound of head

1153

8132

1.34

19.55

2.8

2.9

3.51

3.59

g/l

1.09

1106

7811

Viral warts

251

1356

1.90

19.48

4.9

3.0

3.37

3.53

g/l

1.01

240

1300

N06DA Anticholinesterases

247

3443

0.55

19.47

2.0

2.1

3.68

3.65

g/l

0.10

230

3279

Use of anticholinesterases

247

3443

0.55

19.47

2.0

2.1

3.68

3.65

g/l

0.10

230

3279

Lower back pain or/and sciatica

2366

11983

1.23

19.46

2.6

3.61

g/l

0.09

2248

11488

Poor fetal growth

320

1860

1.76

19.42

2.8

2.4

3.82

3.62

g/l

1.84

304

1759

Unspecific neurodegenerative disorder

340

3872

0.59

19.41

2.0

2.1

3.63

3.65

g/l

0.13

322

3691

Psychiatric diseases

2126

8551

1.25

19.32

2.9

2.6

3.54

3.60

g/l

0.95

2042

8220

Urticaria

673

4642

1.47

19.32

3.7

3.0

3.52

3.55

g/l

0.15

638

4431

Malignant neoplasm of stomach, including Hilmo

113

446

2.60

19.28

2.0

2.1

3.69

3.51

g/l

0.48

106

423

5-aminosalicylic acid

446

2821

1.61

19.28

2.8

2.5

3.54

3.53

g/l

0.03

423

2699

Hemiplegia

128

538

2.46

19.25

5.4

2.3

3.68

3.61

g/l

0.17

121

508

Inflammatory bowel disease

683

4728

1.46

19.24

3.2

2.8

3.52

3.56

g/l

0.33

652

4503

COPD, hospital admissions 1, only main diagnosis

646

3784

1.48

19.23

2.3

3.76

3.63

g/l

1.35

604

3622

Malignant neoplasm of other and ill-defined sites, including Hilmo

104

4.68

19.23

1.9

2.1

3.76

3.69

g/l

0.11

Menorrhagia

699

2662

1.48

19.13

2.7

2.5

3.47

3.63

g/l

2.21

653

2530

Cerebral aneurysm, nonruptured

186

912

2.09

19.11

2.7

2.3

3.54

3.62

g/l

0.33

181

871

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

304

1742

1.78

19.03

4.4

4.3

3.21

3.37

g/l

1.42

289

1674

Inflammatory disease of uterus

320

1870

1.75

18.99

2.2

2.3

3.71

3.64

g/l

0.43

305

1769

Other symptoms and signs involving cognitive functions and awareness

928

6000

1.38

18.93

2.6

2.5

3.60

3.62

g/l

0.11

878

5760

Neuromuscular dysfunction of bladder

204

1038

2.02

18.92

4.4

2.6

3.65

3.52

g/l

0.55

194

994

Asthma and allergy

284

1582

1.80

18.88

3.1

2.4

3.54

3.46

g/l

0.42

268

1501

Inflammatory diseases of female pelvic organs

1315

6882

1.32

18.78

2.6

2.4

3.60

3.62

g/l

0.13

1244

6562

Mucosal proctocolitis

295

1691

1.78

18.76

3.2

2.8

3.49

3.55

g/l

0.28

282

1614

Malignant neoplasm of bronchus and lung

302

1443

1.77

18.66

2.0

2.2

4.01

3.60

g/l

3.65

289

1363

Diabetic retinopathy, strict definition

394

2162

1.65

18.63

2.8

4.05

3.75

g/l

3.25

385

2063

Malignant neoplasm of oral cavity, including Hilmo

368

2.76

18.59

2.1

2.3

3.83

3.55

g/l

0.87

347

Poisoning by medicine

485

3161

1.56

18.46

2.7

2.8

3.60

3.56

g/l

0.23

466

3010

Myocardial infarction, with ST-elevation

335

1996

1.71

18.43

2.8

2.4

3.51

3.64

g/l

0.85

325

1901

Poisoning by drugs, medicaments and biological substances

525

3481

1.53

18.42

2.7

3.60

3.56

g/l

0.27

504

3312

Pyothorax

115

472

2.54

18.31

3.1

2.3

4.10

3.68

g/l

1.31

110

448

Other intracranial haemorrhages

283

3.02

18.30

3.0

2.3

3.79

3.64

g/l

0.37

267

Congenital malformations and deformations of the musculoskeletal system

254

1400

1.86

18.25

4.6

4.8

3.15

3.31

g/l

1.29

243

1350

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

212

3.43

18.24

6.6

3.8

3.11

3.48

g/l

1.81

202

Malignant melanoma of skin, including Hilmo

242

1318

1.87

18.15

2.2

2.3

3.58

3.61

g/l

0.12

236

1244

Ovarian cyst

727

2895

1.45

18.13

2.5

3.61

3.65

g/l

0.25

693

2753

Injury of other and unspecified intrathoracic organs

161

765

2.17

18.10

2.3

2.5

3.56

3.61

g/l

0.13

154

732

Maternal care related to the fetus and amniotic cavity and possible delivery problems

850

3571

1.41

18.09

2.0

2.7

3.73

3.56

g/l

3.11

804

3422

Disorders of eyelid, lacrimal system and orbit

1858

10932

1.25

18.04

2.9

2.6

3.56

3.59

g/l

0.46

1777

10468

Hypothyroidism, strict autoimmune

1520

7812

1.29

17.95

2.7

2.4

3.58

3.60

g/l

0.15

1434

7487

Other general symptoms and signs

130

562

2.36

17.91

3.6

2.8

3.25

3.44

g/l

0.99

125

541

Ulcerative colitis

520

3462

1.52

17.90

3.3

2.8

3.48

3.56

g/l

0.54

492

3295

Fall on and from stairs and steps

548

3691

1.51

17.82

2.3

2.8

3.53

3.59

g/l

0.44

523

3523

Polyuria

439

2822

1.58

17.75

2.7

2.5

3.60

3.59

g/l

0.06

425

2703

Sarcoidosis

278

1594

1.78

17.70

3.7

2.6

3.54

3.59

g/l

0.24

269

1522

Small fibre neuropathy

340

2.82

17.66

5.0

2.6

3.62

g/l

0.00

327

Substance use, excluding alcohol

429

2749

1.59

17.63

2.6

2.8

3.65

3.57

g/l

0.50

407

2624

Conjunctivitis

1682

10805

1.26

17.53

2.7

2.9

3.56

g/l

0.02

1604

10338

Disorders of oesophagus in diseases classified elsewhere

222

3.30

17.53

3.6

2.5

3.44

3.62

g/l

0.47

217

Melanocytic naevi

669

4697

1.44

17.52

3.2

2.6

3.47

3.61

g/l

2.14

636

4477

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

173

856

2.08

17.41

3.9

2.3

4.03

3.54

g/l

4.37

163

810

Irritable bowel syndrome

553

3751

1.49

17.33

2.3

2.5

3.65

3.61

g/l

0.29

527

3563

Complications of labour and delivery

1181

4976

1.33

17.32

2.0

2.5

3.70

3.58

g/l

2.04

1105

4771

Diabetic retinopathy

740

3250

1.43

17.30

2.6

2.7

3.87

3.74

g/l

1.19

717

3116

Use of donepezil

2195

0.42

17.28

2.3

2.0

3.42

3.66

g/l

1.17

2076

Varicose veins

1045

5932

1.34

17.12

2.4

2.3

3.68

3.64

g/l

0.29

996

5676

Other disorders of optic [2nd] nerve and visual pathways

166

816

2.10

17.12

3.1

3.6

3.53

3.52

g/l

0.03

160

776

Spondylopathies

1587

7423

1.27

17.00

2.3

2.5

3.65

3.61

g/l

0.38

1515

7118

Hypercalcemia

111

466

2.48

16.86

3.3

2.5

3.64

3.58

g/l

0.14

105

448

Open wound of ankle and foot

247

1391

1.82

16.79

2.6

3.0

3.83

3.54

g/l

2.30

235

1326

Left hemicolectomy

223

3.23

16.73

2.6

3.96

3.67

g/l

0.81

214

Habitual aborter

239

3.13

16.69

1.9

2.3

3.68

3.61

g/l

0.13

219

Soft tissue disorders related to use, overuse and pressure

548

3741

1.48

16.66

2.7

2.5

3.66

3.59

g/l

0.46

529

3594

Abnormal results of function studies

206

1100

1.92

16.64

3.3

3.0

3.80

3.52

g/l

1.52

194

1053

Malignant neoplasm of brain

328

2.76

16.49

2.7

3.03

3.53

g/l

3.02

311

Dermatitis due to substances taken internally

138

641

2.22

16.48

2.7

3.3

3.77

3.56

g/l

0.88

130

614

Abnormal findings on antenatal screening of mother

213

1154

1.89

16.46

1.8

2.4

3.89

3.51

g/l

4.45

195

1088

Pruritus

255

1458

1.78

16.42

3.1

2.6

3.64

3.57

g/l

0.36

239

1386

Other disorders of the musculoskeletal system and connective tissue

305

1832

1.70

16.41

2.3

2.5

3.75

3.60

g/l

1.03

292

1743

Antenatal screening

403

1414

1.62

16.36

1.9

2.6

3.66

3.55

g/l

0.85

383

1347

Other symptoms and signs involving the digestive system and abdomen

326

1991

1.66

16.36

2.7

2.5

3.25

3.59

g/l

4.52

309

1897

Retinal vascular occlusion

237

1328

1.82

16.34

2.6

2.3

3.61

3.63

g/l

0.04

229

1262

Haemorrhage in early pregnancy

552

3682

1.47

16.24

2.2

2.5

3.67

3.54

g/l

1.45

526

3515

Rash and other nonspecific skin eruption

213

1160

1.88

16.18

2.7

2.9

3.45

3.58

g/l

0.64

204

1102

Retinal vascular disorders

239

1347

1.81

16.15

2.6

2.3

3.61

3.63

g/l

0.06

231

1281

Vitamin deficiency

120

531

2.34

16.14

3.7

2.8

3.44

3.55

g/l

0.32

114

502

Vitamin deficiency, wide

120

531

2.34

16.14

3.7

2.8

3.44

3.55

g/l

0.32

114

502

Seborrhoeic keratosis

465

3092

1.52

16.14

2.9

2.2

3.36

3.62

g/l

4.36

441

2962

Erectile dysfunction

185

965

1.97

16.13

12.3

2.4

3.67

3.63

g/l

0.14

180

920

Herpesviral [herpes simplex] infections, including avohilmo

553

3809

1.47

16.12

2.9

2.6

3.58

3.60

g/l

0.16

522

3629

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

132

606

2.23

16.04

2.4

2.3

3.63

3.65

g/l

0.04

127

577

Assault

303

1829

1.69

16.02

2.6

3.0

3.54

3.55

g/l

0.01

280

1748

Other complications of labour and delivery, not elsewhere classified

269

1386

1.75

16.02

1.8

2.6

3.69

3.56

g/l

0.80

256

1311

Diplopia

278

1645

1.72

15.86

3.7

2.6

3.58

3.57

g/l

0.05

268

1566

Generalized skin eruption due to drugs and medicaments

106

449

2.46

15.83

2.9

3.3

3.77

3.55

g/l

0.66

100

430

Hyposplenism

19.95

15.66

7.7

2.2

3.38

3.85

g/l

0.49

Pneumonia derived septicemia

403

2.54

15.64

7.3

3.4

3.83

3.53

g/l

0.72

381

Disorders of vitreous body and globe

994

7146

1.33

15.64

2.4

3.68

3.61

g/l

0.73

958

6856

Disorders of skin appendages

1092

8384

1.31

15.51

3.2

2.7

3.58

3.57

g/l

0.11

1045

8013

Other diseases of oesophagus

193

1032

1.91

15.50

2.7

2.6

3.70

3.63

g/l

0.20

180

981

Sicca syndrome [Sjögren]

173

893

1.98

15.49

3.5

2.4

3.60

3.62

g/l

0.07

164

849

Nonorganic sleeping disorders, excluding more controls

442

2935

1.53

15.48

3.0

2.6

3.53

3.57

g/l

0.22

422

2813

Other diseases of hard tissues of teeth

1107

4372

1.32

15.47

3.4

2.4

3.59

3.62

g/l

0.27

1057

4180

Other diseases of stomach and duodenum

145

704

2.12

15.43

2.9

2.3

3.35

3.63

g/l

1.52

140

671

Other Crohn's disease

164

833

2.02

15.43

2.9

3.1

3.38

3.52

g/l

0.57

159

796

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

690

4983

1.40

15.43

3.5

2.9

3.51

3.56

g/l

0.42

660

4759

Functional dyspepsia

520

3572

1.47

15.36

2.4

3.56

3.63

g/l

0.44

497

3407

Premature rupture of membranes

435

2029

1.55

15.36

1.8

2.7

3.76

3.55

g/l

2.69

392

1942

Diseases of oral cavity, salivary glands and jaws

1115

4389

1.32

15.33

2.9

2.4

3.58

3.62

g/l

0.41

1066

4197

Malnutrition

269

2.92

15.25

6.7

4.6

3.32

3.37

g/l

0.11

260

Malignant neoplasm of stomach

389

2.50

15.11

2.0

2.1

3.67

3.52

g/l

0.38

369

Disorders of ocular muscles, binocular movement, accommodation and refraction

1055

8066

1.31

15.07

3.7

2.9

3.46

3.55

g/l

1.33

1013

7717

Disorders of vitreous body

967

7010

1.32

15.00

2.5

2.4

3.68

3.62

g/l

0.68

933

6729

Other disorders starting during childhood or adolecense, excluding more controls

153

731

2.07

14.96

8.0

4.1

3.21

3.28

g/l

0.21

146

704

Injuries to the shoulder and upper arm

1801

11367

1.23

14.91

2.8

2.7

3.56

3.60

g/l

0.45

1722

10908

Crohn disease

286

1735

1.68

14.88

3.3

3.0

3.49

3.51

g/l

0.06

281

1652

Acute bronchiolitis

192

938

1.91

14.82

5.2

6.0

3.13

3.12

g/l

0.03

186

908

Polycystic ovarian syndrome, consortium definition

1469

6719

1.26

14.77

2.8

2.3

3.52

3.62

g/l

2.12

1398

6397

Pain and other conditions associated with female genital organs and menstrual cycle

461

2595

1.50

14.72

2.6

3.47

3.64

g/l

1.73

431

2468

Disorders of optic nerve and visual pathways

222

1263

1.80

14.68

3.9

3.3

3.46

3.54

g/l

0.35

215

1200

Acute suppurative otitis media

619

4122

1.42

14.65

3.7

3.1

3.54

3.51

g/l

0.19

588

3934

Other and unspecified visual disturbances

228

1308

1.78

14.60

3.8

2.6

3.49

3.58

g/l

0.42

219

1246

Alcohol abuse, main dg, excluding more controls

314

1960

1.63

14.55

3.1

2.8

3.66

3.59

g/l

0.31

304

1876

Somatoform disorder

336

2133

1.60

14.50

2.9

2.5

3.46

3.61

g/l

1.13

312

2021

Disorders of the thyroid gland

2019

10840

1.21

14.49

2.9

2.5

3.57

3.61

g/l

0.46

1915

10382

Spondyloarthritis

347

2228

1.58

14.21

2.5

3.90

3.58

g/l

3.41

327

2117

Convalescence

112

508

2.27

14.20

3.0

2.2

3.57

3.54

g/l

0.06

106

485

Mental and behavioural disorders due to sedatives or hypnotics

157

811

1.99

14.12

2.6

2.9

3.74

3.54

g/l

0.76

151

776

Post-traumatic stress disorder

219

1256

1.78

14.09

3.0

2.5

3.61

3.58

g/l

0.11

206

1188

Cardiac murmurs and other cardiac sounds

219

1240

1.78

14.08

4.4

4.0

3.29

3.44

g/l

0.98

213

1193

Carcinoma in situ of skin

170

903

1.93

14.03

3.4

2.2

3.58

3.62

g/l

0.13

160

857

Diseases of middle ear and mastoid

1260

8164

1.27

14.01

3.2

2.8

3.61

3.56

g/l

0.46

1202

7801

Diseases of pulp and periapical tissues, including avohilmo

2246

9711

1.20

13.98

2.7

2.8

3.67

3.54

g/l

3.49

2148

9296

Supervision of normal pregnancy

372

1359

1.58

13.97

1.8

2.6

3.69

3.56

g/l

0.99

353

1294

Recurrent aphthous stomatitis , including avohilmo

315

1989

1.61

13.97

4.6

2.9

3.52

3.51

g/l

0.01

306

1899

Dementia in Alzheimer disease

1688

0.44

13.91

1.8

2.0

3.61

3.67

g/l

0.14

1594

Spontaneous abortion

915

4655

1.33

13.88

2.2

2.4

3.60

3.59

g/l

0.04

869

4455

Conjunctivitis (acute, non atopic)

618

4444

1.40

13.88

3.2

3.53

g/l

0.02

586

4250

Abscess of anal and rectal regions

183

999

1.87

13.85

3.0

2.7

3.95

3.53

g/l

2.46

177

961

Superficial injury of abdomen, lower back and pelvis

337

2168

1.58

13.76

3.0

2.9

3.44

3.56

g/l

0.80

319

2066

Injuries to the neck

489

3396

1.46

13.75

2.2

2.7

3.57

3.58

g/l

0.07

468

3232

Tubulo-interstitial nephritis, not specified as acute or chronic

133

654

2.08

13.68

3.0

2.2

3.79

3.52

g/l

1.38

126

617

Vitamin B12 deficiency anaemia

182

997

1.86

13.57

2.5

2.2

3.56

3.65

g/l

0.33

170

952

Speech disturbances, not elsewhere classified

182

1000

1.86

13.51

3.6

2.5

3.65

3.60

g/l

0.17

173

949

Specific development disorders of speech and language

175

917

1.90

13.49

5.7

5.3

3.34

3.18

g/l

0.62

167

895

Other and unspecified urticaria

420

2845

1.50

13.48

4.1

3.1

3.45

3.51

g/l

0.36

400

2708

Abnormal serum enzyme levels

602

4196

1.40

13.46

2.9

2.5

3.58

3.61

g/l

0.16

578

4045

Other specified disorders of kidney and ureter

352

2.52

13.42

3.5

2.9

3.68

3.64

g/l

0.06

342

Otitis media, unspecified

281

1602

1.65

13.41

5.3

3.6

3.54

3.42

g/l

0.57

266

1536

Other (not insulin) diabetes medications

1959

9551

1.21

13.37

2.7

2.4

3.84

3.56

g/l

12.08

1873

9134

Carcinoma in situ of skin of scalp and neck

288

2.69

13.33

2.5

2.3

3.68

3.65

g/l

0.04

271

Disorders of tooth development and eruption

358

1900

1.55

13.31

3.7

2.6

3.35

3.58

g/l

2.27

340

1813

Panic disorder

335

2172

1.57

13.25

2.5

3.74

3.62

g/l

0.77

311

2061

Other diseases of lip and oral mucosa

843

6430

1.32

13.22

3.0

2.7

3.55

3.60

g/l

0.38

803

6151

Chronic rhinitis, nasopharyngitis and pharyngitis

679

5019

1.37

13.19

2.6

2.8

3.49

3.56

g/l

0.70

646

4810

Benign neoplasm: Transverse colon

224

1318

1.74

13.18

2.8

2.4

3.63

g/l

0.00

216

1259

Diseases of the myoneural junction and muscle

248

1500

1.68

13.12

4.5

2.8

3.54

g/l

0.01

239

1432

Alzheimer disease, including avohilmo

307

3290

0.64

13.03

2.0

2.1

3.68

3.66

g/l

0.09

286

3138

Inflammatory diseases of the central nervous system

184

1027

1.83

13.03

3.3

2.8

3.77

3.58

g/l

0.76

177

979

Supplementary factors related to causes of morbidity and mortality classified elsewhere

640

4701

1.38

12.99

3.2

2.7

3.53

3.57

g/l

0.35

613

4487

Antepartum haemorrhage, not elsewhere classified

181

1006

1.84

12.97

2.1

2.6

3.66

3.53

g/l

0.58

174

958

Suppurative and unspecified otitis media

809

5437

1.33

12.95

3.4

2.9

3.59

3.53

g/l

0.49

772

5191

Persistent mood disorders

377

2520

1.52

12.91

2.5

2.6

3.74

3.60

g/l

0.92

367

2396

Malignant neoplasm of bone and articular cartilage, including Hilmo

150

3.35

12.81

5.2

3.1

3.80

3.65

g/l

0.22

145

Spinal stenosis

949

5412

1.30

12.77

2.2

2.3

3.67

3.64

g/l

0.29

909

5193

Pneumococcal septicemia

398

2.38

12.75

7.3

3.5

3.84

3.59

g/l

0.52

379

Dementia

414

4110

0.68

12.72

2.4

2.2

3.59

3.65

g/l

0.42

390

3921

Other disorders of conjunctiva

275

1724

1.62

12.61

3.5

2.5

3.63

3.59

g/l

0.16

260

1639

Other dorsopathies, not elsewhere classified

2165

9466

1.19

12.56

2.7

2.6

3.58

3.59

g/l

0.03

2066

9070

Preterm labour and delivery

454

3163

1.45

12.56

2.4

2.5

3.74

3.59

g/l

1.52

423

3040

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

350

2322

1.53

12.49

2.8

3.70

3.57

g/l

0.77

335

2210

Memory loss

176

985

1.82

12.36

2.3

3.59

3.63

g/l

0.12

168

938

Osteonecrosis due to drugs

165

3.23

12.34

5.5

2.5

3.46

3.63

g/l

0.33

160

Visual impairment including blindness (binocular or monocular)

144

757

1.95

12.32

2.5

2.7

3.42

3.57

g/l

0.55

138

718

Diseases of pulp and periapical tissues and dental caries

1315

5413

1.25

12.32

2.8

2.5

3.56

3.58

g/l

0.16

1257

5179

Rheumatoid arthritis

595

3847

1.38

12.30

2.5

2.4

3.77

3.58

g/l

2.06

567

3686

Benign neoplasm: Rectum, anus and anal canal

372

2506

1.50

12.30

2.4

2.3

3.65

3.61

g/l

0.16

359

2394

Abnormal involuntary movements

283

1798

1.60

12.30

3.6

2.7

3.54

3.53

g/l

0.07

276

1717

Ulcerative colitis, NAS

289

1845

1.59

12.29

3.8

2.9

3.43

3.53

g/l

0.51

272

1757

Diabetic neuropathy

248

1521

1.66

12.29

2.8

2.7

4.04

3.73

g/l

2.35

232

1460

Use of other anti-dementia drugs

193

2633

0.58

12.26

1.6

2.0

3.57

3.67

g/l

0.53

182

2490

Use of memantine

193

2633

0.58

12.26

1.6

2.0

3.57

3.67

g/l

0.53

182

2490

Certain conditions originating in the perinatal period

238

1285

1.68

12.24

5.6

4.8

3.11

3.26

g/l

0.84

228

1241

Sequelae of injuries of lower limb

199

1158

1.75

12.23

2.9

2.6

3.72

3.57

g/l

0.66

190

1100

Familial hypercholesterolemia

256

1589

1.63

12.20

2.4

3.69

3.59

g/l

0.44

244

1519

Personality disorders

569

4147

1.39

12.19

2.5

2.7

3.71

3.59

g/l

1.09

539

3960

Disorders of sclera, cornea, iris and ciliary body

1109

8850

1.26

12.17

2.8

2.6

3.71

3.58

g/l

2.04

1061

8476

Bacterial, viral and other infectious agents, including avohilmo

203

1191

1.74

12.13

5.7

3.1

3.56

3.55

g/l

0.04

197

1132

False labour

558

2487

1.41

12.08

1.9

2.7

3.65

3.56

g/l

0.84

515

2383

Selective serotonin reuptake inhibitors

2082

9114

1.19

12.07

2.3

2.7

3.65

3.58

g/l

1.12

1976

8764

Fracture of foot, except ankle

512

3677

1.41

11.99

2.9

2.8

3.45

3.56

g/l

1.02

493

3518

Endometriosis diagnosis and infertility diagnosis occurring together

224

1356

1.68

11.89

1.8

2.3

3.67

3.62

g/l

0.20

214

1271

Special screening examination for neoplasms

132

682

1.98

11.89

2.4

2.5

3.94

3.73

g/l

0.75

126

656

Bacterial, viral and other infectious agents

188

1087

1.77

11.85

6.0

3.1

3.48

3.55

g/l

0.29

182

1036

Long labour

453

2693

1.44

11.84

2.6

3.77

3.57

g/l

2.67

434

2569

Type of accident

587

4320

1.37

11.83

3.2

2.7

3.54

3.57

g/l

0.17

562

4120

Varicella [chickenpox]

123

624

2.04

11.81

5.6

3.9

3.40

3.56

g/l

0.51

117

606

Other condition

298

1934

1.57

11.81

3.5

2.8

3.53

3.55

g/l

0.11

290

1847

Iron deficiency

464

2.22

11.80

3.2

3.4

3.59

3.42

g/l

0.78

442

Other disorders of amniotic fluid and membranes

274

1686

1.59

11.68

1.9

2.7

3.79

3.56

g/l

2.07

258

1611

Spondylosis

1032

6387

1.27

11.67

2.2

2.4

3.64

3.61

g/l

0.24

984

6130

Disorders of speech understanding and production

134

691

1.97

11.62

5.8

5.6

3.38

3.14

g/l

0.96

126

675

Diabetic maculopathy

271

1631

1.60

11.62

2.7

2.9

4.07

3.75

g/l

2.52

264

1546

Systemic sclerosis (FG)

227

2.76

11.46

3.2

2.5

3.54

3.48

g/l

0.15

218

Endometriosis

655

2829

1.36

11.41

2.1

2.5

3.59

3.65

g/l

0.43

615

2692

IBD patients in KELA-register

465

3315

1.42

11.41

2.9

2.8

3.48

3.55

g/l

0.46

440

3158

Other maltreatment syndromes

342

2.40

11.36

2.4

2.5

3.84

3.56

g/l

0.78

329

Focal brain injury

126

651

1.97

11.35

2.3

2.4

3.52

3.62

g/l

0.32

118

615

Obstructed labour due to malposition and malpresentation of fetus

419

2713

1.45

11.32

2.2

2.6

3.62

3.59

g/l

0.21

398

2592

Disorders of adult personality and behaviour

599

4455

1.36

11.31

2.6

2.7

3.70

3.58

g/l

1.08

564

4254

Benign neoplasm: Caecum

209

1262

1.69

11.24

2.4

3.60

3.61

g/l

0.05

199

1203

Nonsuppurative otitis media

543

3447

1.38

11.18

4.2

3.0

3.61

3.51

g/l

0.74

512

3295

Specific personality disorders

490

3538

1.40

11.17

2.4

2.7

3.71

3.59

g/l

0.93

463

3372

Migraine with aura and triptan purchases

369

2534

1.48

11.17

2.8

2.6

3.36

3.58

g/l

2.87

350

2429

malignant neoplasm of male genital organs, including Hilmo

482

2055

1.42

11.14

2.0

2.6

3.67

3.60

g/l

0.38

461

1974

Polymyalgia rheumatica

232

1440

1.64

11.13

2.0

2.2

3.71

3.65

g/l

0.22

221

1374

Noninflammatory disorders of female genital tract

802

3079

1.32

11.11

2.8

2.6

3.58

3.62

g/l

0.28

762

2928

Systemic sclerosis, icd10

225

2.73

11.11

3.2

2.2

3.56

3.62

g/l

0.13

220

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

155

865

1.83

11.06

2.9

3.2

3.61

3.50

g/l

0.33

149

831

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

103

3.64

11.00

2.6

2.0

3.91

3.78

g/l

0.15

Acute pharyngitis

349

2355

1.49

10.95

4.0

2.9

3.46

3.50

g/l

0.22

335

2249

Faecal incontinence

164

933

1.79

10.91

2.0

2.1

3.76

3.65

g/l

0.47

153

890

Erythema nodosum

299

2.46

10.87

2.9

2.2

3.68

3.66

g/l

0.03

286

Other symptoms and signs involving the circulatory and respiratory systems

132

704

1.91

10.85

3.6

2.8

3.30

3.55

g/l

1.10

122

666

Ulcer of oesophagus

137

743

1.89

10.74

2.0

2.4

3.45

3.62

g/l

0.64

130

706

Nonsuppurative otitis media, including avohilmo

708

4690

1.32

10.67

3.5

2.9

3.67

3.54

g/l

1.43

674

4478

!Aliquae complicationes praecoces traumatis

106

532

2.05

10.52

3.6

2.7

3.81

3.62

g/l

0.59

509

Early complications of trauma

106

532

2.05

10.52

3.6

2.7

3.81

3.62

g/l

0.59

509

Biomechanical lesions, not elsewhere classified

108

546

2.03

10.48

2.6

2.2

3.86

3.65

g/l

0.73

103

521

Alzheimer disease

266

2889

0.65

10.47

1.8

2.0

3.65

3.67

g/l

0.08

247

2746

Benign neoplasm: Sigmoid colon

347

2385

1.47

10.46

2.8

2.4

3.70

3.61

g/l

0.49

332

2284

Inflammatory bowel disease, strict (require KELA)

465

3368

1.40

10.44

2.9

2.8

3.48

3.56

g/l

0.55

440

3214

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1056

8222

1.25

10.43

2.9

2.7

3.58

3.61

g/l

0.25

1017

7910

Left bundle-branch block

118

615

1.95

10.39

2.8

2.3

3.76

3.58

g/l

0.53

111

590

Migraine without aura and triptan purchases

374

2612

1.45

10.39

3.9

2.7

3.48

3.58

g/l

0.71

357

2505

Phobic anxiety disorders

296

1971

1.52

10.35

3.5

2.9

3.39

3.56

g/l

1.42

282

1874

Benign neoplasm: Cerebral meninges

173

1017

1.73

10.31

2.8

2.4

3.44

3.63

g/l

1.07

167

965

Disorders of continuity of bone

207

1276

1.65

10.30

2.6

2.7

3.74

3.58

g/l

0.89

197

1221

Atopic dermatitis

1271

8322

1.22

10.30

2.6

2.9

3.57

3.54

g/l

0.25

1206

7973

Dementia, including avohilmo

478

4449

0.73

10.27

2.3

2.2

3.59

3.65

g/l

0.37

448

4253

Other specified and unspecified personality disorders

194

1178

1.68

10.27

2.8

2.6

3.72

3.56

g/l

0.70

181

1119

Disorders of refraction and accommodation

606

4565

1.34

10.26

3.8

3.2

3.40

3.51

g/l

1.03

583

4368

Polyhydramnios

102

509

2.06

10.26

2.2

2.4

3.64

3.52

g/l

0.39

481

Disorders of muscles

207

1278

1.65

10.22

3.1

2.6

3.68

3.57

g/l

0.44

195

1222

Hypothyroidism, other/unspecified

1822

10157

1.18

10.22

2.8

2.5

3.57

3.61

g/l

0.50

1726

9725

Medicines for HER+ breast cancer

605

4255

1.34

10.21

2.0

2.4

3.58

3.61

g/l

0.26

585

4066

Benign neoplasm: Rectum

328

2242

1.48

10.20

2.4

2.3

3.63

3.62

g/l

0.08

317

2143

Other symptoms and signs involving the urinary system

203

1251

1.65

10.11

2.1

2.6

3.54

3.58

g/l

0.13

195

1191

Urolithiasis

587

4428

1.34

10.11

2.9

2.6

3.64

3.61

g/l

0.20

571

4237

Female infertility, associated with anovulation

186

1123

1.69

10.07

2.1

2.2

3.76

3.63

g/l

0.73

179

1056

Fissure and fistula of anal and rectal regions

427

3067

1.41

10.06

3.1

2.5

3.54

3.59

g/l

0.31

407

2925

Sleep apnoea

1867

10008

1.18

10.05

2.5

2.6

3.76

3.56

g/l

6.39

1773

9617

Dorsopathies

2198

9565

1.17

10.02

2.7

3.58

g/l

0.06

2103

9166

Acute alcohol intoxication

487

3580

1.37

9.98

2.8

2.7

3.71

3.58

g/l

0.92

465

3430

L02BG Aromatase inhibitors

494

3593

1.37

9.96

1.8

2.3

3.65

3.61

g/l

0.28

478

3434

Calculus of kidney and ureter

546

4088

1.35

9.92

2.9

2.6

3.64

3.61

g/l

0.20

532

3907

Acute laryngitis and tracheitis

265

1717

1.54

9.90

3.9

3.0

3.53

3.49

g/l

0.21

256

1634

Unspecified nephritic syndrome

221

2.64

9.90

3.7

2.4

3.53

3.65

g/l

0.18

211

Erosion of teeth , including avohilmo

569

4292

1.34

9.85

3.9

2.9

3.64

3.56

g/l

0.62

543

4098

Alcohol abuse, main dg

314

2146

1.48

9.81

3.1

2.9

3.66

3.57

g/l

0.40

304

2049

Amenorrhoea

157

913

1.75

9.78

5.2

2.4

3.50

3.63

g/l

0.61

148

861

Benign neoplasm of meninges

184

1116

1.68

9.77

2.7

2.3

3.45

3.64

g/l

1.10

178

1060

696

4848

1.30

9.74

2.3

2.2

3.48

3.66

g/l

2.87

663

4625

Rhabdomyosarcoma, including Hilmo

13.02

9.74

4.8

3.5

3.40

3.43

g/l

0.02

Dental caries, including avohilmo

1440

6131

1.21

9.70

2.9

2.5

3.57

3.59

g/l

0.13

1376

5870

Unspecified/other endometriosis

196

1185

1.65

9.69

1.7

2.4

3.55

3.63

g/l

0.34

189

1119

Other and unspecified mood [affective] disorders

165

977

1.72

9.64

3.4

2.8

3.69

3.61

g/l

0.26

160

933

Cyst of kidney

145

829

1.79

9.62

2.5

2.2

3.74

3.64

g/l

0.28

140

793

Hypothyreosis and Thyroxine purchase for inclusion criteria

1885

10555

1.17

9.60

2.7

2.5

3.57

3.61

g/l

0.49

1784

10105

Malignant neoplasm of endocrine gland, including Hilmo

135

755

1.82

9.58

3.4

2.6

3.48

3.56

g/l

0.26

126

709

Arthropathies

1968

8509

1.17

9.53

2.8

2.9

3.62

3.54

g/l

1.49

1865

8182

Benign neoplasm of other and unspecified endocrine glands

252

1657

1.54

9.53

2.2

2.6

3.82

3.57

g/l

1.85

240

1578

Impetigo

123

673

1.88

9.50

4.6

4.4

3.56

3.34

g/l

0.69

112

647

Excessive vomiting in pregnancy

164

974

1.72

9.47

2.4

2.6

3.79

3.52

g/l

1.65

151

918

Thyrotoxicosis, other and/or unspecified

384

2741

1.42

9.46

4.0

2.5

3.61

g/l

0.01

365

2606

Other joint disorders

1897

8449

1.18

9.45

2.7

2.8

3.58

3.55

g/l

0.40

1798

8124

Car occupant injured in other and unspecified transport accidents

384

2743

1.42

9.43

2.8

2.7

3.61

3.57

g/l

0.26

368

2605

Paracetamol or NSAID medication

353

1226

1.47

9.38

3.6

4.0

3.47

3.39

g/l

0.40

342

1177

malignant neoplasm of male genital organs

461

2018

1.39

9.37

2.0

2.6

3.70

3.60

g/l

0.60

441

1938

Keratitis

691

5391

1.29

9.32

2.9

2.7

3.66

3.58

g/l

0.69

655

5147

Benign neoplasm: Ascending colon

260

1731

1.52

9.28

3.0

2.3

3.68

3.59

g/l

0.38

253

1651

Malignant neoplasm of thymus, including Hilmo

8.29

9.26

2.8

2.4

3.88

3.84

g/l

0.03

Iridocyclitis

415

3014

1.39

9.23

2.7

3.89

3.58

g/l

3.53

399

2879

Brain glioblastoma and astrocytoma

137

3.03

9.22

1.7

2.3

3.43

3.74

g/l

0.61

130

Sulfasalazine

494

3685

1.35

9.22

2.3

3.79

3.58

g/l

2.12

470

3515

Retinal detachment with retinal break

240

1573

1.55

9.22

2.5

3.71

3.61

g/l

0.41

232

1494

Generalized anxiety disorder

357

2525

1.43

9.21

2.1

2.5

3.46

3.60

g/l

1.02

336

2402

Striking against or struck by other objects

702

5490

1.29

9.19

2.9

3.1

3.51

3.52

g/l

0.09

670

5263

Degenerative diseases of the nervous system

328

3354

0.70

9.16

2.0

2.1

3.60

3.66

g/l

0.33

305

3198

Actinic keratosis

632

4440

1.30

9.09

2.4

2.2

3.48

3.66

g/l

2.48

602

4232

Cluster headache, wide

457

2.05

9.07

2.0

2.6

3.53

3.65

g/l

0.32

431

Ocular pain

184

1140

1.64

9.06

2.6

2.9

3.59

3.56

g/l

0.11

173

1086

Dermatophytosis

266

1789

1.51

9.05

2.7

2.8

3.53

3.57

g/l

0.17

250

1711

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

167

991

1.69

9.05

7.7

4.7

3.28

3.22

g/l

0.17

160

964

Rheumatoid arthritis, including avohilmo

659

5135

1.29

8.99

2.4

3.77

3.60

g/l

2.06

625

4888

Skin changes due to chronic exposure to nonionizing radiation

650

4568

1.30

8.98

2.4

2.2

3.48

3.66

g/l

2.56

618

4352

Other arthrosis

977

5306

1.24

8.95

2.6

3.57

3.59

g/l

0.10

930

5118

Malignant neoplasm of thymus

9.29

8.92

2.9

2.5

4.01

4.07

g/l

0.04

Nonorganic sleeping disorders

442

3264

1.37

8.89

3.0

2.9

3.53

3.56

g/l

0.15

422

3106

Other diseases of upper respiratory tract

2293

10399

1.15

8.89

2.8

3.57

3.59

g/l

0.23

2191

9969

Heartburn

206

1316

1.59

8.87

2.9

2.6

3.46

3.64

g/l

1.17

200

1256

Pyogenic arthritis

134

768

1.78

8.83

2.7

2.6

4.34

3.53

g/l

4.58

129

737

Other and unspecified injuries of head

151

895

1.72

8.82

2.5

3.2

3.55

3.53

g/l

0.05

145

854

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

314

2192

1.45

8.81

2.6

3.2

3.88

3.50

g/l

4.30

306

2091

Melanocytic naevi of trunk

252

1687

1.52

8.80

3.4

2.6

3.58

3.57

g/l

0.02

238

1603

Nail disorders

172

1056

1.66

8.79

3.8

3.0

3.45

3.52

g/l

0.30

167

1010

Thyroiditis, ILD-related definition

225

1471

1.55

8.78

2.8

2.6

3.63

3.55

g/l

0.38

215

1398

Haemangioma and lymphangioma, any site

185

1158

1.63

8.75

3.1

2.9

3.34

3.54

g/l

1.28

175

1105

Other disorders of bladder

217

1409

1.56

8.72

3.4

2.4

3.52

3.59

g/l

0.26

205

1348

Congenital malformations of genital organs

218

1410

1.56

8.72

2.8

4.0

3.39

3.41

g/l

0.08

212

1345

Suicide or other Intentional self-harm

469

3506

1.35

8.70

2.8

3.64

3.56

g/l

0.49

446

3348

Seropositive rheumatoid arthritis

422

3085

1.37

8.70

2.4

2.3

3.85

3.59

g/l

2.64

403

2939

Other specified/unspecified bacterial intestinal infections

133

765

1.78

8.68

4.4

2.6

3.48

3.60

g/l

0.42

127

725

Any dementia

380

3611

0.72

8.65

2.4

2.1

3.63

3.65

g/l

0.10

356

3446

Varicella [chickenpox], including avohilmo

136

790

1.77

8.62

5.8

4.6

3.40

3.44

g/l

0.09

130

766

Prolonged pregnancy

295

1738

1.47

8.59

1.6

2.8

3.62

3.54

g/l

0.60

279

1664

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

155

932

1.69

8.59

2.3

3.87

3.53

g/l

2.17

143

885

Hordeolum and other deep inflammation of eyelid

134

776

1.77

8.57

4.0

3.0

3.62

3.57

g/l

0.15

129

738

Non-selective monoamine reuptake inhibitors

634

4745

1.29

8.53

2.5

3.83

3.59

g/l

3.32

601

4547

Haemangioma, any site

171

1057

1.65

8.53

3.1

3.0

3.38

3.53

g/l

0.82

162

1006

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

321

2268

1.43

8.46

3.0

2.9

3.46

3.53

g/l

0.40

299

2162

Cluster headache, wide,, including avohilmo

113

625

1.85

8.45

1.9

2.7

3.59

g/l

0.01

107

596

Diseases of salivary glands

614

4784

1.29

8.44

2.5

3.58

3.60

g/l

0.13

587

4557

Injuries to the elbow and forearm

1455

10597

1.18

8.38

2.9

2.8

3.55

3.57

g/l

0.26

1396

10142

Acute alcohol intoxication, ICD10

391

2861

1.38

8.37

3.0

2.9

3.66

3.58

g/l

0.41

376

2743

Benign neoplasm: Adrenal gland

152

918

1.69

8.33

2.0

2.5

3.97

3.61

g/l

2.09

144

878

Special screening examination for other diseases and disorders

214

1398

1.55

8.32

3.2

2.3

3.55

3.70

g/l

0.79

207

1339

Ebstein's anomaly

10.71

8.31

24.2

8.1

3.23

2.96

g/l

0.34

Thyrotoxicosis

456

3419

1.35

8.31

3.7

2.5

3.58

3.60

g/l

0.11

436

3253

Deforming dorsopathies

539

4136

1.31

8.30

3.1

2.7

3.51

3.56

g/l

0.37

521

3954

Hereditary factor IX deficiency

28.18

8.25

7.4

9.4

3.81

3.30

g/l

—

Reactive arthropathies

170

1058

1.63

8.24

2.5

2.7

4.00

3.53

g/l

2.89

163

1015

Other inflammation of eyelid, including avohilmo

926

7580

1.23

8.24

2.7

2.8

3.52

3.57

g/l

0.61

881

7253

Mastocytosis

4.20

8.23

1.8

4.6

2.97

3.57

g/l

1.42

Other disorders starting during childhood or adolescence

158

960

1.67

8.20

8.0

5.5

3.16

3.13

g/l

0.09

151

933

Cluster headache, strict, including avohilmo

108

595

1.86

8.19

2.0

2.7

3.62

3.57

g/l

0.11

103

567

Papulosquamous disorders

723

5768

1.26

8.18

2.5

2.6

3.73

3.57

g/l

2.00

691

5527

Pedestrian injured in transport accident

138

816

1.72

8.18

2.3

2.8

3.64

3.60

g/l

0.11

130

775

Atrophic disorders of skin

272

1876

1.47

8.17

3.6

2.4

3.54

3.59

g/l

0.25

260

1792

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1098

8751

1.21

8.17

2.5

2.7

3.57

g/l

0.03

1047

8373

Assault by bodily force

162

999

1.65

8.17

2.4

3.0

3.73

3.54

g/l

0.78

151

960

Late syphilis

142

2.89

8.16

2.1

2.4

4.33

3.73

g/l

1.35

136

Hyperkinetic disorders, excluding more controls

300

1964

1.44

8.16

4.0

2.9

3.38

3.51

g/l

0.79

276

1877

Complications associated with artificial fertilization

200

2.55

8.14

2.1

2.2

3.44

3.64

g/l

0.48

184

Single delivery by forceps and vacuum extractor

302

1250

1.46

8.13

2.1

3.1

3.65

3.52

g/l

0.83

284

1195

Superficial injury of ankle and foot

273

1897

1.46

7.94

3.2

3.1

3.56

3.52

g/l

0.17

258

1811

Other acute viral hepatitis

133

2.92

7.93

3.4

2.6

3.73

3.58

g/l

0.18

128

Diseases of the ear and mastoid process

2430

10731

1.14

7.87

2.8

2.7

3.56

3.60

g/l

0.68

2306

10308

Strabismus

524

4028

1.31

7.87

3.8

3.3

3.45

3.51

g/l

0.51

504

3841

Other and unspecified tonsillitis

720

4781

1.26

7.87

3.8

2.8

3.58

3.57

g/l

0.09

700

4562

Malignant neoplasm of bone and articular cartilage of limbs

4.93

7.86

8.2

3.3

3.93

3.65

g/l

0.31

Other ulcerative colitis

121

699

1.77

7.84

2.6

2.8

3.38

3.52

g/l

0.47

116

664

Osteosarcoma

9.11

7.82

10.1

3.9

3.66

4.03

g/l

0.32

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

345

2504

1.39

7.81

2.9

2.8

3.45

3.54

g/l

0.63

322

2390

Fall on same level involving ice and snow

1130

9476

1.20

7.77

2.7

3.54

3.59

g/l

0.68

1082

9087

Superficial injury of thorax

280

1962

1.44

7.76

3.2

2.6

3.72

3.58

g/l

0.83

263

1873

208

1377

1.54

7.75

2.5

2.3

3.58

3.62

g/l

0.18

198

1287

Brain glioblastoma

107

3.11

7.75

1.4

2.6

3.46

3.68

g/l

0.35

102

Other and unspecified abdominal hernia

428

1.99

7.73

2.3

2.4

3.44

3.68

g/l

0.74

409

Lesion of lateral popliteal nerve

106

592

1.83

7.73

3.2

2.4

3.62

3.61

g/l

0.00

565

Bronchiectasis

137

822

1.70

7.70

5.0

2.5

3.83

3.53

g/l

1.34

130

787

Open wound of forearm

190

1235

1.56

7.68

3.1

2.8

3.63

3.51

g/l

0.49

180

1178

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

341

2478

1.39

7.66

2.6

3.2

3.81

3.52

g/l

3.01

331

2364

Noonan syndrome

9.51

7.56

3.8

15.1

2.63

3.00

g/l

0.75

Ovarian dysfunction

179

1154

1.58

7.55

2.4

2.3

3.79

3.61

g/l

0.89

174

1079

Infections with a predominantly sexual mode of transmission

612

4829

1.27

7.51

2.8

2.6

3.57

3.58

g/l

0.02

583

4605

Contraceptive management

711

3975

1.26

7.51

3.3

2.9

3.60

3.57

g/l

0.15

677

3818

Endometriosis of ovary

304

2045

1.41

7.50

2.2

2.4

3.57

3.61

g/l

0.20

287

1947

Ulcerative colitis (strict definition, require KELA)

324

2345

1.40

7.49

3.0

2.8

3.46

3.54

g/l

0.52

302

2238

Other (seronegative) rheumatoid arthritis, wide

318

2294

1.40

7.48

2.6

2.4

3.66

3.60

g/l

0.30

302

2184

Primary hyperparathyroidism

187

1219

1.56

7.47

3.4

2.3

3.56

3.60

g/l

0.15

180

1163

Sleep disorders (combined)

2283

10510

1.14

7.46

2.5

2.7

3.66

3.56

g/l

2.22

2179

10089

Other inflammation of eyelid

269

1888

1.44

7.43

2.6

2.7

3.60

3.57

g/l

0.13

255

1806

Astigmatism

150

932

1.64

7.39

4.3

4.2

3.23

3.36

g/l

0.54

145

893

Fracture at wrist and hand level

683

5465

1.25

7.37

2.4

2.9

3.44

3.56

g/l

1.52

655

5241

Adenocarcinoma of small intestine

9.85

7.30

1.6

2.1

2.97

4.22

g/l

1.16

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

515

3483

1.30

7.30

5.4

3.2

3.36

3.48

g/l

1.19

485

3320

Fibromyalgia

167

1068

1.59

7.26

2.3

2.4

3.65

3.59

g/l

0.19

152

1015

Abnormal blood-pressure reading, without diagnosis

480

1.89

7.25

2.6

2.4

3.62

3.55

g/l

0.17

454

Bipolar affective disorders

355

2621

1.37

7.25

2.5

3.75

3.60

g/l

1.00

341

2489

Acne

257

1789

1.45

7.25

3.5

3.1

3.48

3.55

g/l

0.32

244

1706

Allergic conjunctivitis

1145

9310

1.19

7.23

2.5

2.7

3.57

3.56

g/l

0.11

1092

8902

Rhabdomyosarcoma

14.46

7.23

6.2

4.0

3.47

2.77

g/l

0.56

Unspecified maternal hypertension

123

2.90

7.22

2.4

2.2

4.02

3.44

g/l

1.87

117

Caries of dentine, including avohilmo

1557

6848

1.17

7.19

2.8

2.7

3.58

3.56

g/l

0.13

1482

6566

Other disorders of pigmentation

482

1.89

7.18

2.3

2.5

3.43

3.59

g/l

0.47

461

Ptosis of eyelid

201

1344

1.52

7.16

3.5

2.4

3.44

3.64

g/l

1.31

192

1279

Other inflammation of vagina/vulva

462

1.91

7.14

2.0

2.6

3.72

3.60

g/l

0.34

440

Trochanteric bursitis

246

1712

1.45

7.11

2.9

2.3

3.70

3.60

g/l

0.49

234

1641

Crushed, pushed or stepped on by crowd or human stampede

158

1004

1.60

7.11

2.7

3.7

3.46

3.44

g/l

0.08

151

966

Exposure to other and unspecified inanimate mechanical forces

160

1020

1.60

7.11

3.7

3.2

3.56

3.52

g/l

0.12

150

978

Allergic urticaria

170

1099

1.57

7.10

5.3

3.5

3.67

3.53

g/l

0.63

162

1050

Pregnancy with abortive outcome

1220

5372

1.19

7.07

2.3

2.4

3.69

3.60

g/l

1.44

1152

5127

Psoriasis

509

3970

1.29

7.04

2.6

2.7

3.76

3.58

g/l

1.77

486

3796

Alzheimer’s disease, strict definition

203

2406

0.68

6.99

1.9

2.1

3.69

3.68

g/l

0.05

184

2284

Benign neoplasm of ovary

267

1893

1.43

6.98

1.8

2.4

3.66

3.61

g/l

0.21

256

1808

Fitting and adjustment of external prosthetic device

6.63

6.91

2.7

2.1

3.74

3.58

g/l

0.13

Tooth eruption problems

352

2527

1.36

6.90

4.8

3.5

3.34

3.49

g/l

1.16

336

2406

Later onset COPD

440

2699

1.32

6.90

1.9

2.1

3.82

3.62

g/l

1.75

413

2576

Adenomyosis (Endometriosis of uterus)

225

1547

1.47

6.89

1.9

2.4

3.38

3.63

g/l

2.45

215

1464

KRA_PSY_EATING, excluding more controls

195

1295

1.51

6.88

5.6

2.5

3.61

3.60

g/l

0.04

178

1227

Cervicalgia

372

2789

1.35

6.88

3.2

2.4

3.64

3.60

g/l

0.20

361

2661

Other noninflammatory disorders of vulva and perineum

179

1182

1.53

6.78

2.6

2.4

3.43

3.60

g/l

1.12

165

1119

Coxarthrosis

888

4740

1.21

6.77

2.4

2.5

3.64

3.60

g/l

0.38

859

4572

Malignant neoplasm of endocrine gland

111

653

1.73

6.76

3.6

2.6

3.50

3.58

g/l

0.21

103

612

Any dementia, excluding more controls

358

3275

0.75

6.75

2.4

2.1

3.61

3.65

g/l

0.17

335

3125

Emotionally unstable personality disorder

258

1832

1.43

6.74

2.4

2.6

3.60

g/l

0.00

244

1735

Redundant prepuce, phimosis and paraphimosis

383

2847

1.34

6.72

2.6

3.2

3.61

3.57

g/l

0.19

366

2760

Biguanides

1836

9717

1.14

6.72

2.5

3.90

3.56

g/l

15.85

1751

9295

Melanocytic naevi, other sites/unspecified

167

1090

1.56

6.71

3.0

2.7

3.42

3.61

g/l

1.25

159

1035

Endometriosis of pelvic peritoneum

295

1944

1.39

6.71

1.9

2.5

3.63

g/l

0.03

281

1847

Coxarthrosis [arthrosis of hip](FG)

952

5467

1.20

6.67

2.4

3.65

3.60

g/l

0.48

920

5251

Acute and subacute iridocyclitis

335

2487

1.36

6.65

2.9

2.7

3.83

3.59

g/l

1.91

321

2372

Anterior Iridocyclitis

354

2651

1.35

6.63

2.8

2.7

3.83

3.59

g/l

1.92

338

2526

Tobacco use

112

666

1.72

6.62

2.6

2.4

3.94

3.59

g/l

1.37

104

633

Behavioural syndromes associated with physiological disturbances and physical factors

1931

11525

1.14

6.55

2.7

2.8

3.59

g/l

0.00

1838

11071

Ovarian hyperstimulation (induction)

209

2.34

6.55

2.2

2.3

3.45

3.51

g/l

0.11

193

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

550

1.79

6.53

4.5

5.2

3.18

3.23

g/l

0.13

527

Use of pramipexole

363

2736

1.34

6.51

2.9

2.4

3.55

3.63

g/l

0.48

347

2607

Malignant neoplasm of anus and anal canal

5.55

6.51

2.5

2.8

4.95

4.16

g/l

0.81

Fall involving bed

335

2.02

6.50

3.9

2.9

3.45

3.55

g/l

0.24

317

Rheumatic fever incl heart disease

281

2.11

6.47

2.6

3.82

3.62

g/l

0.45

269

Mixed and other personality disorders

156

1012

1.57

6.46

2.9

2.7

3.88

3.60

g/l

1.28

142

962

Orchitis and epididymitis

174

1157

1.52

6.41

3.6

2.9

3.60

3.65

g/l

0.17

166

1116

Diseases of external ear

660

5367

1.24

6.41

2.6

2.9

3.65

3.57

g/l

0.72

625

5130

Hypocalcemia

263

2.16

6.41

2.2

2.9

3.55

3.62

g/l

0.11

256

Other and unspecified myopathies

157

1022

1.56

6.39

4.9

2.6

3.65

3.57

g/l

0.29

150

972

Family history of certain disabilities and chronic diseases leading to disablement

552

1.77

6.39

2.3

3.61

3.63

g/l

0.04

522

Other specified and unspecified retinal disorders

387

1.93

6.36

4.9

2.3

3.58

3.59

g/l

0.02

371

Postprocedural musculoskeletal disorders, not elsewhere classified

130

812

1.63

6.34

2.2

2.3

3.70

3.64

g/l

0.19

124

774

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

137

869

1.60

6.28

3.2

3.61

3.51

g/l

0.27

131

829

Nerve, nerve root and plexus disorders

2124

11341

1.13

6.25

2.7

2.5

3.67

3.61

g/l

1.24

2024

10868

Infections with a predominantly sexual mode of transmission, including avohilmo

810

6159

1.21

6.23

2.8

2.6

3.59

3.58

g/l

0.08

774

5870

Other/unspecified synovitis and tenosynovitis

201

1384

1.47

6.23

2.3

2.6

3.76

3.60

g/l

0.72

189

1319

Corneal ulcer

337

2531

1.34

6.23

2.7

2.8

3.72

3.56

g/l

1.12

312

2419

Methotrexate

226

1590

1.44

6.23

3.3

2.4

3.66

3.57

g/l

0.44

214

1518

Late syphilis, including avohilmo

176

2.42

6.20

2.0

2.3

4.34

3.71

g/l

1.62

168

Suggestive for eosinophilic asthma

165

1094

1.53

6.19

2.2

2.5

3.74

3.59

g/l

0.61

159

1043

Other congenital malformations of skin, including avohilmo

166

1103

1.53

6.19

2.8

3.4

3.53

3.51

g/l

0.06

161

1056

Digestive system disorders of fetus and newborn

6.73

6.16

8.8

11.5

2.93

2.79

g/l

0.14

Acne vulgaris

196

1346

1.48

6.15

3.7

3.2

3.53

3.55

g/l

0.04

184

1282

Disorders in reading

276

2.12

6.12

9.9

5.5

3.09

3.10

g/l

0.02

269

Other salmonella infections, including avohilmo

464

1.83

6.11

2.9

2.4

3.42

3.61

g/l

0.60

436

Postmenopausal osteoporosis with pathological fracture

560

1.74

6.08

3.1

2.2

3.36

3.57

g/l

0.78

540

Spondylopathies (FG)

244

1750

1.41

6.05

2.3

2.6

3.82

3.57

g/l

1.70

230

1668

Malignant neoplasm of nasal cavity and sinuses

3.87

6.03

1.9

2.7

4.20

3.96

g/l

0.17

Other hearing loss

478

3657

1.27

6.00

2.3

3.58

3.64

g/l

0.38

455

3489

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

786

6466

1.21

5.97

3.1

2.9

3.48

3.56

g/l

0.90

756

6166

Carcinoma in situ of skin of trunk

332

1.98

5.97

2.6

2.2

3.54

3.63

g/l

0.16

315

Sciatica+with lumbago

992

7460

1.18

5.96

2.5

3.63

3.60

g/l

0.17

939

7162

Carbimazole or st.post thyroidectomy, condition for graves disease

365

2793

1.32

5.93

3.6

2.5

3.55

3.60

g/l

0.24

346

2657

Other specified/unspecified hearing loss

161

1073

1.52

5.91

2.5

3.71

3.65

g/l

0.23

156

1024

Other and unspecified glaucoma

118

733

1.63

5.90

2.0

2.3

3.68

3.63

g/l

0.13

111

696

Chromosomal abnormalities, not elsewhere classified

406

1.90

5.90

3.1

7.6

3.35

3.09

g/l

0.88

393

Dysplasia of cervi uteri

438

2400

1.29

5.90

2.3

2.5

3.69

3.65

g/l

0.23

412

2283

Delivery, wide proxy

540

2278

1.27

5.87

2.0

2.6

3.73

3.55

g/l

2.15

521

2168

Other disorders of the genitourinary system

200

1394

1.45

5.84

2.3

3.55

3.61

g/l

0.25

186

1332

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

361

2765

1.32

5.84

2.6

2.3

3.44

3.61

g/l

1.57

338

2632

Malignant neoplasm of oropharynx, including Hilmo

168

2.39

5.84

1.6

2.5

3.84

3.66

g/l

0.29

160

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

159

1061

1.52

5.82

2.6

2.4

3.98

3.60

g/l

2.40

146

999

Tuberculosis, IBD comorbidity

106

643

1.67

5.82

3.3

2.2

3.67

3.65

g/l

0.06

101

606

Other strabismus

427

3334

1.29

5.79

4.1

3.4

3.45

3.49

g/l

0.28

409

3182

Injuries to the wrist and hand

2104

12470

1.12

5.77

2.7

3.51

3.60

g/l

1.87

2003

11959

Campylobacter enteritis

316

1.98

5.74

2.8

2.6

3.41

3.61

g/l

0.54

302

Malignant neoplasm of rectosigmoid junction

121

2.64

5.71

2.5

2.3

3.37

3.62

g/l

0.36

112

Post-traumatic wound infection, not elsewhere classified

325

1.96

5.64

2.3

2.9

3.67

3.53

g/l

0.32

309

Hydrocele

206

1454

1.43

5.63

3.3

3.0

3.30

3.62

g/l

2.16

194

1407

Crossbite

177

1119

1.48

5.61

9.6

4.6

2.97

3.23

g/l

1.79

170

1082

Fibroblastic disorders

383

2973

1.30

5.60

2.3

2.4

3.66

3.63

g/l

0.13

370

2842

Other benign neoplasms of skin

635

5225

1.22

5.56

2.5

3.53

3.62

g/l

0.89

602

4984

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

3.63

5.55

2.1

2.7

3.99

3.75

g/l

0.26

Seropositive rheumatoid arthritis, wide

422

3321

1.28

5.54

2.4

3.85

3.62

g/l

2.26

403

3165

Atopic dermatitis, strict definition with reimbursement

631

4986

1.22

5.53

2.7

3.1

3.44

3.52

g/l

0.81

596

4767

Type 1 diabetes, definitions combined

201

1415

1.43

5.52

3.2

4.0

3.67

3.31

g/l

3.16

192

1358

Other abnormal uterine and vaginal bleeding

381

2117

1.30

5.48

2.4

3.58

3.62

g/l

0.23

356

2010

Emotional disorders starting during childhood or adolecense, excluding more controls

114

695

1.62

5.46

8.5

3.7

3.17

3.37

g/l

0.96

107

666

D07AA Corticosteroids, weak (group I)

318

2419

1.33

5.40

3.1

3.7

3.55

3.45

g/l

0.65

297

2311

Intrahepatic Cholestasis of Pregnancy (ICP)

137

903

1.54

5.36

2.6

2.4

4.02

3.61

g/l

2.47

124

849

Lupus nephritis

5.00

5.36

3.7

4.3

3.44

3.41

g/l

0.02

Colonic or urogenital fistula

461

3683

1.26

5.36

3.0

2.6

3.53

3.62

g/l

0.64

440

3516

Injury of muscle and tendon at hip and thigh level

186

1305

1.44

5.31

3.5

2.8

3.56

g/l

0.00

173

1245

Erythema multiforme

249

2.07

5.29

2.3

2.8

3.86

3.57

g/l

0.68

240

Type 1 diabetes, strict (exclude DM2)

200

1419

1.42

5.28

3.2

4.2

3.67

3.31

g/l

3.27

191

1362

Rheumatism, unspecified

209

1497

1.41

5.28

2.1

2.3

3.77

3.64

g/l

0.64

202

1433

Periapical abscess

868

7393

1.18

5.22

2.6

2.8

3.67

3.58

g/l

1.02

837

7096

Salpingitis and oophoritis

268

2002

1.35

5.21

3.8

2.3

3.74

3.62

g/l

0.57

261

1910

Benign paroxysmal vertigo

482

3884

1.25

5.20

2.4

3.56

3.62

g/l

0.43

453

3708

Congenital malformations of ovaries, fallopian tubes and broad ligaments

108

680

1.62

5.19

2.2

2.3

3.64

3.61

g/l

0.08

103

641

Rheumatic valve diseases

191

2.20

5.13

2.8

2.4

3.75

3.60

g/l

0.29

183

Bell's palsy

211

1523

1.40

5.13

3.3

2.6

3.54

3.58

g/l

0.14

201

1454

Benign neoplasm: Descending colon

126

825

1.55

5.11

2.2

2.4

3.73

3.62

g/l

0.32

121

787

Sequelae of injuries of head

103

644

1.63

5.11

2.4

2.7

3.43

3.61

g/l

0.55

617

Alzheimer’s disease (Late onset)

192

2204

0.71

5.09

1.9

2.0

3.72

3.68

g/l

0.11

174

2089

Syphilis, including avohilmo

295

1.95

5.07

2.1

2.7

4.23

3.59

g/l

2.04

286

Syphilis

295

1.95

5.07

2.1

2.7

4.23

3.59

g/l

2.04

286

Other/unspecified seropositive rheumatoid arthritis

413

3281

1.27

5.06

2.4

3.86

3.61

g/l

2.51

394

3128

Myopia

259

1936

1.35

5.06

4.3

3.1

3.60

3.55

g/l

0.22

248

1842

Haemorrhoids and perianal venous thrombosis

546

4439

1.23

5.04

2.4

2.3

3.48

3.63

g/l

1.82

523

4232

All dysplastic lesions of the vulva

433

1.77

5.03

3.2

2.2

3.76

3.58

g/l

0.50

413

Myocardial infarction, unclassifiable

317

2173

1.31

5.02

3.0

2.2

3.65

g/l

0.00

298

2060

Anogenital herpesviral [herpes simplex] infection

131

869

1.53

5.01

2.1

2.5

3.58

3.61

g/l

0.08

120

824

Tuberculosis, wide

108

685

1.60

5.01

3.3

2.2

3.67

3.64

g/l

0.06

103

647

Lesion of ulnar nerve

247

1836

1.36

5.00

3.2

2.6

3.54

3.61

g/l

0.34

241

1754

Vasomotor and allergic rhinitis

753

6216

1.19

4.99

2.6

3.1

3.51

3.53

g/l

0.13

717

5951

Eating disorders

231

1699

1.37

4.98

5.1

2.9

3.66

3.54

g/l

0.60

211

1614

Uterine polyps

461

2153

1.26

4.96

2.3

2.5

3.59

3.61

g/l

0.15

445

2043

Leiomyoma of uterus

1017

4910

1.17

4.94

2.1

2.4

3.52

3.60

g/l

1.03

962

4680

Gonarthrosis [arthrosis of knee](FG)

1287

6488

1.14

4.88

2.1

2.5

3.70

3.60

g/l

1.50

1242

6229

Hypothyroidism, strict autoimmune, 3 medication purchases required

1625

9723

1.13

4.87

2.6

2.5

3.59

3.61

g/l

0.25

1536

9294

Respiratory conditions due to other external agents

189

2.18

4.87

3.3

2.0

3.78

3.62

g/l

0.35

183

Pain in thoracic spine

272

2059

1.33

4.87

2.7

2.6

3.53

3.60

g/l

0.42

261

1968

Psoriasis vulgaris

323

2504

1.30

4.86

2.8

3.72

3.58

g/l

0.87

311

2391

Radiculopathy

259

1947

1.34

4.86

3.8

2.4

3.66

3.64

g/l

0.10

248

1855

Inguinal hernia

1049

6036

1.16

4.84

3.0

2.8

3.43

3.63

g/l

4.28

1009

5793

Infectious mononucleosis, including avohilmo

173

1221

1.44

4.83

3.1

2.8

3.55

3.58

g/l

0.10

158

1171

Infectious mononucleosis

173

1221

1.44

4.83

3.1

2.8

3.55

3.58

g/l

0.10

158

1171

L04AC Interleukin inhibitors

125

829

1.53

4.81

3.3

2.9

3.39

3.56

g/l

0.57

120

793

Lichen simplex chronicus and prurigo

113

733

1.57

4.80

2.1

2.6

3.83

3.60

g/l

0.92

106

700

Other disorders of bone

340

2658

1.29

4.80

3.4

2.7

3.49

3.57

g/l

0.44

325

2535

Schizophrenia

147

2114

0.69

4.78

2.0

2.8

3.86

3.55

g/l

1.53

141

2020

Endometriosis ASRM stages 3,4

377

2988

1.27

4.76

2.1

2.4

3.56

3.59

g/l

0.21

355

2837

Thiazolidinediones

186

1333

1.41

4.75

2.5

2.3

3.94

3.56

g/l

2.21

179

1277

Tuberculosis, wide, including avohilmo

108

695

1.57

4.73

3.3

2.2

3.67

3.64

g/l

0.06

103

657

153

1060

1.46

4.73

2.0

2.5

2.78

3.62

g/l

10.31

137

1020

Monoamine oxidase A inhibitors

192

1385

1.40

4.72

2.9

2.5

3.57

3.55

g/l

0.07

181

1321

Polycystic ovarian syndrome, broad definition

238

1778

1.35

4.71

2.1

2.4

3.80

3.61

g/l

1.34

231

1676

Endometriosis ASRM stages 1,2

303

2340

1.31

4.71

1.9

2.5

3.63

3.59

g/l

0.20

287

2221

Malignant neoplasm of tonsil and base of tongue

166

2.23

4.66

1.9

2.4

3.84

3.71

g/l

0.20

157

Other bursopathies

212

1559

1.37

4.63

3.1

2.4

3.67

3.64

g/l

0.10

202

1492

Hypoparathyroidism

392

1.77

4.63

5.5

2.6

3.60

3.57

g/l

0.05

377

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

177

1245

1.42

4.60

3.5

4.7

3.36

3.32

g/l

0.14

168

1190

Maltreatment syndromes

104

671

1.58

4.56

2.0

3.1

3.78

3.50

g/l

0.93

645

Type 1 diabetes, strict definition, subgroup 1

155

1083

1.45

4.55

2.8

4.2

3.68

3.26

g/l

3.85

148

1042

Malignant neoplasm of thyroid gland, including Hilmo

101

647

1.58

4.53

3.4

2.5

3.47

3.59

g/l

0.42

604

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

403

3240

1.25

4.51

2.5

2.4

3.87

3.61

g/l

2.60

385

3089

L02BA Anti-estrogens

239

1799

1.34

4.48

2.1

2.3

3.39

3.63

g/l

2.03

230

1715

Oligomenorrhoea

426

1.72

4.47

3.6

2.6

3.82

3.62

g/l

0.52

397

Abnormal findings in secretions and smears from cervix uteri vagina vulva

917

5832

1.16

4.46

2.4

3.57

3.63

g/l

0.64

865

5567

Medical abortion

1127

5334

1.15

4.44

2.5

2.4

3.65

3.60

g/l

0.59

1066

5092

Sleep disorders, other/unspecified

427

1.72

4.44

1.9

3.2

3.71

3.47

g/l

0.54

405

Disorders of synovium and tendon

1005

7427

1.15

4.43

2.9

2.5

3.66

3.60

g/l

0.70

953

7133

Superficial injury of shoulder and upper arm

215

1597

1.36

4.43

3.2

2.8

3.59

3.51

g/l

0.36

201

1518

Abnormal weight loss

166

1183

1.42

4.42

3.0

2.8

3.52

3.54

g/l

0.07

158

1126

Polyarthrosis

321

2264

1.28

4.42

2.4

3.67

3.58

g/l

0.50

305

2169

Degenerative macular diseases

183

1326

1.39

4.40

2.5

2.3

3.76

3.63

g/l

0.50

175

1264

Other/unspecified rheumatoid arthritis

186

1352

1.39

4.39

2.4

2.3

3.63

3.60

g/l

0.08

174

1283

Weight loss

181

1311

1.40

4.39

3.5

2.8

3.57

3.52

g/l

0.18

173

1249

Dislocation, sprain and strain of joints and ligaments at neck level

288

2233

1.30

4.39

2.1

2.7

3.60

3.56

g/l

0.18

274

2118

Postprocedural disorders of nervous system

132

904

1.48

4.37

4.0

2.6

3.22

3.56

g/l

3.28

122

863

Seronegative rheumatoid arthritis

183

1328

1.39

4.37

2.8

2.3

3.64

3.60

g/l

0.12

178

1264

Superficial injury of forearm

197

1448

1.38

4.36

2.9

3.1

3.50

3.53

g/l

0.10

188

1376

Triptan medication for migraine, min. 3 purchases

1108

7265

1.14

4.36

2.8

2.6

3.51

3.60

g/l

1.23

1055

6933

Other enthesopathy of foot (+metatarsalgia)

176

1270

1.40

4.35

2.6

2.7

3.77

3.61

g/l

0.71

165

1211

Follicular cysts of skin and subcutaneous tissue

314

2464

1.28

4.35

2.6

2.7

3.76

3.60

g/l

1.22

305

2357

Melanocytic naevi of upper limb, including shoulder

268

1.91

4.34

3.1

2.5

3.42

3.64

g/l

0.55

257

Other disorders of eyelid

725

5832

1.18

4.34

2.6

2.4

3.52

3.64

g/l

1.31

697

5581

Varicose veins of other sites

106

695

1.55

4.33

3.9

2.9

3.06

3.60

g/l

3.95

101

662

Dental operations

1107

4981

1.15

4.29

2.7

2.4

3.57

3.65

g/l

1.00

1058

4761

Right bundle-branch block

297

1.85

4.29

7.7

2.2

3.34

3.59

g/l

0.86

285

Malignant neoplasm of floor of mouth

5.04

4.26

3.2

2.4

3.59

4.30

g/l

0.64

Morphin

179

2.11

4.26

1.8

2.3

3.89

3.59

g/l

0.56

170

Other noninflammatory disorders of vagina

131

901

1.47

4.24

2.5

2.4

3.56

3.61

g/l

0.19

122

847

Sleep disorders

1801

11204

1.11

4.24

2.4

2.7

3.60

g/l

0.06

1711

10755

Malignant neoplasm of cervix uteri

140

2.27

4.24

1.5

1.8

3.72

3.57

g/l

0.18

130

Bitten or struck by other mammals

214

1602

1.35

4.22

2.7

3.0

3.61

3.55

g/l

0.23

200

1528

Ectopic pregnancy

281

2185

1.30

4.20

2.1

2.3

3.38

3.58

g/l

1.53

263

2093

5.00

4.18

3.2

1.9

3.23

3.66

g/l

0.40

Use of rivastigmine

113

1655

0.68

4.17

2.0

3.69

3.64

g/l

0.14

104

1560

Metatarsalgia

162

1163

1.41

4.15

2.7

3.70

3.58

g/l

0.46

153

1110

Ulcer of vagina/vulva

316

1.81

4.14

2.2

3.0

3.37

3.55

g/l

0.43

304

Social phobias

168

1214

1.40

4.14

2.7

2.8

3.42

3.56

g/l

0.62

159

1159

Ankylosing spondylitis

155

1106

1.42

4.13

2.5

2.6

3.92

3.58

g/l

1.93

148

1054

Other hammer toe(s) (acquired)

259

1813

1.31

4.12

2.0

2.4

3.70

3.58

g/l

0.65

249

1736

Bronchitis, not specified as acute or chronic

137

956

1.45

4.12

3.5

2.8

3.82

3.56

g/l

0.92

130

915

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

600

1.57

4.11

3.0

2.5

3.69

3.60

g/l

0.22

573

Entropion and trichiasis of eyelid

129

891

1.46

4.10

2.8

2.2

3.72

3.64

g/l

0.20

122

844

Crowding of teeth, including avohilmo

216

1344

1.35

4.08

5.6

4.4

3.08

3.32

g/l

2.24

209

1283

Psoriatic and enteropathic arthropathies

191

1414

1.36

4.06

2.3

2.6

3.78

3.57

g/l

1.04

180

1354

Ankylosing spondylitis, ICD10

152

1085

1.42

4.05

2.5

2.7

3.90

3.60

g/l

1.52

145

1034

Adhesive capsulitis of shoulder

264

2047

1.30

4.04

2.3

2.4

3.66

3.63

g/l

0.13

249

1960

Fracture of forearm

1022

8068

1.14

4.04

2.8

2.7

3.54

3.57

g/l

0.33

981

7719

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

16.21

4.04

1.2

2.2

4.75

3.32

g/l

—

Other disorders of nervous system

112

756

1.50

4.02

3.5

2.3

3.63

g/l

0.02

107

723

Disorders of puberty, all

291

1.85

4.02

3.4

6.8

3.77

3.04

g/l

2.10

282

Burkitt lymphoma

10.94

4.01

2.3

1.8

3.41

4.21

g/l

—

Burkitt lymphoma, including Hilmo

10.94

4.01

2.3

1.8

3.41

4.21

g/l

—

Sequelae of other and unspecified infectious and parasitic diseases

596

1.57

4.01

3.0

2.5

3.68

3.60

g/l

0.20

569

Injury of eye and orbit

251

1937

1.31

4.00

2.4

3.1

3.63

3.55

g/l

0.40

239

1853

Exposure to other and unspecified animate mechanical forces

395

1.71

3.99

2.8

3.1

3.50

g/l

0.01

376

Other sleep disorders

193

1436

1.36

3.98

2.2

2.8

3.75

3.61

g/l

0.63

182

1370

Degeneration of macula and posterior pole

771

5126

1.17

3.98

2.1

2.3

3.64

3.62

g/l

0.14

737

4893

Algoneurodystrophy

365

1.73

3.97

3.8

2.1

3.38

3.65

g/l

0.86

347

Disorders of puberty

249

1.91

3.96

3.5

6.8

3.87

3.08

g/l

1.99

243

Myositis

255

1.88

3.95

3.0

2.7

3.64

3.49

g/l

0.29

244

Malignant neoplasm of accessory sinuses

7.85

3.95

1.4

5.01

3.21

g/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

313

2488

1.27

3.95

3.1

2.6

3.47

3.61

g/l

0.96

297

2356

Enterohaemorrhagic Escherichia coli infection

6.65

3.95

2.4

2.6

3.47

3.74

g/l

—

Acute gastritis

115

784

1.48

3.93

2.6

2.5

3.60

3.62

g/l

0.06

108

748

Whooping cough, including avohilmo

172

2.09

3.91

3.4

2.5

3.81

3.36

g/l

1.22

167

Dextrocardia

6.16

3.90

8.7

3.32

2.98

g/l

—

Other disorders of penis

185

1372

1.36

3.90

2.7

3.9

3.54

3.52

g/l

0.08

176

1328

Diseases of male genital organs

957

4206

1.15

3.90

2.8

3.3

3.52

3.58

g/l

0.53

916

4074

Eating disorder

197

1475

1.35

3.89

5.6

2.9

3.61

3.57

g/l

0.13

180

1401

Type 1 diabetes, strict definition

159

1150

1.40

3.88

2.9

4.2

3.67

3.27

g/l

3.82

152

1106

Rotator cuff syndrome

1066

6473

1.14

3.88

2.4

2.5

3.62

3.63

g/l

0.04

1015

6217

Open wound of thorax

173

2.08

3.87

2.5

3.2

3.46

3.57

g/l

0.15

166

Diseases of appendix

1423

11434

1.12

3.86

2.8

2.6

3.61

g/l

0.01

1366

10962

Childhood allergy (age < 16)

358

2385

1.25

3.84

3.0

4.2

3.39

3.43

g/l

0.26

339

2283

Appendicitis, broad definition

1412

11388

1.12

3.83

2.7

2.6

3.60

3.61

g/l

0.05

1355

10919

Alcohol withdrawal state with delirium

122

847

1.46

3.83

2.5

2.6

3.83

3.58

g/l

0.75

113

813

Hereditary erythropoietic porphyria

9.79

3.79

4.4

2.0

3.04

g/l

—

Atopic dermatitis, strict definition

605

5038

1.18

3.78

2.7

3.4

3.43

3.50

g/l

0.73

572

4821

Lactose intolerance

333

1.74

3.77

1.9

3.3

3.45

3.53

g/l

0.14

321

Other disorders of breast

222

1702

1.32

3.75

2.2

2.4

3.35

3.60

g/l

2.17

208

1606

Benign neoplasm of breast

177

1314

1.36

3.73

2.2

2.3

3.45

3.57

g/l

0.61

171

1251

Polyp of the female genital tract

478

2245

1.21

3.72

2.2

2.5

3.60

3.62

g/l

0.13

462

2130

Other lesions of median nerve

253

1.85

3.72

1.5

2.5

4.25

3.56

g/l

1.81

246

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

159

1163

1.38

3.71

2.6

2.2

3.98

3.66

g/l

1.85

146

1099

Embedded teeth, including avohilmo

188

1412

1.35

3.70

3.2

3.0

3.49

3.55

g/l

0.23

177

1347

Unspecified dementia

981

0.63

3.68

2.4

2.1

3.38

3.65

g/l

0.80

921

Sleep apnoea, including avohilmo

1899

10472

1.10

3.68

2.5

2.6

3.72

3.57

g/l

4.22

1806

10051

Dermatophytosis, including avohilmo

1251

10988

1.12

3.64

2.4

2.7

3.64

3.59

g/l

0.53

1184

10559

Pregnancy, childbirth and the puerperium

442

1902

1.22

3.63

2.1

2.6

3.70

3.53

g/l

1.67

423

1805

Chronic laryngitis and laryngotracheitis

227

1754

1.30

3.63

2.9

2.5

3.73

3.61

g/l

0.61

213

1667

Internal derangement of knee

668

5698

1.17

3.61

2.5

2.7

3.52

3.58

g/l

0.46

634

5491

Emotional disorders and disorders of social functioning with onset specific to childhood

130

905

1.43

3.61

8.1

4.5

3.09

3.27

g/l

0.94

121

877

Benign neoplasm: Kidney

368

1.69

3.60

2.1

2.4

3.60

3.67

g/l

0.18

353

Previous suicide attempt

131

2.21

3.60

2.0

3.5

3.53

3.43

g/l

0.09

126

Chronic conjunctivitis

361

1.70

3.59

3.0

3.1

3.42

g/l

0.00

348

Unspecified lump in breast

235

1827

1.30

3.58

2.8

2.3

3.61

3.63

g/l

0.08

227

1728

Mucinous and mucinous cystic tumor of rectum

4.08

3.56

2.0

2.5

3.33

4.28

g/l

0.98

Benign neoplasm: Skin of eyelid, including canthus

240

1874

1.29

3.55

2.3

2.4

3.69

3.59

g/l

0.54

229

1787

Nonspecific lymphadenitis

638

1.51

3.54

5.0

2.9

3.62

3.60

g/l

0.03

603

Chronic iridocyclitis

574

1.54

3.54

2.5

2.6

3.81

3.57

g/l

0.58

548

Non-seminoma of testis

4.92

3.53

1.3

2.4

2.83

3.91

g/l

—

Postmenopausal bleeding

389

1662

1.23

3.53

2.2

2.6

3.66

3.63

g/l

0.12

383

1592

Triptan medication for migraine, single purchase ok

1477

9042

1.11

3.53

2.8

2.7

3.55

3.59

g/l

0.47

1401

8671

Migraine, single triptan purchase ok & required. ICD-code if available is included

1477

9042

1.11

3.53

2.8

2.7

3.55

3.59

g/l

0.47

1401

8671

Pollen allergy

391

3181

1.22

3.53

3.2

3.7

3.45

3.44

g/l

0.06

377

3032

Brain glioblastoma, helper endpoint

159

2.08

3.52

1.4

2.4

3.46

3.63

g/l

0.29

154

Shoulder lesions

1329

7152

1.12

3.52

2.5

3.63

3.62

g/l

0.10

1267

6865

Enthesopathies of lower limb, excluding foot

393

3247

1.22

3.50

2.4

2.6

3.59

g/l

0.02

375

3102

Other perinatal digestive system disorders

5.53

3.49

11.4

9.7

2.77

2.68

g/l

—

Nutritional marasmus

5.53

3.49

5.1

4.9

3.50

3.48

g/l

—

Non-allergic asthma

158

1166

1.37

3.49

2.7

4.1

3.37

3.46

g/l

0.37

151

1119

Anomalies of dental arch relationship, including avohilmo

386

2877

1.22

3.49

4.9

3.2

3.25

3.52

g/l

3.15

368

2747

Tooth agenesis EXCLUDE clefts and syndromes

633

1.51

3.48

5.3

4.5

3.20

3.26

g/l

0.16

611

Rosacea

216

1669

1.31

3.48

3.7

2.6

3.39

3.60

g/l

1.65

207

1584

Bullous disorders

625

1.51

3.47

3.5

2.5

3.53

3.63

g/l

0.25

591

Obsessive-compulsive disorder

137

990

1.40

3.46

3.1

2.9

3.54

3.57

g/l

0.10

130

943

Insomnia

1756

11150

1.10

3.45

2.4

2.7

3.61

g/l

0.09

1663

10687

Colorectal neuroendocrine tumor and carcinoma

107

2.30

3.43

2.0

2.1

3.52

3.67

g/l

0.18

102

Intracranial nontraumatic haemorrhage of fetus and newborn

3.62

3.43

5.6

12.4

2.38

2.67

g/l

0.60

Nummular dermatitis

142

1035

1.39

3.41

3.7

2.7

3.68

3.57

g/l

0.33

135

986

Fibrosis and sclerosis of liver

10.01

3.40

5.7

2.1

2.23

4.81

g/l

—

Open wound of hip and thigh

421

1.62

3.40

2.9

3.1

3.75

3.58

g/l

0.34

404

Other and unspecified disorders of vitreous body

684

5803

1.16

3.39

2.5

2.4

3.66

3.62

g/l

0.33

659

5577

Mental and behavioural disorders due to cannabinoids

337

1.69

3.36

1.9

3.8

3.53

3.31

g/l

0.45

329

Glucagon-like peptide-1 (GLP-1) analogues

521

4435

1.18

3.34

3.0

2.6

4.05

3.55

g/l

8.82

491

4261

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

521

4435

1.18

3.34

3.0

2.6

4.05

3.55

g/l

8.82

491

4261

Diphtheria

6.01

3.32

2.6

1.3

3.37

3.45

g/l

—

Congenital absence, atresia and stenosis of small intestine

5.35

3.32

16.2

8.3

2.59

3.00

g/l

—

Open bite

121

865

1.42

3.31

5.5

4.3

3.22

3.31

g/l

0.33

114

833

Ulcerative rectosigmoiditis

137

999

1.39

3.30

3.1

2.7

3.37

3.58

g/l

1.11

127

953

Other and unspecified rosacea

149

1102

1.37

3.28

3.9

2.4

3.52

3.57

g/l

0.18

143

1045

Acute appendicitis

1317

11054

1.11

3.27

2.8

2.6

3.60

g/l

0.07

1264

10600

Other follicular disorders

133

967

1.39

3.27

2.5

2.8

3.83

3.58

g/l

0.91

125

919

Other female pelvic inflammatory diseases

236

1862

1.28

3.24

2.3

3.58

3.60

g/l

0.09

224

1773

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

513

4374

1.18

3.24

2.9

2.7

3.55

3.59

g/l

0.28

491

4189

Endometriosis of rectovaginal septum and vagina

121

867

1.41

3.24

2.0

2.4

3.42

3.62

g/l

0.89

114

816

Allergic rhinitis

606

5168

1.16

3.24

2.8

3.3

3.51

3.49

g/l

0.12

575

4944

578

1.51

3.23

4.4

8.5

2.85

2.83

g/l

0.08

570

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

137

1004

1.38

3.22

2.6

2.1

4.02

3.67

g/l

1.86

124

945

Restless leg syndrome

233

1838

1.28

3.22

1.8

2.5

3.53

3.59

g/l

0.23

223

1755

Contusion of ankle

539

1.53

3.21

2.8

3.2

3.52

3.51

g/l

0.03

513

Arthropathy in hypersensitivity reactions classified elsewhere

5.73

3.20

7.9

3.6

2.88

3.31

g/l

—

Drug-induced thyroiditis

4.34

3.19

3.5

1.9

3.10

3.68

g/l

—

Neuralgia and neuritis, unspecified

580

1.50

3.19

2.2

2.4

3.55

3.60

g/l

0.13

550

Pedal cyclist injured in other and unspecified transport accidents

195

1507

1.31

3.18

2.2

2.9

3.63

3.52

g/l

0.48

181

1442

Benign neoplasm of urinary organs

516

1.53

3.17

2.2

2.3

3.60

3.62

g/l

0.04

491

Leisure time condition

310

2530

1.23

3.17

2.9

2.8

3.52

3.55

g/l

0.12

293

2414

Meniscus derangement

946

5573

1.13

3.17

2.6

3.65

3.59

g/l

0.64

907

5373

Other extrapyramidal and movement disorders in other diseases

399

3337

1.20

3.17

1.9

2.6

3.56

3.61

g/l

0.28

379

3186

Tonsillectomy and adenotomy

1139

7116

1.12

3.17

3.2

3.1

3.51

3.53

g/l

0.20

1082

6812

Diphtheria, including avohilmo

5.53

3.16

2.6

1.3

3.37

3.48

g/l

—

Hypermobility syndrome

631

1.48

3.14

2.2

2.9

3.25

3.52

g/l

1.48

600

Diseases of inner ear

912

7756

1.13

3.14

2.4

2.5

3.59

3.62

g/l

0.23

861

7431

Event of undetermined intent

114

814

1.42

3.13

3.3

3.1

3.36

3.51

g/l

0.44

109

780

Sequelae of infectious and parasitic diseases, including avohilmo

114

814

1.41

3.12

3.1

2.4

3.60

3.59

g/l

0.03

108

775

Ulcerative colitis (strict definition, all Crohn cases excluded)

245

1954

1.26

3.10

2.7

2.9

3.58

3.53

g/l

0.21

225

1865

Rapidly progressive nephritic syndrome

4.67

3.09

7.7

2.9

3.17

3.47

g/l

—

Dermatographic urticaria

115

825

1.41

3.08

2.1

2.6

3.62

3.58

g/l

0.13

104

782

Malignant neoplasm of thyroid gland

592

1.48

3.08

3.8

2.5

3.47

3.61

g/l

0.44

551

Other abnormal immunological findings in serum

240

1.79

3.07

4.4

3.4

3.75

3.47

g/l

0.55

230

Coeliac disease

203

1585

1.29

3.07

2.4

3.1

3.62

3.55

g/l

0.27

190

1518

Sequelae of infectious and parasitic diseases

112

800

1.41

3.07

3.2

2.4

3.61

3.59

g/l

0.04

106

762

Disorders of vestibular function (Vertigo)

771

6619

1.14

3.07

2.4

2.5

3.56

3.63

g/l

0.66

724

6328

Benign leiomyoma with endometriosis

215

1691

1.28

3.06

2.1

2.4

3.49

3.60

g/l

0.48

203

1606

Other and unspecified mental retardation

377

1.64

3.05

4.2

8.6

2.66

2.93

g/l

1.00

370

Hereditary sideroblastic anaemia

4.50

3.05

14.8

1.8

3.72

3.90

g/l

—

Otitis externa

397

3334

1.20

3.03

2.7

3.0

3.70

3.56

g/l

1.03

372

3186

Otalgia

154

1162

1.34

3.01

3.2

3.7

3.37

3.48

g/l

0.48

141

1111

Toxic effect of other and unspecified substances

148

2.02

3.01

1.8

2.8

3.60

3.53

g/l

0.07

142

Viral infections of the central nervous system, including avohilmo

129

949

1.37

2.98

3.4

2.8

3.69

3.54

g/l

0.48

120

903

Malignant neoplasm of prostate, including Hilmo

397

1957

1.20

2.98

2.0

2.5

3.72

3.62

g/l

0.55

377

1877

Heterophoria

149

1121

1.34

2.98

5.4

3.6

3.45

3.46

g/l

0.02

140

1068

Anogenital herpesviral [herpes simplex] infection, including avohilmo

215

1699

1.28

2.97

2.5

2.6

3.58

3.59

g/l

0.04

199

1605

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

383

3214

1.20

2.97

2.9

2.7

3.51

3.58

g/l

0.41

364

3061

Malignant neoplasm of palate

4.37

2.96

2.0

2.3

3.60

3.89

g/l

—

Traumatic secondary and recurrent haemorrhage

5.90

2.96

3.1

4.1

4.27

3.10

g/l

—

Other symptoms and signs involving the nervous and musculoskeletal systems

733

6461

1.14

2.95

3.4

2.8

3.48

3.56

g/l

0.91

697

6162

Pilonidal cyst

148

1114

1.34

2.95

3.4

2.9

3.94

3.50

g/l

2.10

143

1064

Malignant neoplasm of tonsil, including Hilmo

142

2.02

2.94

1.6

2.4

3.78

3.65

g/l

0.17

135

Infective dermatitis

183

1419

1.30

2.94

2.9

2.6

3.61

3.55

g/l

0.22

171

1355

Biological medication for rheuma

312

2572

1.22

2.93

3.1

3.62

3.53

g/l

0.48

294

2459

Undefined dementia

954

0.66

2.93

2.4

2.1

3.38

3.66

g/l

0.85

897

Pyoderma

207

1.83

2.92

4.1

3.4

4.05

3.59

g/l

0.84

201

All dysplastic lesions of the cervix uteri, vagina or vulva

524

4408

1.16

2.90

2.5

2.4

3.67

3.60

g/l

0.45

492

4189

523

1.51

2.88

4.0

8.9

2.79

2.78

g/l

0.02

516

Dentofacial anomalies [including malocclusion]

1368

9759

1.10

2.88

3.3

2.7

3.44

3.60

g/l

3.82

1300

9346

Telogen effluvium

4.81

2.88

4.0

2.3

2.66

3.53

g/l

—

Urethral stricture

643

1.45

2.88

2.1

2.6

3.43

3.59

g/l

0.42

619

Congenital absence, atresia and stenosis of large intestine

3.68

2.85

9.7

10.2

2.62

2.87

g/l

0.40

Functional disorders of polymorphonuclear neutrophils

7.17

2.84

5.5

4.0

3.78

3.38

g/l

—

Behçet disease

4.16

2.84

2.1

2.8

3.98

3.64

g/l

—

Bulimia nervosa (incl. atypical)

490

1.51

2.83

2.4

2.7

3.99

3.56

g/l

1.52

461

Hyperkinetic disorders

311

2509

1.22

2.83

3.9

3.8

3.36

3.41

g/l

0.25

287

2401

Disturbance of activity and attention

292

2345

1.22

2.81

4.0

3.3

3.35

3.44

g/l

0.49

271

2241

Other factor of the environment

131

2.04

2.81

3.3

2.3

3.40

3.68

g/l

0.38

125

Etanercept

114

832

1.39

2.80

3.2

3.68

3.52

g/l

0.64

105

797

Otitis externa, unspecified

201

1589

1.28

2.79

2.8

3.0

3.75

3.52

g/l

1.26

193

1517

Malignant neoplasm of oropharynx

138

2.00

2.79

1.7

2.6

3.75

3.69

g/l

0.07

131

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

6.67

2.78

1.2

1.7

2.95

4.32

g/l

—

Spontaneous rupture of synovium and tendon

128

952

1.36

2.78

3.4

2.4

3.74

3.61

g/l

0.43

116

906

Other noninflammatory disorders of uterus, except cervix

307

1686

1.22

2.77

1.9

2.5

3.68

3.63

g/l

0.23

297

1607

Other eating disorders

113

826

1.39

2.76

5.7

3.2

3.64

3.54

g/l

0.27

103

781

Chronic diseases of tonsils and adenoids

1560

9033

1.09

2.75

2.8

2.9

3.57

g/l

0.05

1494

8679

Use of antiglaucoma preparations and miotics

108

783

1.39

2.75

2.2

2.3

3.66

3.59

g/l

0.22

746

Postmenopausal atrophic vaginitis

258

1729

0.81

2.74

2.0

2.6

3.49

3.63

g/l

0.88

245

1651

Arthrosis

1233

6132

1.10

2.74

2.5

2.6

3.61

3.57

g/l

0.41

1181

5903

Other and/or unspecified nontoxic goitre

122

904

1.36

2.72

2.3

3.66

3.60

g/l

0.17

116

862

Congenital malformations of uterus and cervix

266

1.69

2.68

2.6

2.4

3.71

3.58

g/l

0.34

251

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

3.56

2.68

1.5

2.4

3.78

3.44

g/l

—

Retinoblastoma, including Hilmo

6.46

2.68

4.7

12.2

3.70

3.74

g/l

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

4.45

2.67

3.0

5.1

3.00

3.05

g/l

—

LSIL lesion of the cervix uteri, vagina or vulva

235

1905

1.24

2.64

2.7

2.4

3.57

3.62

g/l

0.20

228

1801

Disorders of breast

843

6642

1.12

2.62

2.3

2.4

3.56

3.61

g/l

0.40

801

6325

Hypertensive encephalopathy

3.77

2.62

3.8

2.4

3.20

g/l

—

Carcinoma in situ of breast, intraductal

120

893

1.36

2.62

2.9

2.4

3.55

3.58

g/l

0.10

113

854

Perforation of tympanic membrane

159

1233

1.30

2.60

2.5

2.8

3.71

3.53

g/l

0.68

147

1178

Toxic effects of substances chiefly nonmedicinal as to source

198

1578

1.26

2.60

2.5

3.0

3.53

3.51

g/l

0.08

186

1510

Malignant neoplasm of tonsil

121

2.03

2.59

1.8

2.5

3.76

3.78

g/l

0.02

116

Causalgia

179

1.83

2.56

3.8

2.3

3.84

3.47

g/l

0.77

174

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

3.71

2.56

1.6

2.2

3.93

3.55

g/l

—

Radial styloid tenosynovitis [de Quervain]

642

1.42

2.55

1.9

2.6

3.63

3.61

g/l

0.05

611

Mental and behavioural disorders due to tobacco

146

1124

1.31

2.54

2.5

2.6

3.68

3.59

g/l

0.31

140

1076

Smoking dependency

146

1124

1.31

2.54

2.5

2.6

3.68

3.58

g/l

0.35

140

1074

Deep endometriosis

142

1090

1.31

2.52

1.9

2.4

3.41

3.57

g/l

0.82

135

1031

Peroneal tendinitis

195

1.78

2.51

2.3

2.4

3.51

3.76

g/l

0.53

185

Lifestyle-related condition

116

2.04

2.50

3.2

2.1

3.40

3.72

g/l

0.41

111

Disorders of fatty-acid metabolism

5.67

2.50

3.7

2.7

3.03

2.68

g/l

—

Malignant neoplasm of palate, including Hilmo

2.76

2.49

1.9

2.5

3.69

4.00

g/l

0.33

Benign neoplasm of bone and articular cartilage

136

1040

1.32

2.49

2.3

2.6

3.56

3.60

g/l

0.11

127

994

Necrosis of pulp, including avohilmo

1102

9923

1.10

2.49

2.6

2.7

3.66

3.59

g/l

0.93

1049

9523

Poisoning by narcotics and psychodysleptics [hallucinogens]

181

1.81

2.48

2.4

2.8

3.90

3.38

g/l

1.00

174

Malignant neoplasm of nasal cavity and middle ear

3.25

2.48

2.3

2.4

3.55

3.90

g/l

—

Injury of muscle and tendon at lower leg level

241

1975

1.23

2.47

3.4

2.7

3.79

3.60

g/l

0.98

234

1886

Acne, including avohilmo

481

3378

1.16

2.46

2.8

2.9

3.54

3.56

g/l

0.08

451

3211

Other bullous disorders

288

1.62

2.46

2.3

2.9

3.36

3.58

g/l

0.49

277

Psychotic depression

723

1.38

2.46

2.1

2.8

3.51

3.54

g/l

0.06

685

Other keratitis

194

1554

1.26

2.46

3.1

2.7

3.79

3.54

g/l

1.37

184

1482

Neuromyelitis optica

3.55

2.46

6.7

3.7

2.80

3.33

g/l

—

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

5.36

2.46

2.7

2.6

3.73

4.17

g/l

—

Anaemia due to enzyme disorders

7.00

2.45

24.8

3.0

2.78

3.39

g/l

—

Malignant neoplasm of vagina

5.30

2.45

1.8

3.30

2.95

g/l

—

HSIL lesion of the cervix uteri, vagina or vulva

353

3000

1.18

2.44

2.4

3.67

3.59

g/l

0.49

323

2853

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

3.92

2.44

7.9

2.6

2.88

2.94

g/l

—

Brain mixed glioma

6.83

2.43

1.0

2.4

2.28

3.74

g/l

—

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

3.45

2.43

1.8

2.6

3.44

4.03

g/l

—

Deep bite

219

1562

1.24

2.42

4.4

3.11

3.31

g/l

1.38

210

1495

Type1 diabetes, definitions combined, early onset

137

1051

1.31

2.40

3.1

4.9

3.68

3.26

g/l

3.46

131

1018

Lactose intolerance, other/unspecified

282

1.62

2.40

1.8

3.4

3.62

3.56

g/l

0.10

271

Other papulosquamous disorders

118

2.00

2.40

2.7

3.0

4.02

3.57

g/l

0.50

113

Abnormalities of forces of labour

149

1160

1.29

2.39

3.7

2.6

3.71

3.65

g/l

0.21

142

1107

Malignant neoplasm of prostate

382

1925

1.18

2.39

2.0

2.5

3.74

3.62

g/l

0.68

363

1847

Dental pulpitis, including avohilmo

1826

10877

1.08

2.38

2.5

2.7

3.70

3.58

g/l

2.65

1734

10436

Obstructive hydrocephalus

169

1.82

2.37

2.7

4.3

3.16

3.38

g/l

0.37

163

Precocious puberty

2.18

2.36

2.6

6.3

4.06

3.11

g/l

0.95

Sequelae of injuries of upper limb

159

1254

1.28

2.32

2.6

2.8

3.64

3.56

g/l

0.28

154

1200

Night blindness

6.40

2.30

1.8

2.0

3.78

3.80

g/l

—

Acute appendicitis, with complications

303

2556

1.19

2.30

2.9

2.7

3.74

3.60

g/l

0.82

286

2439

Pedal cyclist injured in transport accident

387

3331

1.17

2.30

2.3

3.0

3.45

3.56

g/l

0.85

360

3189

Spondylolisthesis/Spondylolysis

280

2346

1.20

2.30

3.0

2.4

3.55

3.60

g/l

0.19

266

2239

Anankastic personality disorder

480

1.46

2.29

2.3

2.6

3.64

3.56

g/l

0.17

457

Glaucoma-related operations

597

1.41

2.29

2.0

2.2

3.69

3.59

g/l

0.28

569

Emotional disorders starting during childhood or adolescence

119

898

1.33

2.29

8.3

4.4

3.15

3.24

g/l

0.32

112

873

Injuries involving multiple body regions

448

1.47

2.27

3.2

2.7

3.25

3.61

g/l

1.61

426

Other sideroblastic anaemias

3.24

2.27

6.3

1.7

3.18

3.70

g/l

—

Gonarthrosis

1063

5473

1.10

2.26

2.1

2.5

3.69

3.59

g/l

1.28

1024

5273

Acute lymphadenitis

709

1.37

2.26

3.1

3.71

3.46

g/l

0.71

677

Chorioretinal scars

3.00

2.26

6.4

4.3

3.58

3.67

g/l

—

Ulcerative proctitis

101

753

1.35

2.24

2.6

2.7

3.52

3.56

g/l

0.16

717

Demyelinating diseases of the central nervous system

140

1093

1.29

2.23

3.9

2.6

3.48

3.60

g/l

0.37

135

1041

Other blood glucose lowering drugs, excl. Insulins

228

1880

1.22

2.23

2.0

2.3

3.92

3.57

g/l

2.57

223

1798

Simple and mucopurulent chronic bronchitis

425

1.47

2.22

4.8

3.6

3.86

3.52

g/l

0.82

411

Burn and corrosion of other internal organs

3.49

2.22

1.4

2.6

2.89

3.36

g/l

—

Infective bursitis

304

1.57

2.22

2.7

2.6

4.01

3.58

g/l

1.07

294

Congenital heart conduction disorder

4.67

2.21

5.5

8.4

2.82

3.17

g/l

—

Reduction defects of lower limb, including avohilmo

2.92

2.19

1.7

5.0

3.60

3.58

g/l

—

Cysts of oral region, not elsewhere classified

732

1.35

2.16

2.0

2.7

3.65

3.60

g/l

0.11

700

Vulvovaginal ulceration/inflammation in other diseases

116

888

1.32

2.16

2.5

3.58

3.59

g/l

0.03

108

845

Presence of other devices

325

2730

1.18

2.15

2.4

2.1

3.67

3.68

g/l

0.07

311

2589

LSIL lesion of the cervix uteri

191

1555

1.24

2.14

2.6

2.2

3.55

3.63

g/l

0.35

185

1459

Extrapyramidal and movement disorders

608

5425

1.12

2.13

2.0

2.5

3.54

3.62

g/l

0.68

578

5185

Presbycusis

187

1499

1.24

2.13

2.0

2.1

3.60

3.66

g/l

0.23

178

1423

Pemphigoid

260

1.60

2.12

1.7

2.3

3.66

g/l

0.00

249

Necrotizing enterocolitis of fetus and newborn

7.12

2.11

2.6

13.1

2.24

2.84

g/l

—

Other disorders of patella

277

2340

1.19

2.11

2.3

2.5

3.65

3.58

g/l

0.30

263

2237

Other fall from one level to another

407

3543

1.15

2.10

3.0

3.2

3.49

3.51

g/l

0.13

390

3390

Autoimmune hyperthyroidism

676

1.36

2.08

2.7

2.3

3.58

g/l

0.00

652

Delivery

617

2893

1.13

2.08

2.1

2.6

3.71

3.57

g/l

1.65

588

2757

Acute appendicitis, no complications

1014

9246

1.09

2.05

2.8

2.7

3.55

3.60

g/l

0.43

978

8865

Other congenital malformations of intestine, including avohilmo

148

1.81

2.03

14.0

4.5

3.02

3.30

g/l

0.80

143

Retinoblastoma

5.27

2.03

5.2

12.2

3.70

3.74

g/l

—

Fenamates

283

1630

1.19

2.03

2.5

2.9

3.62

3.58

g/l

0.19

272

1564

Autoimmune thyroiditis

201

1.67

2.02

2.8

2.5

3.21

3.70

g/l

1.34

192

Frostbite involving multiple body regions and unspecified frostbite

3.54

2.01

2.1

2.6

2.99

3.66

g/l

—

Other and unspecified injuries of lower leg

127

995

1.29

2.01

3.7

3.1

3.74

3.50

g/l

1.15

120

945

Eustachian salpingitis and obstruction

128

1004

1.28

2.00

2.5

2.9

3.60

3.52

g/l

0.24

121

953

Dislocation, sprain and strain of joints and ligaments of knee

1140

9507

1.09

2.00

2.4

2.7

3.56

3.60

g/l

0.37

1095

9108

Transepidermal elimination disorders

4.08

1.99

2.0

1.7

4.90

4.14

g/l

—

Colitis due to radiation

1.99

5.8

2.2

3.43

3.75

g/l

0.32

Chronic mastoiditis

257

1.58

1.98

1.7

2.4

3.69

3.55

g/l

0.20

249

Endometriosis of intestine

173

1.71

1.92

1.7

2.0

3.20

3.78

g/l

2.31

159

Alpha thalassaemia

3.90

1.91

4.2

1.3

2.88

3.35

g/l

—

Measles

114

1.88

1.90

2.5

2.4

3.64

3.46

g/l

0.27

109

Oxicams

324

2134

0.86

1.90

2.2

2.9

3.66

3.59

g/l

0.33

314

2047

Measles, including avohilmo

114

1.88

1.90

2.5

2.4

3.64

3.46

g/l

0.27

109

Benign neoplasm: Tongue

284

1.54

1.90

2.1

2.5

3.68

3.59

g/l

0.17

274

Vitamin A deficiency

2.74

1.89

2.0

2.6

3.67

3.74

g/l

—

Ependymoma

3.79

1.88

11.7

4.6

2.95

3.16

g/l

—

Filariasis

4.56

1.88

8.2

2.3

3.82

3.17

g/l

—

Filariasis, including avohilmo

4.56

1.88

8.2

2.3

3.82

3.17

g/l

—

Other combined immunodeficiencies

4.49

1.87

1.0

3.3

4.62

3.42

g/l

—

Lichen sclerosus et atrophicus

154

1247

1.24

1.86

2.6

2.3

3.51

3.62

g/l

0.45

146

1192

Pain associated with micturition

181

1491

1.22

1.85

4.8

2.8

3.55

3.53

g/l

0.05

168

1420

Arthropathic psoriasis

170

1393

1.23

1.84

2.3

2.6

3.83

3.54

g/l

1.48

162

1327

Excessive attrition of teeth

1158

10630

1.08

1.83

3.2

2.7

3.53

3.58

g/l

0.63

1104

10189

Other intervertebral disc disorders

1507

8398

1.07

1.80

2.6

2.5

3.57

3.61

g/l

0.60

1426

8056

Tibial collateral bursitis [Pellegrini-Stieda]

102

1.90

1.79

1.3

1.9

3.76

3.63

g/l

0.17

Disorders of urea cycle metabolism

4.36

1.79

4.8

2.4

2.82

3.12

g/l

—

Failure of sterile precautions during surgical operation

2.79

1.76

2.9

2.3

4.74

3.62

g/l

—

Malignant neoplasm of other endocrine glands and related structures

4.06

1.74

2.0

2.9

2.86

4.60

g/l

—

Other and unspecified follicular disorders

500

1.37

1.73

3.2

2.7

3.96

3.64

g/l

0.63

473

Pustulosis palmaris et plantaris

466

1.39

1.72

1.7

2.4

3.99

3.60

g/l

1.07

445

Retinal breaks without detachment

240

2045

1.18

1.72

2.4

2.5

3.60

3.61

g/l

0.03

234

1953

Third [oculomotor] nerve palsy

187

1.63

1.72

3.8

3.0

3.35

3.61

g/l

0.43

181

Other superficial mycoses, including avohilmo

183

1524

1.21

1.71

2.6

2.8

3.59

3.57

g/l

0.09

173

1453

Other infective otitis externa

735

1.30

1.71

2.4

2.8

3.86

3.60

g/l

0.83

700

Superficial injury of wrist and hand

377

3323

1.14

1.70

3.8

3.1

3.45

3.53

g/l

0.50

355

3177

Other congenital malformations of respiratory system

3.00

1.70

1.3

9.2

3.66

3.02

g/l

—

Congenital lactase deficiency

2.93

1.68

3.4

1.8

2.80

3.42

g/l

—

Chondrosarcoma, including Hilmo

2.65

1.68

1.3

2.6

4.26

4.12

g/l

—

Impacted cerumen

174

1445

1.21

1.68

3.0

2.9

3.53

3.50

g/l

0.09

166

1383

Trigger finger

215

1820

1.19

1.67

4.0

2.5

3.81

3.64

g/l

0.89

209

1743

Benign lipomatous neoplasm

441

3932

1.13

1.66

2.5

3.62

3.60

g/l

0.10

425

3754

Wet age-related macular degeneration

223

1827

1.18

1.64

2.5

2.1

3.59

3.65

g/l

0.21

211

1728

Pustular psoriasis

522

1.35

1.64

1.8

2.8

4.00

3.63

g/l

1.07

498

Chronic suppurative otitis media

103

810

1.28

1.64

2.9

3.0

3.50

g/l

0.01

777

All dysplastic lesions of the cervix uteri

453

3986

1.12

1.63

2.4

3.64

3.61

g/l

0.22

426

3789

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

132

1070

1.24

1.63

2.5

3.68

3.56

g/l

0.37

123

1022

Psoriatic arthropathies

151

1242

1.22

1.62

2.3

2.6

3.77

3.59

g/l

0.71

143

1193

Sudden idiopathic hearing loss

153

1263

1.22

1.59

2.4

3.41

3.64

g/l

1.40

143

1203

Macular pucker

231

1980

1.17

1.57

2.0

2.3

3.71

3.64

g/l

0.29

218

1886

Pyogenic granuloma

200

1.57

1.56

2.2

2.3

3.62

3.61

g/l

0.02

194

Other chromosome abnormalities, not elsewhere classified

124

1.79

1.56

3.4

8.7

2.73

2.86

g/l

0.19

119

Acute necrotizing ulcerative gingivitis, including avohilmo

3.55

1.55

1.6

2.4

3.02

3.87

g/l

—

Anorexia (incl.atypical)

109

870

1.26

1.55

5.0

2.9

3.67

3.58

g/l

0.25

825

Benign thyroid growths and nodules

488

4085

1.11

1.53

2.3

2.4

3.66

3.62

g/l

0.24

468

3889

Beningn neoplasm: Meninges, unspecified

146

1.67

1.53

3.8

2.1

3.27

3.74

g/l

1.19

141

Chondrosarcoma

2.96

1.52

1.3

2.8

4.40

3.96

g/l

—

Fistulae involving female genital tract

170

1.61

1.51

1.9

2.5

3.22

3.74

g/l

1.29

162

Foreign body on external eye

171

2031

0.84

1.51

2.6

3.0

3.42

3.56

g/l

0.64

160

1950

Polyglandular dysfunction

2.62

1.48

4.4

2.6

3.97

3.67

g/l

—

Brain mixed glioma, helper endpoint

3.37

1.47

1.0

3.1

2.28

3.41

g/l

—

Need for immunization against other single infectious diseases

3.35

1.47

7.2

7.1

2.76

3.42

g/l

—

Myasthenia gravis, drug-induced

3.32

1.47

5.0

2.9

2.62

3.90

g/l

—

Pedal cyclist injured in noncollision transport accidents

185

1568

1.19

1.47

2.2

3.1

3.25

3.51

g/l

2.10

176

1503

Nephropathy induced by other drugs, medicaments and biological substances

2.89

1.47

7.5

2.0

3.92

3.65

g/l

—

Other diseases caused by chlamydiae

102

1.80

1.47

4.7

2.1

3.17

3.42

g/l

0.44

Allergic contact dermatitis

207

1773

1.17

1.45

2.2

2.7

3.66

3.60

g/l

0.24

198

1699

Unspecified chronic bronchitis

319

1.42

1.45

2.6

2.4

3.87

3.59

g/l

0.55

307

Malignant neoplasm of lip, including Hilmo

2.00

1.45

1.8

2.3

3.41

3.80

g/l

0.58

Injury of nerves at shoulder and upper arm level

118

1.73

1.44

1.9

2.1

3.62

3.65

g/l

0.03

113

Precocious central puberty

1.91

1.43

2.4

5.2

2.89

3.26

g/l

0.65

Synovial cyst of popliteal space [Baker]

101

808

1.26

1.43

4.2

2.4

3.73

3.59

g/l

0.37

768

Embedded and impacted teeth

541

3991

1.10

1.43

3.5

3.0

3.47

3.55

g/l

0.65

520

3796

Artificial joint operation, meniscal resection

1564

9449

1.06

1.42

2.2

2.6

3.69

3.61

g/l

1.05

1511

9064

Other and unspecified injuries of thorax

197

1.54

1.42

4.2

2.3

3.38

3.66

g/l

0.53

191

Inguinal or femoral hernia, bilateral

155

1298

1.20

1.42

2.8

2.7

3.05

3.70

g/l

8.96

148

1250

Profound mental retardation

2.85

1.42

2.5

7.6

2.28

2.95

g/l

—

Other disorders of cornea

144

1198

1.21

1.42

2.3

2.6

3.63

3.58

g/l

0.16

138

1143

Convulsions of newborn

3.01

1.41

10.2

10.0

2.78

2.84

g/l

—

Panhypopituitarism

206

1.53

1.40

3.1

3.2

3.32

3.57

g/l

0.55

200

Meningococcal infection

2.04

1.40

2.1

2.6

4.57

3.28

g/l

1.83

Other meningitis

182

1.56

1.39

3.6

2.7

3.65

3.48

g/l

0.28

176

Benign neoplasm of middle ear and respiratory system

113

920

1.24

1.38

2.6

2.5

3.94

3.58

g/l

1.50

108

877

Sequelae of hyperalimentation

3.10

1.38

1.2

1.6

3.18

3.21

g/l

—

Open wound of wrist and hand

829

7435

1.08

1.38

2.5

2.9

3.55

3.60

g/l

0.49

784

7153

Exposure to excessive natural cold

112

1.73

1.37

2.2

2.7

3.34

3.49

g/l

0.24

107

Presbyopia

116

948

1.23

1.37

2.1

2.5

3.37

3.63

g/l

1.50

109

903

Diseases caused by chlamydiae, including avohilmo

143

1.63

1.37

3.9

2.8

3.00

3.45

g/l

1.35

137

HSIL lesion of the cervix uteri

312

2766

1.13

1.36

2.5

2.4

3.64

3.60

g/l

0.15

287

2625

Meningococcal infection, including avohilmo

2.01

1.34

2.1

2.5

4.57

3.29

g/l

1.82

Tinnitus

369

3307

1.12

1.34

2.2

2.6

3.45

3.63

g/l

1.93

352

3171

Nasal polyp

287

2536

1.14

1.32

2.3

2.6

3.74

3.61

g/l

0.65

276

2423

Brain astrocytoma

2.42

1.31

3.0

2.3

3.34

3.92

g/l

—

Brain astrocytoma, including Hilmo

2.42

1.31

3.0

2.3

3.34

3.92

g/l

—

Other diseases caused by chlamydiae, including avohilmo

153

1.59

1.30

3.8

2.7

3.08

3.45

g/l

0.99

146

Other enthesopathies

465

4224

1.10

1.30

2.4

2.6

3.57

3.59

g/l

0.13

443

4055

Combinations of oral blood glucose lowering drugs

429

3883

1.11

1.30

2.3

2.4

3.77

3.53

g/l

2.46

413

3733

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1050

7644

1.07

1.30

2.4

3.55

3.64

g/l

1.29

993

7298

Intussusception

202

1.50

1.28

1.8

2.8

3.52

3.63

g/l

0.11

195

Anisometropia and aniseikonia

388

1.35

1.28

3.6

3.25

3.39

g/l

0.35

370

Calculus of lower urinary tract

598

1.28

1.27

2.3

3.55

3.64

g/l

0.20

562

Inguinal hernia, bilateral

151

1277

1.19

1.27

2.8

2.7

3.05

3.71

g/l

9.23

144

1229

Lichen planus

180

1545

1.17

1.27

2.1

2.5

3.64

3.55

g/l

0.38

172

1473

Melanocytic naevi of other and unspecified parts of face

688

1.26

4.3

2.7

3.70

3.62

g/l

0.24

653

Seropositive rheumatoid arthritis, strict definition

212

1844

1.15

1.25

2.2

2.4

3.97

3.57

g/l

2.87

206

1754

Parkinson's disease

151

1777

0.85

1.25

2.0

2.3

3.59

3.63

g/l

0.13

142

1697

406

3154

1.11

1.24

2.1

3.61

3.64

g/l

0.11

385

2996

Multiple delivery

127

1061

1.20

1.24

3.9

2.7

3.67

3.63

g/l

0.13

120

1008

Conductive hearing loss, unspecified

128

1070

1.20

1.24

3.4

3.0

3.83

3.56

g/l

1.04

123

1020

Cardiomyopathy due to drugs and other external agents

2.74

1.23

1.2

2.3

3.14

3.53

g/l

—

Benign mammary dysplasia

179

1540

1.17

1.23

2.2

2.3

3.52

3.62

g/l

0.46

171

1464

Parkinson's disease, including avohilmo

160

1870

0.85

1.22

2.0

2.3

3.58

3.63

g/l

0.17

149

1788

Chronic suppurative otitis media, including avohilmo

123

1026

1.21

1.22

2.8

3.5

3.58

3.45

g/l

0.48

118

978

Digeorge syndrome

2.90

1.22

3.6

13.9

3.10

2.44

g/l

—

Traumatic cerebral oedema

2.37

1.20

2.5

1.9

3.08

3.54

g/l

—

Adalimumab

160

1370

1.17

1.18

3.5

3.0

3.62

3.53

g/l

0.34

155

1310

Myotonic dystrophy (Steinert)

0.00

1.18

0.0

2.8

—

3.34

—

Other disorders of male genital organs

490

1.30

1.18

3.1

3.3

3.25

3.51

g/l

0.59

471

Unspecified organic or symptomatic mental disorder

0.00

1.17

0.0

2.0

—

3.90

—

Infections of genitourinary tract in pregnancy

139

1178

1.19

1.17

1.7

2.5

3.66

3.54

g/l

0.54

134

1119

Bullous pemphigoid

207

1.47

1.16

1.8

2.3

3.55

3.72

g/l

0.23

199

Schizophrenia or delusion, excluding more controls

461

4162

1.10

1.16

2.3

2.6

3.68

3.60

g/l

0.52

437

3985

Carcinoma in situ of cervix uteri

171

1476

1.16

1.15

2.7

2.3

3.49

3.63

g/l

0.73

156

1389

Obstructed labour due to maternal pelvic abnormality

144

1687

0.85

1.15

2.6

2.5

3.72

3.59

g/l

0.50

137

1615

Sulfonylureas

472

3431

1.10

1.14

2.2

3.96

3.55

g/l

5.68

452

3280

Propionic acid derivatives

497

2729

0.91

1.14

2.8

3.5

3.63

3.50

g/l

1.16

474

2626

Temporomandibular joint disorders, including avohilmo

818

7415

1.07

1.14

2.6

3.46

3.60

g/l

2.45

769

7082

Adenocarcinomas of cervix

2.39

1.14

1.4

2.0

4.33

3.55

g/l

—

Foreign body in respiratory tract

654

1.25

1.13

3.3

3.62

3.52

g/l

0.20

626

Seborrhoeic dermatitis

149

1275

1.17

1.13

2.8

3.54

g/l

0.00

143

1221

Epidermolysis bullosa

2.51

1.11

4.0

9.5

3.26

2.80

g/l

—

Tumor necrosis factor alpha inhibitors

256

2278

1.13

1.11

3.0

3.1

3.66

3.53

g/l

0.83

242

2177

Drug-induced fever

2.49

1.11

8.4

1.9

4.64

3.34

g/l

—

Sleep terrors [night terrors]

2.29

1.11

2.1

5.1

3.89

3.24

g/l

—

Neurofibromatosis, type 2

2.48

1.11

2.0

8.1

3.42

3.36

g/l

—

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

2.48

1.11

3.4

5.1

3.54

3.36

g/l

—

Use of disulfiram, acamprosate or naltrexone

129

1093

1.19

1.10

2.6

2.7

3.61

3.56

g/l

0.14

123

1043

Other benign neoplasms of connective and other soft tissue

139

1186

1.18

1.10

1.8

2.6

3.47

3.57

g/l

0.44

134

1126

Contact with and exposure to communicable diseases

568

5234

1.08

1.09

4.0

3.0

3.48

3.52

g/l

0.26

531

5003

Disease of hard tissues of teeth, NOS

870

4267

1.07

1.09

2.6

2.3

3.51

3.63

g/l

1.64

832

4084

Ganglion

325

2936

1.11

1.08

2.3

2.4

3.54

3.60

g/l

0.32

313

2810

Viral encephalitis, not elsewhere classified/unspecified

228

1.42

1.07

3.6

2.5

3.84

3.44

g/l

0.60

217

Respiratory tuberculosis, clinically confirmed

113

1.61

1.07

2.2

2.0

3.54

3.81

g/l

0.27

108

Alzheimer disease, excluding more controls

181

1343

0.87

1.07

1.9

2.2

3.71

3.67

g/l

0.12

168

1287

Acute epiglottitis

162

1.50

1.05

3.0

2.2

3.66

g/l

0.00

157

Acute disseminated encephalitis/encephalomyelitis

2.37

1.05

6.2

1.9

3.20

3.50

g/l

—

Thyrotoxicosis with diffuse goitre

207

1826

1.14

1.05

3.2

2.5

3.46

3.64

g/l

1.02

200

1737

Exposure to excessive natural heat

2.35

1.05

2.6

2.4

4.12

3.55

g/l

—

Contact with lifting and transmission devices, not elsewhere classified

204

1.44

1.04

1.8

2.8

3.24

3.71

g/l

1.20

198

Open wounds involving multiple body regions

2.11

1.04

3.1

3.9

3.37

3.12

g/l

—

Use of levodopa decarboxylase inhibitor

137

1595

0.86

1.04

1.9

2.3

3.44

3.64

g/l

1.09

128

1519

Ankylosing spondylitis, strict definition

509

1.27

1.03

2.2

2.7

3.84

3.58

g/l

0.76

488

Spirochaetal infections, other/unspecified

133

1138

1.17

1.03

1.9

2.7

3.30

3.60

g/l

2.40

127

1091

Lumbar disc prolapse

1129

7924

1.06

1.03

2.6

2.5

3.59

3.61

g/l

0.18

1068

7607

Hallux valgus (acquired)

477

3139

1.09

1.03

2.1

2.5

3.53

3.59

g/l

0.34

450

3008

Other obstructed labour

798

1.21

1.03

2.1

2.7

3.67

3.63

g/l

0.10

764

Artrosis, including avohilmo

1383

7943

0.95

1.02

2.3

2.7

3.60

g/l

0.00

1310

7626

Cervicobrachial syndrome

274

3045

0.90

1.02

2.3

2.5

3.50

3.61

g/l

0.69

260

2903

Sacroiliitis, not elsewhere classified

600

1.24

1.02

2.2

2.5

3.87

3.61

g/l

0.79

570

Acute thyroiditis

2.05

1.01

1.3

1.8

4.84

3.82

g/l

—

Sensorineural hearing loss

1166

8178

0.95

1.01

2.5

2.6

3.57

3.63

g/l

0.65

1102

7869

Brachial plexus disorders

141

1215

1.17

1.01

2.4

2.6

3.37

3.63

g/l

1.53

130

1160

Severe mental retardation

1.95

1.01

1.7

8.6

2.74

2.93

g/l

—

Hypertrophy of breast in women and men

284

2560

1.11

1.00

2.1

2.6

3.57

3.62

g/l

0.23

269

2428

L02BX Other hormone antagonists and related agents

692

1.22

1.00

1.9

2.3

4.10

3.67

g/l

1.29

657

Other disorders of thyroid

132

1.54

0.98

7.0

2.1

3.30

3.68

g/l

0.79

126

Dependent personality disorder

207

1.42

0.98

1.9

2.4

4.40

3.59

g/l

1.48

201

Anti-inflammatory and antirheumatic products, non-steroids

502

2730

0.92

0.97

2.7

3.5

3.58

3.50

g/l

0.57

481

2627

Kela-code for severe mental illness

501

5396

0.93

0.95

2.1

2.7

3.71

3.58

g/l

1.18

475

5160

Cerebral arteritis

2.30

0.95

1.8

3.0

3.70

3.39

g/l

—

Other and unspecified nerve root and plexus disorders, also in other diseases

263

2914

0.90

0.95

2.1

2.6

3.57

3.62

g/l

0.21

243

2787

Acetic acid derivatives and related substances

512

2450

1.08

0.94

2.4

3.0

3.60

3.58

g/l

0.12

483

2353

Hereditary ataxia

146

0.54

0.94

7.4

4.1

2.97

3.52

g/l

—

141

277

2337

1.11

0.93

2.0

2.1

3.67

3.66

g/l

0.05

262

2217

Acute nasopharyngitis (common cold)

176

1539

1.14

0.93

3.3

3.0

3.57

3.53

g/l

0.10

169

1476

Other psoriatic arthropathies

146

1272

1.15

0.92

2.3

2.6

3.77

3.60

g/l

0.65

138

1213

Coxarthrosis, primary

927

7289

1.06

0.91

2.4

2.3

3.65

3.63

g/l

0.21

895

6977

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

627

1.22

0.91

2.2

2.4

3.78

3.60

g/l

0.49

606

Struck by thrown, projected or falling objec

691

1.21

0.91

2.7

3.0

3.42

3.55

g/l

0.40

660

Reduction defects of lower limb

2.14

0.91

1.7

5.1

4.05

3.64

g/l

—

Mental and behavioural disorders due to use of volatile solvents

2.13

0.91

1.2

2.2

3.60

3.41

g/l

—

Other appendicitis

119

1023

1.17

0.90

2.1

2.5

3.71

3.62

g/l

0.25

114

967

Retinoschisis and retinal cysts

229

1.37

0.87

1.6

2.5

4.06

3.69

g/l

0.53

220

Pediculosis, acariasis and other infestations, including avohilmo

292

2662

1.10

0.87

3.3

3.1

3.61

3.50

g/l

0.64

279

2530

Transient global amnesia

1041

0.84

0.86

2.3

3.43

3.63

g/l

0.66

994

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

506

4720

1.07

0.86

2.4

2.9

3.58

3.57

g/l

0.05

484

4524

Conductive and sensorineural hearing loss

1251

8678

0.96

0.86

2.6

2.7

3.58

3.62

g/l

0.45

1183

8348

Isolated growth hormone deficiency

189

1.42

0.85

6.3

11.6

3.03

2.83

g/l

0.34

182

Other degenerative diseases of the nervous system

387

2602

1.09

0.85

2.7

2.3

3.58

3.64

g/l

0.34

365

2488

Parkinson's disease, strict definition

143

1627

0.88

0.84

2.0

2.3

3.56

3.64

g/l

0.31

134

1553

Carpal tunnel syndrome

940

8556

0.95

0.84

2.3

2.5

3.73

3.60

g/l

2.06

905

8197

Psoriatic arthropathies, ICD10

148

1304

1.14

0.82

2.3

2.6

3.77

3.59

g/l

0.68

140

1245

Primary coxarthrosis, bilateral

399

3698

1.08

0.82

2.4

2.3

3.84

3.63

g/l

1.88

384

3530

Hirsutism in women

232

1.35

0.82

1.8

2.9

3.80

3.54

g/l

0.44

220

Acute alcohol intoxication ICD-9

355

1.28

0.82

1.7

2.3

4.16

3.69

g/l

1.03

336

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

130

1.48

0.82

1.7

2.0

4.03

3.59

g/l

0.46

125

Hand

1.73

0.81

6.0

2.2

3.21

3.54

g/l

—

Nontoxic goitre/thyroid nodule

397

3681

1.08

0.81

2.4

3.62

3.60

g/l

0.10

379

3506

Brain astrocytoma, helper endpoint

1.70

0.80

3.0

2.1

3.34

3.64

g/l

—

Other and unspecified degenerative diseases of nervous system

270

0.70

0.79

1.4

2.4

3.53

3.65

g/l

0.19

255

Cyst of spleen

2.26

0.78

1.0

5.0

3.40

3.47

g/l

—

Syndactyly

2.25

0.77

9.4

4.7

2.78

3.55

g/l

—

Diseases of thymus

2.24

0.77

5.4

2.6

2.68

3.44

g/l

—

Acanthosis nigricans

2.22

0.77

2.8

3.34

3.66

g/l

—

Benign muscular dystrophy (Becker)

2.19

0.76

3.2

5.8

2.36

3.17

g/l

—

Pectus carinatum, including avohilmo

2.17

0.76

5.4

5.5

3.26

3.22

g/l

—

Benign neoplasm: Skin of ear and external auricular canal

395

1.25

0.76

1.8

2.2

3.61

3.63

g/l

0.03

374

Other peripheral vertigo

119

1040

1.15

0.76

2.2

2.4

3.64

3.63

g/l

0.01

109

984

Disorder of thyroid, unspecified

124

1.47

0.76

7.5

2.0

3.29

3.69

g/l

0.81

117

Benign neoplasm of other and unspecified sites

342

1.27

0.75

2.5

2.4

3.33

3.62

g/l

0.86

330

Medial epicondylitis

423

1.24

0.75

1.8

2.5

3.55

3.65

g/l

0.20

402

Primary open-angle glaucoma

371

3840

0.93

0.75

2.1

2.2

3.58

3.64

g/l

0.35

356

3649

Other and unspecified atrophic disorders of skin

1.88

0.74

9.0

2.2

4.97

3.87

g/l

—

Hypertrophy of breast

238

2172

1.10

0.73

2.0

2.5

3.66

3.61

g/l

0.20

225

2059

Scarlet fever

1.69

0.73

5.4

3.0

3.62

3.22

g/l

—

Impacted teeth

390

3116

1.08

0.73

3.6

3.0

3.44

3.54

g/l

0.80

380

2962

Alzheimer’s disease (Late onset), excluding more controls

145

1061

0.89

0.73

2.1

2.2

3.79

3.74

g/l

0.17

133

1013

Deviated nasal septum

516

4847

1.07

0.73

2.5

2.6

3.61

3.62

g/l

0.08

496

4660

Burns and corrosions

216

1963

1.10

0.73

3.4

3.2

3.39

3.52

g/l

0.57

211

1876

Other parasitologically confirmed or unspecified malaria

1.98

0.72

3.0

2.1

2.70

3.39

g/l

—

Exposure to other and unspecified man-made environmental factors

238

1.32

0.72

6.3

3.0

3.11

3.47

g/l

1.31

229

Relapsing fevers, including avohilmo

1.97

0.71

4.4

3.4

3.04

3.25

g/l

—

Inguinal of femoral hernia, unilateral

265

1.29

0.70

2.9

2.5

3.33

3.62

g/l

0.65

253

Inguinal hernia, unilateral

265

1.29

0.70

2.9

2.5

3.33

3.62

g/l

0.65

253

Femoral hernia, unilateral

265

1.29

0.70

2.9

2.5

3.33

3.62

g/l

0.65

253

Single spontaneous delivery

579

2883

1.06

0.70

1.9

2.6

3.60

3.57

g/l

0.20

550

2749

Klinefelter syndrome, karyotype 47 XXY

1.91

0.69

1.8

7.3

3.70

3.22

g/l

—

Other conditions originating in the perinatal period

1.93

0.69

2.2

9.4

3.38

2.91

g/l

—

Exclusion endpoint for supernumerary teeth

197

1.34

0.67

3.0

5.6

3.07

3.24

g/l

0.34

192

Multiple congenital exostoses, including avohilmo

1.76

0.64

1.2

3.6

3.90

3.32

g/l

—

Excessive earwax

1021

9618

0.96

0.64

2.5

2.7

3.56

3.59

g/l

0.26

973

9219

Burn and corrosion of head and neck

257

0.73

0.63

3.4

3.2

2.87

3.61

g/l

1.52

247

Hypertrichosis

270

1.27

0.63

1.8

2.9

3.71

3.58

g/l

0.19

256

Injury of muscle and tendon at forearm level

208

1.31

0.63

2.4

3.1

3.90

3.45

g/l

0.77

199

L02BB Anti-androgens

119

1058

1.13

0.62

2.0

2.1

4.01

3.67

g/l

1.30

112

1000

Fusion of the labia, including avohilmo

0.00

0.62

0.0

6.9

—

3.05

—

Crystal arthropathies, rheuma endpoint

182

1.33

0.62

2.7

2.4

3.54

3.70

g/l

0.22

172

Hirsutism, drug-induced

0.00

0.61

0.0

2.2

—

3.33

—

Puerperal sepsis

161

1459

1.11

0.61

2.0

2.4

3.62

3.61

g/l

0.04

154

1393

Pleural plaque without asbestos

362

1.22

0.60

2.6

2.3

3.78

3.64

g/l

0.21

341

Other crystal arthropathies

183

1.32

0.60

2.7

2.1

3.54

3.68

g/l

0.19

172

Contact with other hot fluids

427

1.20

0.59

3.9

3.25

3.48

g/l

0.48

410

Lichen planus, including avohilmo

261

2422

1.08

0.59

2.3

2.6

3.66

3.60

g/l

0.23

247

2312

Vascular syndromes of brain in cerebrovascular disorders

455

1.19

0.59

3.4

2.2

3.72

3.64

g/l

0.14

429

Wide developmental disorders

624

0.84

0.59

2.4

6.4

3.42

3.03

g/l

1.49

608

Schizotypal disorder

264

0.75

0.58

2.5

3.74

3.60

g/l

0.17

253

Scabies, including avohilmo

246

2280

1.08

0.57

3.4

3.2

3.59

3.47

g/l

0.65

233

2168

Kyphosis

132

1.38

0.57

2.8

3.61

3.57

g/l

0.03

125

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.64

0.56

2.7

2.5

3.93

3.56

g/l

—

Motor- or nonmotor-vehicle accident in traffic area

1.48

0.55

1.6

3.2

2.97

3.36

g/l

0.72

Raynaud syndrome

128

1155

1.11

0.55

2.5

3.30

3.62

g/l

2.24

122

1094

Type 1 diabetes, wide definition, subgroup 2

147

0.68

0.54

3.8

4.4

2.58

3.50

g/l

—

142

Mitochondrial myopathy

1.56

0.53

4.0

3.9

3.65

3.29

g/l

—

Other and unspecified nonorganic psychotic disorders

293

2745

1.07

0.53

2.6

2.8

3.65

3.55

g/l

0.57

279

2617

Other disorders of ear

1668

10484

1.03

0.52

2.7

2.8

3.52

3.59

g/l

1.09

1582

10081

Fasciculation

144

1.33

0.51

14.6

2.4

3.18

3.48

g/l

0.65

139

Peritonsillar abscess

336

3168

1.06

0.51

3.0

2.6

3.59

g/l

0.02

325

3032

Coxarthrosis, primary, with hip surgery

678

6031

1.04

0.51

2.3

3.66

3.63

g/l

0.26

660

5765

Coxibs

453

2500

0.95

0.49

2.3

3.1

3.67

3.56

g/l

0.74

428

2402

Oral lichen planus, including avohilmo , including avohilmo

803

1.12

0.49

2.5

2.4

3.71

3.62

g/l

0.23

771

Other and unspecified pemphigoid

1.41

0.49

1.3

2.2

3.42

3.60

g/l

0.20

Other nonscarring hair loss

119

1.36

0.49

4.6

2.2

2.87

3.72

g/l

1.74

114

Lichen ruber planus, wide definition including periferal and oral lichen planus

309

2912

1.06

0.48

2.4

2.5

3.72

3.61

g/l

0.66

294

2786

Other chondrocalcinosis

128

1.34

0.48

2.0

2.4

3.95

3.72

g/l

0.26

122

Glucosamine medication

643

4925

1.04

0.48

2.4

2.3

3.67

3.64

g/l

0.20

607

4711

Other and unspecified disorders of skin and subcutaneous tissue

673

1.13

0.47

2.6

2.4

3.42

3.62

g/l

0.57

640

Palmar fascial fibromatosis [Dupuytren]

197

1832

1.08

0.46

2.2

2.4

3.58

3.60

g/l

0.09

190

1748

Chronic respiratory disease originating in the perinatal period

1.50

0.46

7.2

10.4

2.36

2.69

g/l

—

Superficial injuries involving multiple body regions

301

1.20

0.46

3.1

2.7

3.36

3.60

g/l

0.70

291

Other cranial nerve disorders in other disorders

1.65

0.43

4.4

2.0

2.86

3.78

g/l

—

Burns and corrosions of multiple and unspecified body regions

276

1.20

0.43

4.2

3.2

3.32

3.55

g/l

0.41

267

Cyst of iris, ciliary body and anterior chamber

0.00

0.41

0.0

2.6

—

3.19

—

Other otitis externa (chronic)

826

1.10

0.39

2.6

2.8

3.81

3.59

g/l

0.65

785

Other menopausal disorders

361

1916

1.05

0.39

2.2

2.5

3.46

3.60

g/l

1.06

347

1826

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

243

1.20

0.38

1.9

2.3

3.67

3.60

g/l

0.08

236

Toxic effect of contact with venomous animals

524

1.13

0.38

2.1

3.3

3.66

3.56

g/l

0.20

501

Bullous keratopathy

1.40

0.37

3.8

2.5

3.21

3.39

g/l

—

Other congenital malformations of female genitalia

1.33

0.36

2.3

2.9

3.64

3.52

g/l

0.10

Congenital malformations of lung

1.42

0.36

7.8

5.7

3.63

3.42

g/l

—

Benign neoplasm of eye and adnexa

137

1275

1.08

0.35

2.8

2.6

3.59

g/l

0.01

132

1209

Benign neoplasm of other and unspecified female genital organs

423

1.14

0.35

1.9

2.2

3.83

3.57

g/l

0.46

405

Glaucoma

843

6958

1.03

0.35

2.3

2.4

3.61

3.62

g/l

0.12

812

6650

Achilles tendinitis

146

1363

1.07

0.35

2.7

2.6

3.72

3.60

g/l

0.49

137

1307

Iridocyclitis in diseases classified elsewhere

209

1.20

0.34

2.7

3.4

4.09

3.59

g/l

0.90

202

Organic, including symptomatic, mental disorders

725

5250

0.97

0.34

2.4

2.3

3.65

3.64

g/l

0.07

691

5026

Other infestations, including avohilmo

191

1.21

0.33

1.8

2.8

3.64

3.55

g/l

0.09

186

Congenital malformations of lung, including avohilmo

1.32

0.33

7.8

5.5

3.63

3.41

g/l

—

Normotensive glaucoma

102

941

1.09

0.33

1.9

2.3

3.59

3.63

g/l

0.13

896

Mixed conductive and sensorineural hearing loss

160

1504

1.07

0.32

1.9

2.4

3.75

3.62

g/l

0.45

149

1437

Benign neoplasm: Skin of other and unspecified parts of face

130

1214

1.07

0.32

2.5

2.4

3.40

3.62

g/l

1.16

120

1150

Cervical disc disorders

533

5161

1.03

0.31

2.4

2.5

3.65

3.61

g/l

0.26

512

4958

Parkinson's disease, strict definition, excluding more controls

143

1250

1.07

0.31

2.0

2.2

3.56

3.69

g/l

0.54

134

1199

Other respiratory conditions originating in the perinatal period

1.30

0.31

2.6

12.2

2.13

2.78

g/l

—

Cleft palate

129

1.25

0.30

2.4

4.9

3.08

3.28

g/l

0.30

124

Benign neoplasm: Peripheral nerves and autonomic nervous system

175

1.21

0.30

2.8

2.5

3.38

3.64

g/l

0.41

169

Nontoxic multinodular goitre

242

2309

1.05

0.30

2.3

3.62

3.64

g/l

0.04

232

2195

Fitting and adjustment of other devices

438

3725

1.04

0.30

3.1

2.3

3.70

3.57

g/l

1.07

418

3560

Gonarthrosis,primary

1446

8550

1.02

0.29

2.0

2.6

3.71

3.62

g/l

1.46

1396

8209

Mouth breathing

636

6179

1.03

0.28

2.6

3.1

3.60

3.54

g/l

0.44

608

5939

Ethmoidectomy

176

1669

1.06

0.28

2.3

2.7

3.67

3.56

g/l

0.40

165

1593

Cleft lip, lip and palate or palate

205

1.18

0.27

2.6

4.3

3.13

3.37

g/l

0.50

200

Injury of muscle and tendon at shoulder and upper arm level

537

5218

1.03

0.27

2.2

2.6

3.62

3.63

g/l

0.07

508

5029

Chalazion

160

1516

1.06

0.27

2.0

2.8

3.45

3.54

g/l

0.38

147

1449

Other congenital malformations of ear

178

1.19

0.26

5.7

4.6

3.32

g/l

0.00

172

Narcolepsy and cataplexy

1.26

0.26

2.2

2.0

3.98

3.49

g/l

—

Flat foot [pes planus] (acquired)

108

1151

0.94

0.26

2.8

2.6

3.65

3.56

g/l

0.24

102

1102

Carcinoma in situ of cervix uteri, endocervix

127

0.78

0.25

2.4

3.72

3.69

g/l

—

120

Inflammatory diseases of prostate (prostatitis)

159

1674

0.95

0.25

2.3

2.7

3.68

3.64

g/l

0.12

151

1620

Glaucoma suspect

476

4889

0.97

0.24

2.5

2.4

3.57

3.62

g/l

0.30

459

4664

Cleft lip

1.37

0.24

3.8

6.1

3.16

3.28

g/l

—

Use of peginterferon beta-1a

1.29

0.23

1.0

1.9

4.16

3.63

g/l

—

Congenital deformities of hip, including avohilmo

313

1.12

0.23

5.1

5.5

2.71

3.07

g/l

1.31

304

Female genital prolapse

375

2021

1.03

0.22

2.0

2.5

3.45

3.62

g/l

1.80

352

1921

Intrauterine hypoxia

0.00

0.22

0.0

4.1

—

2.78

—

Fall involving playground equipment

188

0.84

0.22

4.6

8.4

2.67

2.93

g/l

0.60

183

Retained (old) foreign body following penetrating wound of orbit

0.00

0.22

0.0

2.0

—

3.36

—

Drug-induced tics and other tics of organic origin

0.00

0.22

0.0

3.9

—

2.96

—

Exposure to smoke, fire and flames

286

1.12

0.22

2.4

3.4

3.57

3.59

g/l

0.03

273

Defect, injury or illness of skull

0.00

0.22

0.0

1.6

—

3.95

—

Retained (old) intraocular foreign body

0.00

0.22

0.0

1.6

—

3.63

—

Indeterminate sex and pseudohermaphroditism

0.00

0.22

0.0

3.2

—

3.45

—

Iodine-deficiency-related thyroid disorders and allied conditions

0.00

0.22

0.0

1.5

—

3.30

—

Hydroxyapatite deposition disease

0.00

0.22

0.0

3.9

—

3.70

—

Localized hypertrichosis

0.00

0.22

0.0

2.0

—

4.09

—

Degeneration of iris and ciliary body

0.00

0.22

0.0

1.4

—

3.43

—

Interstitial myositis

0.00

0.22

0.0

3.7

—

3.55

—

Follicular keratosis (Darier-White)

0.00

0.21

0.0

3.7

—

3.09

—

Bacterial meningoencephalitis and meningomyelitis

0.00

0.21

0.0

1.5

—

3.48

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

340

1810

1.03

0.21

2.4

2.8

3.55

3.59

g/l

0.18

312

1733

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

0.21

0.0

2.8

—

3.19

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.21

0.0

1.5

—

3.22

—

Systemic atrophies primarily affecting the central nervous system

440

0.91

0.21

3.7

3.3

3.25

3.56

g/l

0.65

419

FESS (DNB20)

168

1609

1.05

0.21

2.3

2.5

3.65

3.57

g/l

0.29

157

1537

Other disorders of bone development and growth

0.00

0.21

0.0

7.3

—

3.52

—

Defect, injury or illness of chest

0.00

0.21

0.0

2.5

—

3.83

—

Follicular keratosis (Darier-White), including avohilmo

0.00

0.21

0.0

3.2

—

3.38

—

Fusion of the labia

0.00

0.20

0.0

5.1

—

3.20

—

Erythema annulare centrifugum

0.00

0.20

0.0

1.9

—

3.93

—

Hallux rigidus

173

1660

1.04

0.20

2.0

2.3

3.66

3.58

g/l

0.27

165

1589

Melanoma in situ of trunk

174

1.15

0.20

2.7

2.3

3.34

3.63

g/l

0.38

167

Congenital deformities of hip

288

1.11

0.19

5.4

5.6

2.69

3.06

g/l

1.16

280

Injury of nerves at wrist and hand level

466

0.92

0.18

4.1

2.9

3.66

g/l

0.00

448

Torticollis

195

1.13

0.17

4.8

3.0

3.38

3.66

g/l

0.31

186

Motor neuron disease ALS

173

0.86

0.17

3.0

2.3

3.62

3.67

g/l

0.04

165

Dislocation, sprain and strain of joints and ligaments of elbow

875

1.05

0.17

3.4

3.7

3.50

3.43

g/l

0.18

834

Impingement syndrome of shoulder

311

3190

0.97

0.16

2.4

3.63

3.61

g/l

0.09

302

3067

Other specified/unspecified deforming dorsopathies

177

1.13

0.16

2.6

2.3

3.80

3.71

g/l

0.08

169

Primary gonarthrosis, bilateral

778

6410

1.02

0.16

1.9

2.4

3.75

3.61

g/l

1.62

747

6151

Hyperplasia of prostate

562

3105

1.02

0.16

2.6

2.7

3.54

3.69

g/l

1.45

536

3002

Injury of muscle and tendon at wrist and hand level

176

1819

0.97

0.15

2.9

2.8

3.57

3.56

g/l

0.03

170

1745

Early lumbar disc prolapse operation

135

1400

0.96

0.15

2.1

2.8

3.67

3.52

g/l

0.62

127

1329

Contact with machinery

138

1430

0.96

0.14

2.8

3.19

3.61

g/l

3.25

131

1372

Stenosis and insufficiency of lacrimal passages

112

1077

1.04

0.14

2.0

2.6

3.58

3.62

g/l

0.11

107

1022

Crystalline deposits in vitreous body

0.81

0.14

1.6

2.6

3.56

3.67

g/l

—

Graves disease, strict definition

132

1277

1.03

0.13

2.8

2.5

3.52

3.60

g/l

0.25

126

1218

Unspecified mental disorder

630

6212

1.01

0.12

2.4

2.7

3.71

3.59

g/l

1.31

601

5940

Foreign body entering into or through eye or natural orifice

110

1062

1.04

0.12

3.0

3.2

3.58

3.49

g/l

0.28

102

1019

Blepharochalasis

381

3744

1.02

0.12

2.0

2.4

3.54

3.64

g/l

0.64

363

3582

Parkinson's disease, excluding more controls

151

1349

1.03

0.12

2.0

2.3

3.59

3.68

g/l

0.30

142

1298

Mandibular prognathia

231

1.09

0.10

2.6

4.9

3.06

3.24

g/l

0.37

223

Other spirochaetal diseases, including avohilmo

509

5022

1.01

0.10

2.2

2.6

3.51

3.59

g/l

0.65

480

4804

Ankylosing hyperostosis [Forestier]

144

1.11

0.10

2.3

2.4

3.42

3.83

g/l

0.55

136

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

1.13

0.10

5.2

11.2

3.50

2.57

g/l

—

Wide developmental disorders, excluding more controls

493

1.05

0.10

2.4

4.5

3.42

3.11

g/l

1.01

475

Generalized pustular psoriasis

1.14

0.10

3.6

5.4

3.72

3.60

g/l

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

1.09

0.10

1.2

7.7

4.24

3.05

g/l

—

Contact with sharp object, undetermined intent

311

1.06

0.09

3.8

3.0

3.74

3.62

g/l

0.13

300

Abrasion of teeth

543

5372

1.01

0.08

2.4

2.6

3.50

3.61

g/l

1.06

512

5135

Anorexia

166

1.09

0.08

7.8

3.0

3.98

3.46

g/l

0.87

160

Ménière disease

105

1024

1.03

0.07

2.3

2.4

3.66

3.62

g/l

0.10

100

971

Primary open-angle glaucoma, strict

318

3213

0.99

0.07

2.1

2.2

3.60

3.65

g/l

0.27

305

3060

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

153

0.91

0.07

2.3

6.2

2.71

3.17

g/l

0.86

147

Acute and transient psychotic disorders

148

1452

1.02

0.07

1.9

2.7

3.51

3.59

g/l

0.25

137

1388

Lateral epicondylitis

160

1629

0.98

0.07

2.3

2.5

3.49

3.61

g/l

0.48

154

1558

Burn and corrosion of trunk

374

1.04

0.06

2.9

3.30

3.55

g/l

0.48

357

Certain zoonotic bacterial diseases, including avohilmo

325

0.95

0.06

4.8

2.6

3.50

3.58

g/l

0.13

311

Inflammatory disease of cervix uteri

602

1.03

0.06

1.5

2.3

3.88

3.62

g/l

0.58

577

Labour and delivery complicated by umbilical cord complications

523

1.03

0.06

2.0

2.6

3.59

3.62

g/l

0.08

500

Schizophrenia or delusion

461

4572

1.01

0.05

2.3

2.7

3.68

3.57

g/l

0.77

437

4365

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

524

1.03

0.05

2.6

3.46

3.58

g/l

0.25

501

Spinal enthesopathy

181

0.94

0.05

1.9

1.8

3.84

3.68

g/l

0.17

171

Psoriasis (vulgaris), strict definition

416

1.03

0.05

3.2

2.6

3.30

3.63

g/l

0.72

400

Other contact dermatitis

101

992

1.02

0.04

2.8

2.6

3.73

3.59

g/l

0.39

946

Feeding problems of newborn

140

1.08

0.04

2.2

8.4

3.32

2.81

g/l

0.36

134

Vestibular neuronitis

107

1052

1.02

0.04

2.7

2.4

3.37

3.59

g/l

0.99

101

1001

Spirochaetal infections, other/unspecified, including avohilmo

497

4939

1.01

0.04

2.1

2.6

3.51

3.59

g/l

0.62

468

4726

Other spirochaetal diseases

498

4952

1.01

0.04

2.2

2.6

3.51

3.59

g/l

0.65

469

4737

Sequelae of tuberculosis

131

1.07

0.03

4.8

2.0

3.01

3.67

g/l

1.49

122

Use of cabergoline

161

1.06

0.03

1.9

2.3

3.97

3.58

g/l

0.61

156

Early lumbar disc prolapse, operated

131

1296

1.01

0.03

2.1

2.7

3.67

3.58

g/l

0.31

123

1226

Autism

380

1.03

0.02

2.6

5.6

3.48

3.19

g/l

0.85

368

Deep bite that required surgery

132

1.06

0.02

1.5

2.4

3.86

3.55

g/l

0.25

127

Adhesive middle ear disease

172

1.05

0.02

1.8

3.0

4.68

3.64

g/l

1.31

166

Motor neuron disease (with DMD)

188

0.96

0.02

2.9

2.6

3.56

3.65

g/l

0.08

180

Effects of foreign body entering through natural orifice

366

3645

1.00

0.02

2.8

3.2

3.50

3.53

g/l

0.15

338

3495

Occlusion and stenosis of arteries, not leading to stroke

1.08

0.02

1.4

2.1

4.35

3.68

g/l

—

Benign neoplasm of thyroid gland

332

1.02

0.01

2.4

2.1

3.70

3.63

g/l

0.10

322

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

171

1699

1.01

0.01

2.1

2.5

3.57

3.58

g/l

0.00

164

1618

Sequelae of tuberculosis, including avohilmo

133

1.05

0.01

4.8

2.0

3.01

3.67

g/l

1.51

124

Gonarthrosis, primary, with knee surgery

867

6758

1.00

0.01

1.9

2.4

3.74

3.62

g/l

1.46

830

6485

Schizophrenia, schizotypal and delusional disorders

459

4578

1.00

0.01

2.4

2.7

3.67

3.57

g/l

0.71

435

4370

Benign neoplasm: Lip

206

0.97

0.00

2.3

3.48

3.56

g/l

0.14

200

Lyme disease

490

4899

1.00

0.00

2.2

2.6

3.52

3.59

g/l

0.53

461

4689

Lyme disease, including avohilmo

490

4899

1.00

0.00

2.2

2.6

3.52

3.59

g/l

0.53

461

4689

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

135

1.04

0.00

1.6

2.1

3.18

3.60

g/l

0.64

126

Spermatocele

941

1.00

0.00

2.1

2.7

3.35

3.68

g/l

1.39

906

Alcohol abuse counselling and surveillance

194

0.98

0.00

3.1

2.6

3.56

3.63

g/l

0.07

189

Chondropathies

207

2068

1.00

0.00

3.3

2.9

3.48

3.55

g/l

0.27

201

1979

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

449

1.00

0.00

2.1

3.6

3.18

3.55

g/l

1.80

431

Lesion of sciatic nerve

413

0.99

0.00

1.7

2.3

3.82

3.57

g/l

0.61

392

Pityriasis alba

0.00

0.0

1.7

—

3.84

—

Other early complications of trauma

0.00

0.0

2.6

—

3.41

—

Osteolysis

0.00

0.0

2.4

—

3.29

—

Hanging, strangulation and suffocation, undetermined intent

0.00

0.0

1.4

—

2.88

—

Coccidioidomycosis

0.00

0.0

1.1

—

4.22

—

Miliaria rubra

0.00

0.0

1.6

—

4.36

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

0.0

3.8

—

3.13

—

Brain medulloblastoma, helper endpoint

0.00

0.0

8.0

—

3.20

—

Fracture of upper limb, level unspecified

0.00

0.0

1.8

—

2.58

—

Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons

0.00

0.0

3.6

—

3.38

—

Dietary zinc deficiency

0.00

-0.00

0.0

3.0

—

3.44

—

Induced delusional disorder

0.00

-0.00

0.0

2.0

—

3.10

—

Trachoma, including avohilmo

0.00

-0.00

0.0

1.4

—

3.84

—

Crushing injury of thorax and traumatic amputation of part of thorax

0.00

-0.00

0.0

2.2

—

3.24

—

Toxic effect of metals

0.00

-0.00

0.0

1.6

—

3.15

—

Other chorioretinal disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

3.43

—

Choroidal degeneration

0.00

-0.00

0.0

3.3

—

4.20

—

Unspecified visual impairment

0.00

-0.00

0.0

6.0

—

2.90

—

Use of benzatropine

0.00

-0.00

0.0

1.0

—

3.32

—

Coccidioidomycosis, including avohilmo

0.00

-0.00

0.0

1.1

—

4.22

—

Plasmodium vivax malaria, including avohilmo

0.00

-0.00

0.0

2.4

—

4.04

—

Unspecified pneumoconiosis

0.00

-0.00

0.0

2.2

—

2.70

—

Erysipeloid

0.00

-0.00

0.0

1.7

—

3.82

—

Plasmodium vivax malaria

0.00

-0.00

0.0

2.4

—

4.04

—

Transitory neonatal disorders of calcium and magnesium metabolism

0.00

-0.00

0.0

18.0

—

2.67

—

Brucellosis, including avohilmo

0.00

-0.00

0.0

1.9

—

3.34

—

Brucellosis

0.00

-0.00

0.0

1.4

—

3.52

—

Dysplastic lesion of the vagina of unknown severity

0.00

-0.00

0.0

1.6

—

2.88

—

Plague, including avohilmo, including avohilmo

0.00

-0.00

0.0

2.9

—

2.90

—

Other specified diseases of spinal cord, drug-induced

0.00

-0.00

0.0

1.6

—

4.94

—

Drowning and submersion, undetermined intent

0.00

-0.00

0.0

2.5

—

3.22

—

Wrist or foot drop (acquired)

0.00

-0.00

0.0

3.8

—

2.92

—

Glanders and melioidosis

0.00

-0.00

0.0

3.8

—

4.62

—

Glanders and melioidosis, including avohilmo

0.00

-0.00

0.0

3.8

—

4.62

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

-0.00

0.0

7.5

—

3.38

—

Vascular dementia (multiple infarctions)

0.97

-0.00

2.4

2.0

3.83

3.57

g/l

—

Lichen ruber moniliformis

0.00

-0.00

0.0

4.4

—

2.80

—

Plague

0.00

-0.00

0.0

3.2

—

3.22

—

Soft tissue disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.5

—

3.44

—

Other gangliosidosis

0.00

-0.00

0.0

1.8

—

3.28

—

Vibratory urticaria

0.00

-0.00

0.0

2.5

—

3.67

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

-0.00

0.0

1.5

—

3.95

—

Pseudohypoparathyroidism

0.00

-0.00

0.0

8.0

—

2.81

—

Brain medulloblastoma

0.00

-0.00

0.0

1.2

—

3.26

—

Brain medulloblastoma, including Hilmo

0.00

-0.00

0.0

1.2

—

3.26

—

Huntington disease

0.00

-0.00

0.0

2.4

—

3.15

—

Drowning and submersion in swimming-pool or bath

0.00

-0.00

0.0

1.4

—

4.86

—

Melanoma in situ of eyelid, including canthus

0.00

-0.00

0.0

3.6

—

3.46

—

Neuropathy in association with hereditary ataxia

0.00

-0.00

0.0

2.0

—

2.92

—

Carcinoma in situ, other and unspecified urinary organs

0.00

-0.00

0.0

1.9

—

3.41

—

Bladder disorders in in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

3.46

—

Arthropathy in neoplastic disease

0.00

-0.00

0.0

1.4

—

3.30

—

Disorders of sulfur-bearing amino-acid metabolism

0.00

-0.00

0.0

1.0

—

3.20

—

Accidental poisoning by and exposure to other gases and vapours

0.91

-0.00

5.4

2.0

3.90

3.83

g/l

—

Granuloma faciale [eosinophilic granuloma of skin]

0.00

-0.00

0.0

1.2

—

3.52

—

Exposure to vibration

0.00

-0.00

0.0

2.8

—

3.13

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS